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A B S T R A C T
Background
Cardiotocography (CTG) records changes in the fetal heart rate and their temporal relationship to uterine contractions. The aim is to
identify babies who may be short of oxygen (hypoxic) to guide additional assessments of fetal wellbeing, or determine if the baby needs
to be delivered by caesarean section or instrumental vaginal birth. This is an update of a review previously published in 2013, 2006
and 2001.
Objectives
To evaluate the effectiveness and safety of continuous cardiotocography when used as a method to monitor fetal wellbeing during
labour.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group Trials Register (30 November 2016) and reference lists of retrieved studies.
Selection criteria
Randomised and quasi-randomised controlled trials involving a comparison of continuous cardiotocography (with and without fetal
blood sampling) with no fetal monitoring, intermittent auscultation intermittent cardiotocography.
Data collection and analysis
Two review authors independently assessed study eligibility, quality and extracted data from included studies. Data were checked for
accuracy.
Main results
We included 13 trials involving over 37,000 women. No new studies were included in this update.
One trial (4044 women) compared continuous CTG with intermittent CTG, all other trials compared continuous CTG with inter-
mittent auscultation. No data were found comparing no fetal monitoring with continuous CTG. Overall, methodological quality was
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mixed. All included studies were at high risk of performance bias, unclear or high risk of detection bias, and unclear risk of reporting
bias. Only two trials were assessed at high methodological quality.
Compared with intermittent auscultation, continuous cardiotocography showed no significant improvement in overall perinatal death
rate (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.59 to 1.23, N = 33,513, 11 trials, low quality evidence), but was associated
with halving neonatal seizure rates (RR 0.50, 95% CI 0.31 to 0.80, N = 32,386, 9 trials, moderate quality evidence). There was no
difference in cerebral palsy rates (RR 1.75, 95% CI 0.84 to 3.63, N = 13,252, 2 trials, low quality evidence). There was an increase
in caesarean sections associated with continuous CTG (RR 1.63, 95% CI 1.29 to 2.07, N = 18,861, 11 trials, low quality evidence).
Women were also more likely to have instrumental vaginal births (RR 1.15, 95% CI 1.01 to 1.33, N = 18,615, 10 trials, low quality
evidence). There was no difference in the incidence of cord blood acidosis (RR 0.92, 95% CI 0.27 to 3.11, N = 2494, 2 trials, very low
quality evidence) or use of any pharmacological analgesia (RR 0.98, 95% CI 0.88 to 1.09, N = 1677, 3 trials, low quality evidence).
Compared with intermittent CTG, continuous CTG made no difference to caesarean section rates (RR 1.29, 95% CI 0.84 to 1.97,
N = 4044, 1 trial) or instrumental births (RR 1.16, 95% CI 0.92 to 1.46, N = 4044, 1 trial). Less cord blood acidosis was observed in
women who had intermittent CTG, however, this result could have been due to chance (RR 1.43, 95% CI 0.95 to 2.14, N = 4044, 1
trial).
Data for low risk, high risk, preterm pregnancy and high-quality trials subgroups were consistent with overall results. Access to fetal
blood sampling did not appear to influence differences in neonatal seizures or other outcomes.
Evidence was assessed using GRADE. Most outcomes were graded as low quality evidence (rates of perinatal death, cerebral palsy,
caesarean section, instrumental vaginal births, and any pharmacological analgesia), and downgraded for limitations in design, incon-
sistency and imprecision of results. The remaining outcomes were downgraded to moderate quality (neonatal seizures) and very low
quality (cord blood acidosis) due to similar concerns over limitations in design, inconsistency and imprecision.
Authors’ conclusions
CTG during labour is associated with reduced rates of neonatal seizures, but no clear differences in cerebral palsy, infant mortality or
other standard measures of neonatal wellbeing. However, continuous CTG was associated with an increase in caesarean sections and
instrumental vaginal births. The challenge is how best to convey these results to women to enable them to make an informed decision
without compromising the normality of labour.
The question remains as to whether future randomised trials should measure efficacy (the intrinsic value of continuous CTG in trying
to prevent adverse neonatal outcomes under optimal clinical conditions) or effectiveness (the effect of this technique in routine clinical
practice).
Alongwith the need for further investigations into long-term effects of operative births forwomen andbabies,much remains to be learned
about the causation and possible links between antenatal or intrapartum events, neonatal seizures and long-term neurodevelopmental
outcomes, whilst considering changes in clinical practice over the intervening years (one-to-one-support during labour, caesarean section
rates). The large number of babies randomised to the trials in this review have now reached adulthood and could potentially provide a
unique opportunity to clarify if a reduction in neonatal seizures is something inconsequential that should not greatly influence women’s
and clinicians’ choices, or if seizure reduction leads to long-term benefits for babies. Defining meaningful neurological and behavioural
outcomes that could be measured in large cohorts of young adults poses huge challenges. However, it is important to collect data from
these women and babies while medical records still exist, where possible describe women’s mobility and positions during labour and
birth, and clarify if these might impact on outcomes. Research should also address the possible contribution of the supine position to
adverse outcomes for babies, and assess whether the use of mobility and positions can further reduce the low incidence of neonatal
seizures and improve psychological outcomes for women.
P L A I N L A N G U A G E S U M M A R Y
Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
What is the issue?
Is continuous cardiotocography (CTG) to electronically monitor babies’ heartbeats and wellbeing during labour better at identifying
problems than listening intermittently?
Why is this important?
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Monitoring babies’ heartbeats is used to check wellbeing during labour. Listening and recording the baby’s heartbeat aims to identify
babies who are becoming short of oxygen and may benefit from an early delivery by caesarean section or instrumental vaginal birth.
A baby’s heartbeat can be monitored intermittently using a special trumpet-shaped device, or hand-held Doppler device. The heartbeat
can also be checked continuously using a CTG machine. Continuous CTG produces a paper recording of the baby’s heart rate and the
mother’s labour contractions. Although continuous CTG provides a written record, mothers cannot move freely during labour, change
positions easily, or use a birthing pool to help with comfort and control during labour. It also means that some resources tend to be
focused on the need to constantly interpret the CTG and not on the needs of a woman in labour.
What evidence did we find?
We searched for evidence on 30 November 2016, but found no new studies for this update. We included 12 trials that compared
continuous CTG monitoring with intermittent listening, and one trial compared continuous CTG with intermittent CTG. Together,
the trials involved over 37,000 women. No trial compared continuous CTG with no monitoring. Most studies were undertaken before
1994, and apart from two, were not high quality. The review was dominated by one large, well-conducted trial from 1985 which
involved almost 13,000 women who received one-to-one care throughout labour. The mothers’ membranes were ruptured artificially
as early as possible and about a quarter received oxytocin to stimulate contractions.
Overall, there was no difference in numbers of babies who died during or shortly after labour (about one in 300) (low quality evidence).
Fits in babies were rare (about one in 500 births) (moderate quality evidence), but occurred less often when continuous CTG was used
to monitor the baby’s heart rate. There was no difference in the rate of cerebral palsy (low quality evidence); however, other possible
long-term effects have not been fully assessed and need further study. Continuous monitoring was associated with significantly more
deliveries by caesarean section (low quality evidence) and instrumental vaginal births (low quality evidence). Although both procedures
carry risks for mothers, these were not assessed in the included studies.
There was no difference in numbers of cord blood acidosis (very low quality evidence), or women using any drugs for pain relief (low
quality evidence) between groups.
Compared with intermittent CTG, continuous CTG made no difference to how many women had caesarean sections or instrumental
births. There was less cord blood acidosis in women who had intermittent CTG but this result could have been due to chance.
What does this mean?
Most studies were undertaken many years ago and showed benefits and problems with both methods of monitoring the baby’s wellbeing
in labour. Continuous CTG was associated with fewer fits for babies although there was no difference in cerebral palsy; both were rare
events. However, continuous CTG was also associated with increased numbers of caesarean sections and instrumental births, both of
which carry risks for mothers. Continuous CTG also makes moving and changing positions difficult in labour and women are unable
to use a birthing pool. This can impact on women’s coping strategies. Women and their doctors need to discuss the woman’s individual
needs and wishes about monitoring the baby’s wellbeing in labour.
Future research should focus on events that happen in pregnancy and labour that could be the cause of long term problems for the
baby.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Continuous CTG versus intermittent auscultation for fetal assessment during labour
Patient or population: Pregnant women undergoing fetal assessment during labour
Settings: Australia, Denmark, Greece, Ireland, Pakistan, United Kingdom and United States
Intervention: Continuous CTG versus interm it tent auscultat ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control ContinuousCTGversus
intermittent ausculta-
tion
Perinatal mortality Study population RR 0.86
(0.59 to 1.24)
33,513
(11 studies)
⊕⊕©©
low1,2
3 per 1000 3 per 1000
(2 to 4)
Moderate
4 per 1000 3 per 1000
(2 to 5)
Neonatal seizures Study population RR 0.5
(0.31 to 0.8)
32,386
(9 studies)
⊕⊕⊕©
moderate1
3 per 1000 1 per 1000
(1 to 2)
Moderate
4 per 1000 2 per 1000
(1 to 3)
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Cerebral palsy Study population RR 1.75
(0.84 to 3.63)
13,252
(2 studies)
⊕⊕©©
low1,2
3 per 1000 4 per 1000
(2 to 9)
Moderate
39 per 1000 68 per 1000
(33 to 142)
Caesarean section Study population RR 1.63
(1.29 to 2.07)
18,861
(11 studies)
⊕⊕©©
low1,3
36 per 1000 59 per 1000
(47 to 75)
Moderate
66 per 1000 108 per 1000
(85 to 137)
Instrumental vaginal
birth
Study population RR 1.15
(1.01 to 1.33)
18,615
(10 studies)
⊕⊕©©
low1,3
102 per 1000 118 per 1000
(103 to 136)
Moderate
222 per 1000 255 per 1000
(224 to 295)
Cord blood acidosis Study population RR 0.92
(0.27 to 3.11)
2494
(2 studies)
⊕©©©
very low2,4,5
24 per 1000 22 per 1000
(6 to 74)
Moderate
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24 per 1000 22 per 1000
(6 to 75)
Any pharmacological
analgesia
Study population RR 0.98
(0.88 to 1.09)
1677
(3 studies)
⊕⊕©©
low1,6
754 per 1000 739 per 1000
(663 to 822)
Moderate
805 per 1000 789 per 1000
(708 to 877)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: Conf idence interval; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Lim itat ions in design: Most studies contribut ing data had design lim itat ions (< 40%weight).
2 Wide conf idence interval crossing the line of no ef fect.
3 Stat ist ical heterogeneity (I² = 60%)
4 Lim itat ions in design: One study with serious design lim itat ions contribut ing 56.4%weight.
5 Stat ist ical heterogeneity (I² = 77%)
6 Stat ist ical heterogeneity (I² = 72%)
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B A C K G R O U N D
The baby’s heart beat was first thought to be heard in utero in the
middle of the seventeenth or eighteenth century (Grant 1989a;
Gibb 1992), but it was not until the early nineteenth century
that de Kergeradee suggested that listening to the baby’s heartbeat
might be clinically useful (Grant 1989a). De Kergeradee proposed
that listening to the baby’s heartbeat could be used to diagnose
fetal life and multiple pregnancies, and wondered if it would be
possible to assess fetal compromise from variations in the fetal
heart rate (FHR). Since then, various methods of listening to the
fetal heart have been developed and introduced into maternity
care (Table 1), eachwith the aim of improving outcomes for babies
and reducing the heartache for mothers and families when a baby
dies or sustains long-term disability. Today, monitoring the fetal
heart during labour, by one method or another, appears to have
become a routine part of care during labour, although access to
such care varies across the world.
Description of the condition
The incidence of neonatal morbidity and mortality varies around
the world, although direct comparisons may be difficult because
of varying definitions and classifications. Nevertheless, large dif-
ferences are reported between high-income countries with aver-
age neonatal mortality rates (NMR) of four per 1000 live births)
and low- or middle-income countries with average NMRs of 33
per 1000 births) (Lawn 2005). Although most perinatal morbid-
ity and mortality may not be prevented by improved fetal mon-
itoring in labour (Nelson 1996), failure in identifying abnormal
FHR patterns and lack of appropriate actions are considered to be
significant contributing factors (MCHRC 1997; MCHRC 1998;
MCHRC 1999).
Description of the intervention
The baby’s heart rate can be monitored either intermittently (at
regular intervals during labour) or continuously (recording the
baby’s heart rate throughout labour, stopping only briefly, such as
for visits to the toilet) as follows.
Fetal stethoscope (Pinard) and hand-held Doppler
Intermittent monitoring can be undertaken either by listening to
the baby’s heart rate using a fetal stethoscope (Pinard), or with
a hand-held Doppler ultrasound device, and by palpating the
mother’s uterine contractions by hand. This is known as intermit-
tent auscultation.
Cardiotocograph (CTG)
The baby’s heart rate and the mother’s uterine contractions can
be recorded electronically on a paper trace known as a cardiotoco-
graph. This is done using a Doppler ultrasound transducer to
monitor the baby’s heart rate and a pressure transducer to mon-
itor uterine contractions, both of which are linked to a record-
ing device. This is known as external cardiotocography (external
CTG) and is usually undertaken continuously in labour, although
it is sometimes used intermittently (intermittent CTG). In most
units, external CTG requires the mother to wear a belt across her
abdomen during monitoring, which restricts her mobility. An al-
ternative means of monitoring the baby’s heart rate with the CTG
machine is to attach an electrode directly to the baby’s present-
ing part, usually the head. This form of continuous monitoring
is known as internal CTG and requires a ruptured amniotic sac
(either spontaneously or artificially) and a scalp electrode (clip) at-
tached to the baby’s head. This also restricts the woman’s mobility.
The term electronic fetal monitoring (EFM) is sometimes used
synonymously withCTGmonitoring, but is considered to be a less
precise term because CTG monitoring also includes monitoring
the mother’s contractions, and other forms of fetal monitoring
might also be classed as ’electronic’, such as fetal electrocardiograph
or fetal pulse oximetry.
Intermittent auscultation was the predominant method of mon-
itoring during labour until CTGs became widely used in the lat-
ter part of the twentieth century (Enkin 2000). Although there
is a lack of empirical evidence on the optimal frequency of in-
termittent auscultation, there is a consensus in clinical guidelines
that the fetal heart should be auscultated at least every 15 minutes
in the first stage of labour and at least every five minutes in the
second stage of labour (ACOG 2009; Liston 2007; NICE 2014;
RANZCOG 2014) with each auscultation lasting at least 60 sec-
onds (Liston 2007; NICE 2014). It appears that these auscultation
protocols were developed initially in the context of clinical trials
and were based on common sense rather than research evidence.
Compliance with these guidelines, whilst maintaining contempo-
raneous records, poses a significant challenge for caregivers during
labour who usually have multiple tasks to fulfil simultaneously.
Information and interpretation
Both intermittent auscultation and CTG provide information on
the baseline heart rate (usually between 110 and 160 beats per
minute in the term fetus), accelerations (transient increases in the
FHR) and decelerations (transient decreases in the FHR). Some
aspects of labour cause natural alterations in FHR patterns. For
example, the baby’s sleep FHR pattern differs from the waking
FHR pattern. External stimuli, such as uterine contractions and
the mother moving, can cause FHR changes, as can administra-
tion of opiates to the mother. Some of these changes are subtle
and can only be detected by continuous CTG, such as baseline
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variability and temporal shape of decelerations. Consideration is
needed about whether such information improves detection and
outcomes for babies who are truly compromised and if there are
technology-related disadvantages for those who are not compro-
mised.
Sensitivity and specificity
While specific abnormalities of the FHR pattern on CTG are
proposed as being associated with an increased risk of cerebral
palsy (Nelson 1996), CTG specificity to predict cerebral palsy is
low, with a reported false positive rate as high as 99.8%, even in
the presence of multiple late decelerations or decreased variability
(Nelson 1996).
FHRpattern recognition, including the relationship between uter-
ine contractions and FHR decelerations, are fundamental to the
use of continuous CTG monitoring. Algorithms have been de-
veloped to assess and record what is normal, what requires more
careful attention, and what is considered abnormal requiring im-
mediate delivery of the baby (NICE 2014). However, CTG traces
are often interpreted differently by different caregivers (inter-ob-
server variation) and even by the same caregiver interpreting the
same record at different times (intra-observer variation) (Devane
2005). Such variation in interpretation of CTG tracings may re-
sult in inappropriate interventions, or false reassurance and lack of
appropriate intervention. Although we were unable to find stud-
ies that sought to investigate inter- and intra-observer variation
in intermittent auscultation, it would seem reasonable to suggest
that intermittent auscultation is not immune to similar problems
caused by inter- and intra-observer variation. However, given that
the FHR parameter of interest in intermittent auscultation is the
baseline FHR, it is likely that inter- and intra-observer variation is
less in intermittent auscultation than that found in CTG interpre-
tation where other aspects of FHR patterns including variability
and assessment and deceleration classification require interpreta-
tion.
Additional tests
Fetal blood sampling is a procedure where a small amount of blood
is taken from the baby, usually from the scalp. Performing fetal
blood sampling andmeasuring the parameters of acid-base balance
(pH, base excess/deficit, etc) seeks to identify those babies who
are truly compromised and need to be born immediately. It is
important to establish the value of this test as an adjunct to CTG.
This question was addressed in a subgroup analysis in this review.
Other methods have been considered as additional tests, but there
is little evidence to support their use, for example, vibroacoustic
stimulation (East 2013). Several othermethods of fetalmonitoring
have been proposed, either as an adjunct or an alternative to CTG,
such as pulse oximetry (Carbonne 1997; East 2007), near-infrared
spectroscopy (Mozurkewich 2000), fetal ECG (Neilson 2015),
ST segment analysis of the fetal ECG (Luttkus 2004). and fetal
stimulation tests (Skupski 2002).
Possible advantages of CTG
• More measurable parameters related to FHR patterns.
• The CTG trace gives a continuous recording of the FHR
and uterine activity. This is a physical record, which can be
examined at any time in labour, or subsequently, if required. The
examples where physical records may be useful include clinical
audits, counselling parents if there has been as adverse outcome,
and medico-legal situations.
Possible disadvantages of CTG
• The complexity of FHR patterns makes standardisation
difficult.
• CTG prevents mobility and restricts the use of massage,
different positions, or immersion in water used to improve
comfort, control and coping strategies during labour.
• Shifting staff focus and resources away from the mother
may encourage a belief that all perinatal mortality and
neurological injury can be prevented.
Specific situations that may influence the
effectiveness or otherwise of CTG
1. Continuous CTG is generally recommended for women
who are regarded as being at increased risk of perinatal morbidity
and mortality (Liston 2007; NICE 2014; RANZCOG 2014).
This review addressed the issue of differential effects of CTG in
terms of risk status.
2. Induction of labour is primarily performed where it is
anticipated that outcomes for mothers and infants would be
improved were labour induced. Given that induction of labour
includes iatrogenic stimulation of uterine activity, which puts the
baby at greater risk, we determined to perform a subgroup
analysis by induction of labour (NICE 2008).
3. Preterm birth is associated with an increased risk of
mortality and neurological morbidity, and these babies might
benefit from being monitored more intensively. Further, there is
debate about what is normal for the different parameters of the
CTG for preterm infants at varying gestational ages. Therefore,
we performed a preterm subgroup analysis.
4. Twin pregnancies carry a higher perinatal mortality rate
than singleton pregnancies (NICE 2011), thus we conducted a
subgroup analysis by twin pregnancy.
Women’s and professional views
Some studies looking at women’s preferences found that the sup-
port that women received from staff and labour companions was
more important to them than the type of monitoring used (Garcia
1985; Killien 1989). A more recent study of women’s views of
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routine continuous CTG in labour in the UK identified a lack
of discussion about the need for and appropriateness of CTG. In
addition, women felt that CTG limited their mobility and led to
an acceptance of the machine’s place as the focus of attention for
the woman and her partner (Munro 2004).
In a synthesis of 11 studies on professionals’ views of FHR mon-
itoring during labour, Smith 2012 identified that despite an ab-
sence of evidence, maternity care professionals perceived the CTG
as offering ’proof ’ of the compromised baby and that this min-
imises their exposure to criticism and potential litigation. Never-
theless, professionals also recognised that the CTG offered a false
sense of security.
How the intervention might work
Although monitoring FHR changes during labour, it is hoped to
identify those babies who may be compromised, or potentially
compromised, by a shortage of oxygen (fetal hypoxia). If the short-
age of oxygen is both prolonged and severe, babies are at risk of
being born with a disability (physical, mental or both), or death
during labour or shortly thereafter. When alterations in the FHR
during labour suggest that the baby is hypoxic, or at risk of hy-
poxia, additional methods of assessment of fetal wellbeing (e.g.
fetal blood sampling) may be used. Sometimes FHR alterations
trigger delivery by caesarean section or use of instruments, such as
forceps or vacuum extractor, even without recourse to additional
diagnostic tests.
Why it is important to do this review
Concerns have been raised about the efficacy and safety of routine
use of continuous CTG in labour (Thacker 1995). The apparent
contradiction between the widespread use of continuous CTG
with claims of its effectiveness in lowering early neonatal mortality
and morbidity (Chen 2011) and recommendations to limit its
routine use on all women (NICE 2014), indicates that a regular
reassessment of this practice is warranted.
Several Cochrane reviews have addressed othermethods for assess-
ing the condition of the fetus during labour including fetal elec-
trocardiogram/ECG (Neilson 2015); fetal pulse oximetry (East
2007); near-infrared spectroscopy (Mozurkewich 2000) and vi-
broacoustic stimulation (East 2013). Also, the comparison of car-
diotocography versus intermittent auscultation of fetal heart as
an admission test on arrival to labour ward is assessed elsewhere
(Devane 2017).
O B J E C T I V E S
To evaluate the effectiveness and safety of continuous cardiotocog-
raphy (CTG) when used as a method to monitor fetal wellbeing
during labour.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised trials and quasi-randomised studies comparing
continuous CTG during labour, with and without fetal blood
sampling, with no fetal monitoring, intermittent auscultation of
the fetal heart rate with a Pinard stethoscope or hand-heldDoppler
ultrasound device, or intermittent CTG. Sensitivity analysis was
undertaken for studies graded as low risk of bias based on sequence
generation and allocation concealment.
Types of participants
Pregnant women in labour and their babies.
Types of interventions
The main intervention of interest was continuous CTG during
labour.
For the purpose of this review, the intervention was defined as
an attempt to produce a continuous and simultaneous hard-copy
recording of the fetal heart rate and uterine contractions in real
time throughout the woman’s labour. As a guide, continuous CTG
should be discontinued only for short periods (for example, during
visits to the toilet) and theCTGshould be used for clinical decision
making during labour.
Control groups of interest included: no fetal monitoring, intermit-
tent auscultation of the fetal heart rate with a Pinard stethoscope
or hand-held Doppler ultrasound device, or intermittent CTG.
Types of outcome measures
Main outcomes
1. Perinatal mortality;
2. seizures in the neonatal period, either apparent clinically or
detected by electro-encephalographic recordings;
3. cerebral palsy;
4. caesarean section;
5. instrumental vaginal birth;
6. cord blood acidosis (low pH/low base excess as defined by
trialists; where reports included a range of pH values we used
cord pH < 7.10 as a cut off for acidosis); and
9Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
7. use of all forms of pharmacological analgesia during labour
and birth (including epidural but excluding anaesthesia for
caesarean section).
Other important outcomes
1. Hypoxic ischaemic encephalopathy (as defined by trialists);
2. neurodevelopmental disability assessed at 12 months of age
or more. Neurodevelopmental disability, defined as any one or
combination of the following: non-ambulant cerebral palsy,
developmental delay, auditory and visual impairment.
Development should have been assessed by means of a previously
validated tool, such as Bayley Scales of Infant Development
(Psychomotor Developmental Index and Mental Developmental
Index (Bayley 1993);
3. Apgar less than seven at five minutes;
4. Apgar less than four at five minutes;
5. admission to neonatal special care and/or intensive care
unit;
6. fetal blood sampling;
7. damage/infection to baby’s head from scalp electrode or
fetal blood sampling;
8. caesarean section for abnormal fetal heart rate pattern and
fetal acidosis or both;
9. instrumental vaginal birth for abnormal fetal heart rate
pattern and fetal acidosis or both;
10. spontaneous vaginal birth not achieved;
11. epidural analgesia;
12. use of non pharmacological methods of coping with labour,
e.g. transcutaneous electrical nerve stimulation, hydrotherapy;
13. amniotomy (artificial rupture of membranes);
14. oxytocin during labour;
15. perineal trauma requiring repair (including episiotomy);
16. inability to adopt preferred position during labour;
17. dissatisfaction with labour and perceived loss of control
during labour or both;
18. postpartum depression;
19. exclusively breastfeeding at discharge from hospital; and
20. length of stay in neonatal special care and intensive care
unit or both.
Search methods for identification of studies
The following section of this review was based on a standard tem-
plate used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (30 November 2016).
The Register is a database containing over 22,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full search
methods used to populate Pregnancy andChildbirth’s Trials Regis-
ter including the detailed search strategies for CENTRAL, MED-
LINE, Embase and CINAHL; the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
the current awareness service, please follow this link to the edi-
torial information about the Cochrane Pregnancy and Childbirth
in the Cochrane Library and select the ‘Specialized Register ’ sec-
tion from the options on the left side of the screen.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches
the Register for each review using this topic number rather than
keywords. This results in a more specific search set which has
been fully accounted for in the relevant review sections (Included
studies; Excluded studies; Studies awaiting classification).
[We carried out additional author searching in the Alfirevic 2006
version of this review. We subsequently chose not to repeat these
additional searches because they yielded no additional studies.]
Searching other resources
We searched the reference lists of retrieved studies. We did not
apply any language or date restrictions.
Data collection and analysis
For methods used in the previous version of this review, see
Alfirevic 2013.
For this update, there were no reports identified as a result of the
updated search. In future updates, the following methods will be
used for assessing the reports that are identified as a result of the
updated search.
The followingmethods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
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Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified as a result of the search strategy. We
resolved any disagreement through discussion or, if required, we
consulted a third review author.
Data extraction and management
We designed a form to extract data. For eligible studies, two re-
view authors extracted the data using the agreed form.We resolved
discrepancies through discussion or, if required, we consulted the
third review author. Data were entered into Review Manager soft-
ware (RevMan 2014) and checked for accuracy.
When information regarding any of the above was unclear, we
planned to contact authors of the original reports to provide fur-
ther details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in theCochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). Any disagreement
was resolved by discussion or by involving a third review author.
(1) Random sequence generation (checking for possible
selection bias)
We described the method used to generate the allocation sequence
in sufficient detail to allow an assessment of whether it should
produce comparable groups for each included study.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described the method used to conceal allocation to interven-
tions prior to assignment and assessed whether intervention allo-
cation could have been foreseen in advance of, or during recruit-
ment, or changed after assignment for each included study
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described the methods used, if any, to blind study participants
and personnel fromknowledge of which intervention a participant
received for each included study. We considered that studies were
at low risk of bias if they were blinded, or if we judged that the
lack of blinding unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
For each included study, and for each outcome or class of out-
comes, we described the completeness of data including attrition
and exclusions from the analysis. We stated whether attrition and
exclusions were reported and the numbers included in the analysis
at each stage (compared with the total randomised participants),
reasons for attrition or exclusion where reported, and whether
missing data were balanced across groups or related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we planned to re-include missing data in the
analyses.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We described how we investigated the possibility of selective out-
come reporting bias and what we found for each included study.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
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• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not
covered by points (1) to (5))
We described any important concerns we had about other possible
sources of bias for each included study.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria in the Handbook (Higgins
2011).With reference to points (1) to (6), we planned to assess the
likely magnitude and direction of the bias and if we considered it
was likely to impact on findings. In future updates, we will explore
the impact of the level of bias through undertaking sensitivity
analyses (see Sensitivity analysis).
Assessment of the quality of the evidence using the
GRADE approach
For this update, the quality of the evidence was assessed using
the GRADE approach as outlined in the GRADE handbook to
assess the quality of the body of evidence relating to the following
main outcomes for themain comparison (ContinuousCTGversus
intermittent auscultation for fetal assessment during labour).
1. Perinatal mortality;
2. seizures in the neonatal period, either apparent clinically or
detected by electro-encephalographic recordings;
3. cerebral palsy;
4. caesarean section;
5. instrumental vaginal birth;
6. cord blood acidosis (low pH/low base excess as defined by
trialists; where report included a range of pH values we have used
cord pH < 7.10 as a cut off for acidosis); and
7. use of all forms of pharmacological analgesia during labour
and birth (including epidural but excluding anaesthesia for
caesarean section).
GRADEproGuidelineDevelopmentTool was used to import data
from Review Manager 5.3 (RevMan 2014) to create a ’Summary
of findings’ table. A summary of the intervention effect and a
measure of quality for each of the outcomes was produced using
the GRADE approach. The GRADE approach uses five consid-
erations (study limitations, consistency of effect, imprecision, in-
directness and publication bias) to assess the quality of the body
of evidence for each outcome. The evidence can be downgraded
from high quality by one level for serious (or by two levels for very
serious) limitations, depending on assessments for risk of bias, in-
directness of evidence, serious inconsistency, imprecision of effect
estimates or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
We used the mean difference if outcomes were measured in the
same way between trials. We used the standardised mean differ-
ence to combine trials that measured the same outcome, but used
different methods.
Unit of analysis issues
Cluster-randomised trials
No cluster-randomised trials were identified for inclusion in this
review. In future updates, we will include cluster-randomised tri-
als in the analyses along with individually randomised trials. We
will adjust their sample sizes using the methods described in the
Handbook (Section 16.3.4) using an estimate of the intracluster
correlation co-efficient (ICC) derived from the trial (if possible),
from a similar trial or from a study of a similar population. If we
use ICCs from other sources, we will report this and conduct sen-
sitivity analyses to investigate the effect of variation in the ICC. If
we identify both cluster-randomised trials and individually-ran-
domised trials, we plan to synthesise the relevant information.
We will consider it reasonable to combine the results from both
if there is little heterogeneity between the study designs and the
interaction between the effect of intervention and the choice of
randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
Cross-over trials
Cross-over trials are not a suitable trial design for this type of
intervention.
Other unit of analysis issues
Multiple pregnancies
Outcomes for babies from the same pregnancy (twins or higher
multiples) are not independent. For some outcomes (e.g. preterm
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birth) outcomes for babies from the same pregnancy are likely to
be the same, or very highly correlated. For other outcomes there
would be a lower correlation (e.g. fetal death or infant anomaly).
We were unable to include any separate data for multiple pregnan-
cies in the analysis, so did not make any adjustments. In future
updates, to take account of the non-independence of outcomes
for babies from multiple pregnancies, we will treat each multiple
pregnancy as a cluster and analyse data using methods described
for cluster-randomised trials. We will seek ICCs for outcomes for
twins and higher multiples from trials (if available) from similar
trials or from observational studies. Where published ICCs are
not available, we will consult with experts in the field to estimate
ICCs, and conduct sensitivity analysis using a range of ICC values.
Trials with more than two arms
We included one trial (Denver 1979) which had three treatment
arms. For analysis of the main comparison and subgroups, we
pooled results of the treatment arms (continuous CTG with fetal
blood sampling (FBS), and continuous CTG without FBS) using
the methods set out in the Handbook (Higgins 2011) to avoid
double-counting. In the subgroup analysis 6 (access to fetal blood
sampling (FBS) during labour versus no access to FBS during
labour), we reported the two trial arms separately and divided the
control group in the analysis using the methods set out in the
Handbook ( Higgins 2011) to avoid double-counting.
Dealing with missing data
Levels of attrition were noted for included studies. In future up-
dates, if more eligible studies are included, the impact of including
studies with high levels of missing data on the overall assessment
of treatment effect will be explored in sensitivity analyses.
For all outcomes, analyses were carried out, as far as possible,
on an intention-to-treat basis. That is, we attempted to include
all participants randomised to each group in the analyses. The
denominator for each outcome in each trial was the number of
participants randomised minus any participants whose outcomes
were known to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in meta-analyses using the
Tau², I² and Chi² statistics. We regarded heterogeneity as substan-
tial if I² was greater than 30% and either Tau² was greater than
zero, or there was a low P value (< 0.10) in the Chi² test for het-
erogeneity. If we identified substantial heterogeneity (> 30%), we
planned to explore it by pre-specified subgroup analysis.
Assessment of reporting biases
Where there were 10 or more studies in the meta-analysis we in-
vestigated reporting biases (such as publication bias) using funnel
plots. We assessed funnel plot asymmetry visually. If asymmetry
was suggested by a visual assessment, we performed exploratory
analyses to investigate.
Data synthesis
We carried out statistical analysis using Review Manager software
(RevMan 2014).We used fixed-effectmeta-analysis for combining
datawhere it was reasonable to assume that studies were estimating
the same underlying treatment effect: that is, where trials were
examining the same intervention, and the trials’ populations and
methods were judged to be sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the
underlying treatment effects differed among trials, or if substan-
tial statistical heterogeneity was detected, we used random-effects
meta-analysis to produce an overall summary if an average treat-
ment effect across trials was considered clinically meaningful. The
random-effects summary was to be treated as the average range of
possible treatment effects and we planned to discuss the clinical
implications of treatment effects differing among trials. If the av-
erage treatment effect was not clinically meaningful, we did not
combine trials. If we used random-effects analyses, the results were
presented as the average treatment effect with 95% confidence in-
tervals, and the estimates of Tau² and I².
Subgroup analysis and investigation of heterogeneity
If we identified substantial heterogeneity, it was investigated us-
ing subgroup and sensitivity analyses. We considered whether an
overall summary was meaningful, and if it was, we used random-
effects analysis to produce the effect.
We carried out the following subgroup analyses:
1. high risk for perinatal mortality and morbidity (as defined
by trialists) versus low risk (absence of identifiable risk factors
associated with increased in perinatal mortality and morbidity as
defined by trialists);
2. spontaneous onset of labour versus induction of labour;
3. preterm (less than 37 + 0 weeks) versus term (> 37 + 0
weeks);
4. singleton pregnancy versus twin pregnancy;
5. access to fetal blood sampling (FBS) during labour versus
no access to FBS during labour;
6. primiparous versus multiparous.
Subgroup analysis was restricted to the review’s main outcomes.
We assessed subgroup differences by interaction tests available
within RevMan (RevMan 2014). We reported the results of sub-
group analyses quoting the Chi² statistic and P value, and the in-
teraction test I² value.
Sensitivity analysis
We carried out sensitivity analyses to explore the effect of trial
quality assessed by concealment of allocation, high attrition rates,
or both, with poor quality studies being excluded from the anal-
yses to assess if this made any difference to the overall result. We
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also explored the effect of high and unclear quality studies on the
analysis by performing interaction tests. This is documented in
Comparison 8 in Effects of interventions.
R E S U L T S
Description of studies
Results of the search
Our search strategy identified 383 citations corresponding to 17
studies for potential inclusion. Of those, 13 studies that involved a
total of 37,715 women were included (Athens 1993; Copenhagen
1985; Dallas 1986; Denver 1976; Denver 1979; Dublin 1985;
Lund 1994;Melbourne 1976;Melbourne 1981;NewDelhi 2006;
Pakistan 1989; Seattle 1987; Sheffield 1978) and four were ex-
cluded (Harare 1994; Ioannina 2001; Manchester 1982; North
America 2000). In the 2016 update, Greece 2012 was also ex-
cluded. The updated search in November 2016 did not retrieve
any further reports.
Included studies
Of the 13 included studies, two were quasi-RCTs (Copenhagen
1985; Dallas 1986), two used block randomisation (Dublin 1985;
Lund 1994), and six used individual randomisation (Athens 1993;
Denver 1976; Denver 1979; Melbourne 1976; Melbourne 1981;
Pakistan 1989). Three studies (New Delhi 2006; Seattle 1987;
Sheffield1978) did not provide details of randomisation processes.
Of the 13 included studies, 12 (N = 33,681 women) compared
continuous CTG with intermittent auscultation (Athens 1993;
Copenhagen 1985; Dallas 1986; Denver 1976; Denver 1979;
Dublin 1985; Melbourne 1976; Melbourne 1981; New Delhi
2006; Pakistan 1989; Seattle 1987; Sheffield 1978). Five stud-
ies compared continuous CTG plus fetal blood sampling ver-
sus intermittent auscultation (Copenhagen 1985; Dublin 1985;
Melbourne 1976; Pakistan 1989; Seattle 1987) and six compared
continuousCTGwithout fetal blood sampling versus intermittent
auscultation (Athens 1993;Dallas 1986;Denver 1976;Melbourne
1981; New Delhi 2006; Sheffield 1978). One study had three
groups comparing continuous CTG with and without fetal blood
sampling versus intermittent auscultation (Denver 1979). One
study compared continuous CTG with fetal blood sampling ver-
sus intermittent CTG with fetal blood sampling (Lund 1994).
Participants were assessed as being at low risk of complications in
four studies (Dallas 1986; Lund 1994;Melbourne 1981; Sheffield
1978) and outcome data for women at low risk were available
for one outcome, neonatal seizures, from another study (Dublin
1985). Participants were assessed as being at high risk of com-
plications in six studies (Denver 1976; Denver 1979; Melbourne
1976; New Delhi 2006; Pakistan 1989; Seattle 1987) including
one study that specifically included women in preterm labour (28
to 32 weeks) and assessed outcomes for babies below 1750 g birth-
weight (Seattle 1987). The data for neonatal seizures in women at
high risk of complications were available from one study (Dublin
1985). Participants were assessed as mixed risk (mixture of women
at high risk and low risk of complications) in three studies (Athens
1993; Copenhagen 1985; Dublin 1985).
Five studies had overall caesarean section rates below 10%
(Athens1993;Copenhagen 1985;Dublin 1985;Melbourne 1981;
Sheffield 1978). The highest overall caesarean section rates were
reported in Pakistan 1989 (23.5%) and New Delhi 2006 (28%).
Table 2 shows additional descriptive information for all included
studies.
Excluded studies
We excluded five studies (Characteristics of excluded studies). Of
these, three studies (Greece 2012; Harare 1994; North America
2000) were excluded because the interventions compared did
not meet our inclusion criteria; one study was non-randomised
(Ioannina 2001); and one study did not report any data for the
control group (Manchester 1982).
Risk of bias in included studies
See Figure 1 for a summary of risk of bias assessments.
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study
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Allocation
Allocation concealment was assessed as low risk of bias in three
trials (Dublin 1985; Lund 1994; Melbourne 1976); unclear in six
trials (Copenhagen 1985; Denver 1976; Denver 1979; NewDelhi
2006; Seattle 1987; Sheffield 1978); and high risk in four trials
(Athens 1993; Dallas 1986; Melbourne 1981; Pakistan 1989).
Blinding
Blinding of participants and personnel was assessed as high risk of
bias in all 13 studies. Blinding of outcome assessment was assessed
as unclear in all but one study where it was assessed as high risk of
bias (Athens 1993).
Incomplete outcome data
Attrition bias was graded as low risk in eight trials (Athens 1993;
Copenhagen 1985; Denver 1976; Denver 1979; Dublin 1985;
Lund 1994; New Delhi 2006; Pakistan 1989); unclear in three
trials (Dallas 1986; Melbourne 1976; ; Sheffield 1978); and high
risk in two trials (Melbourne 1981; Seattle 1987).
Selective reporting
This was assessed as ’unclear risk of bias’ in all 13 studies as we did
not have access to any of the trial protocols.
Other potential sources of bias
All 13 studies were considered at low risk for other potential
sources of bias.
Effects of interventions
See: Summary of findings for themain comparisonContinuous
CTG versus intermittent auscultation for fetal assessment during
labour
Continuous cardiotocography (CTG) versus
intermittent auscultation (IA) (Comparisons 1 to 8)
A total of 13 randomised trials were included in this com-
parison with over 33,000 women participating (Athens 1993;
Copenhagen 1985; Dallas 1986; Denver 1976; Denver 1979;
Dublin 1985; Melbourne 1976; Melbourne 1981; New Delhi
2006; Pakistan 1989; Seattle 1987; Sheffield 1978). Denver 1979
was a three-arm trial comparing continuous CTG alone, versus
continuous CTG plus fetal bood sampling (FBS) versus intermit-
tent auscultation.
Main outcomes
For the infant
There was no significant difference in perinatal mortality between
the groups. Risk ratio (RR) was 0.86 with, 95% confidence in-
tervals (CIs) ranging from 0.59 to 1.24, N = 33,513, 11 tri-
als, (Analysis 1.1). The funnel plot analysis indicated no miss-
ing studies (Figure 2). The quality of the evidence for this out-
come was assessed as moderate (Summary of findings for the main
comparison).
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Figure 2. Funnel plot of comparison: 1 Continuous CTG versus intermittent auscultation, outcome: 1.1
Perinatal mortality (main outcome)
The use of continuous CTG monitoring in labour halved the risk
of neonatal seizures (RR 0.50, 95%CI 0.31 to 0.80, N = 32,386, 9
trials, Analysis 1.2). The funnel plot indicated no missing studies
(Figure 3) and the quality of the evidence was assessed as moderate
(Summary of findings for the main comparison). This reduction
was consistent across the trials and subgroups, although the in-
cidence of neonatal seizures varied considerably among trials. In
the two largest trials of 14,618 women (Dallas 1986) and 12,964
women (Dublin 1985), the incidence of neonatal seizures in the
intermittent auscultation groupswas 0.04%and 0.4% respectively
(Analysis 1.2). In the two high-quality trials reporting data for this
outcome (Dublin 1985; Melbourne 1976), the risk of neonatal
seizures was RR 0.40, 95% CI 0.21 to 0.77 (Analysis 8.2).
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Figure 3. Funnel plot of comparison: 1 Continuous CTG versus intermittent auscultation, outcome: 1.2
Neonatal seizures (main outcome)
There was no difference in the incidence of cerebral palsy (average
RR 1.75, 95% CI 0.84 to 3.63, N = 13,252, 2 trials, random-
effects, Analysis 1.3). The quality of the evidence was assessed as
moderate (Summary of findings for the main comparison). The
data on cerebral palsy are heavily influenced by one small trial
(Seattle 1987) that randomised only very preterm babies (less than
32 weeks) and assessed outcomes for 173 babies of birthweight
less than 1750 g with a cerebral palsy rate of 19.5% in the CTG
group compared with 7.7% in the controls (RR 2.54, 95% CI
1.10 to 5.86). The other trial in this comparison (Dublin 1985)
showed no significant difference in the incidence of cerebral palsy
(RR 1.20, 95% CI 0.52 to 2.79, N = 13,079) with a cerebral palsy
rate of 0.18% in the continuous CTG group and 0.15% in the
intermittently monitored group.
There was no difference in the incidence of cord blood acidosis
between the groups (Analysis 1.6). The quality of the evidence was
assessed as very low, mainly due to very significant heterogeneity
and design limitations in many of the included studies (Summary
of findings for the main comparison).
For the mother
There was a significant increase in the caesarean section rate in
the CTG group (average RR 1.63, 95% CI 1.29 to 2.07, 18,861,
11 trials, Analysis 1.4). However, the quality of this evidence
was assessed as low, mainly due to very significant heterogeneity
and study design limitations (Summary of findings for the main
comparison). Risk difference in the caesarean section rate was 5%
(95%CI 2% to 8%), with two-thirds of data coming fromDublin
1985, where the overall caesarean section rate was 2.3%. In ad-
dition, the funnel plot indicated the possibility of missing studies
(Figure 4).
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Figure 4. Funnel plot of comparison: 1 Continuous CTG versus intermittent auscultation, outcome: 1.4
Caesarean section (main outcome)
Although numbers needed to treat to benefit or harm (NNTB/
NNTH) analyses remain controversial in the context of meta-
analysis and should be interpreted with caution, we calculated
that there would be one additional caesarean section for every 44
women monitored continuously (95% CI 26 to 96). This calcula-
tion was based on the pooled caesarean section rate of 3.6% (337/
9313) in the intermittent auscultation group from this meta-anal-
ysis. However, in most settings caesarean section rates are likely to
be much higher. Assuming a caesarean section rate with intermit-
tent auscultation of around 15%, there would be an additional
caesarean section for every 11 women monitored (95% CI 7 to
23).
Continuous CTG was also associated with an increase in instru-
mental vaginal birth (Analysis 1.5). The funnel plot indicated that
some studies might be missing (Figure 5). The quality of this ev-
idence was assessed as low, mainly due to very significant hetero-
geneity and study design limitations (Summary of findings for the
main comparison). There was no difference identified in the use
of any pharmacological analgesia (Analysis 1.7), with the quality
of the evidence assessed as low (Summary of findings for the main
comparison).
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Figure 5. Funnel plot of comparison: 1 Continuous CTG versus intermittent auscultation, outcome: 1.5
Instrumental vaginal birth (main outcome)
Other important outcomes
For the infant
There was no evidence of any other benefit or harm for babies in
terms of hypoxic Ischaemic encephalopathy (Analysis 1.8), Apgar
scores (Analysis 1.10), or admission to neonatal intensive care unit
(Analysis 1.12).
For the mother
Women in the continuous CTG group were more likely to have
a caesarean section for abnormal fetal heart rate, acidosis or both
(Analysis 1.15) and less likely to have a spontaneous vaginal birth
(Analysis 1.17). There was no difference in the use of epidural
analgesia (Analysis 1.18). The use of fetal blood sampling was re-
ported in two trials (Copenhagen 1985; Dublin 1985) with sig-
nificantly more sampling tests performed in the continuous CTG
group (Analysis 1.13). There were no reported data suitable for
analysis for the use of non-pharmacological methods for coping
with labour, amniotomy, perineal trauma, inability to adopt pre-
ferred position in labour, dissatisfaction in labour and postpartum
depression.
Overall findings
Notwithstanding the caution regarding NNTB/NNTH calcula-
tions, when the risk of neonatal seizures is around 3 per 1000, 667
women would have to be continuously monitored during labour
to prevent one such seizure (95%CI 484 to 1667). There is an op-
posite effect on caesarean section. Assuming a 3.6% caesarean sec-
tion rate with intermittent auscultation, there would be 15 more
caesarean sections in this cohort associated with preventing one
neonatal seizure. However, if caesarean section with intermittent
auscultation is higher (15%), 61 extra caesarean sections would be
associated with preventing one neonatal seizure.
Continuous CTG versus intermittent auscultation
(Subgroup: pregnancy risk status - high/low/unclear or
both - Comparison 2)
Of the 12 studies that compared continuous CTG with intermit-
tent auscultation, six included women at increased risk of compli-
cations (Denver 1976;Denver 1979;Melbourne 1976;NewDelhi
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2006; Pakistan 1989; Seattle 1987), three included women at low
risk of complications (Dallas 1986; Melbourne 1981; Sheffield
1978) and three studies included both groups of women or did not
specify (Athens 1993; Copenhagen 1985; Dublin 1985). There
was a significant difference in the impact of CTG monitoring on
caesarean section rate depending on the risk status of women (P
= 0.004; I² = 81.6%), although heterogeneity can be attributed
to the group with combined risk rather than to the subgroups
where the risk was clearly defined. There were no other statistically
significant differences between the subgroups for any other main
outcomes.
Subgroups analysis by onset of labour
(spontaneous/induced/unclear or both - Comparison 3)
None of the included trials provided separate data for spontaneous
and induced labours. Hence, there is no information to determine
if there might be a difference in the impact of CTG for women
in spontaneous labour compared with those with induction of
labour.
Subgroup analysis by gestational age (preterm/term/unclear
or both - Comparison 4)
Of the 12 studies that compared continuous CTG with inter-
mittent auscultation, one included only preterm labours (Seattle
1987). Three studies included only term labours (Copenhagen
1985;Melbourne 1981; Sheffield1978) and eight studies included
both or did not specify (Athens 1993; Dallas 1986; Denver 1979;
Denver 1979; Dublin 1985; Melbourne 1976; New Delhi 2006;
Pakistan 1989). We found no evidence of a difference between
subgroups.
Subgroup analysis by number of babies being monitored
(singleton/twin pregnancy/unclear or both - Comparison 5)
Eight studies included only singleton pregnancies (Athens 1993;
Dallas 1986; Denver 1976; Melbourne 1981; New Delhi 2006;
Pakistan 1989; Seattle 1987; Sheffield 1978) and four in-
cluded both singleton and twin pregnancies or did not spec-
ify (Copenhagen 1985; Denver 1979; Dublin 1985; Melbourne
1976). There was a significant subgroup effect for the rate of
neonatal acidosis (P = 0.04; I² = 77%) with more acidosis in CTG
monitored singletons and less in CTG monitored twins. There
was also a subgroup difference in the use of pharmacological anal-
gesia (P = 0.02; I² = 83%), but the data were only available for
singletons and mixed group with no data for twins only. There
were no subgroup differences for the other main outcomes.
Subgroup analysis by access to fetal blood sampling during
labour (Comparison 6)
Six studies offered fetal blood sampling alongside the CTG
(Copenhagen 1985; Dublin 1985; Melbourne 1976; Melbourne
1981; Pakistan 1989; Seattle 1987), five studies did not use fetal
blood sampling (Athens 1993; Dallas 1986; Denver 1976; New
Delhi 2006; Sheffield 1978) and one study randomised to three
groups, CTG with fetal blood sampling, CTG alone and inter-
mittent auscultation (Denver 1979).
There was a significant subgroup effect on instrumental vaginal
birth with apparently more instrumental deliveries (P = 0.04; I²
= 77%), but less neonatal acidosis (P = 0.04; I² = 76.5%) in the
fetal blood sampling subgroup. However, there were no subgroup
differences for the other main outcomes.
Subgroups by parity (primiparous/multiparous
women/unclear or both - Comparison 7)
None of the studies included only primiparous women, one study
included onlymultiparouswomen (New Delhi 2006) and11 stud-
ies included both primiparous and multiparous women (Athens
1993; Copenhagen 1985; Dallas 1986; Denver 1976; Denver
1979; Dublin 1985; Melbourne 1976; Melbourne 1981; Pakistan
1989; Seattle 1987; Sheffield 1978). As only one of these studies
reported results based on the parity of the women involved, it was
not possible to perform a meaningful subgroup analysis.
Continuous CTG versus intermittent auscultation
(sensitivity analysis: high/low/unclear quality of studies -
Comparison 8)
Of the 12 studies that compared continuous CTG with intermit-
tent auscultation, two were considered to be of high methodolog-
ical quality (Dublin 1985; Melbourne 1976), four studies where
considered to be lowmethodological quality (Athens 1993; Dallas
1986;Melbourne 1981; Pakistan 1989) and methodological qual-
ity was unclear for six studies (Copenhagen 1985; Denver 1976;
Denver 1979; New Delhi 2006; Seattle 1987; Sheffield 1978).
Removing the low quality trials made very little difference to the
analysis for perinatal mortality (Analysis 8.1), neonatal seizures
(Analysis 8.2), caesarean section (Analysis 8.4), and instrumen-
tal vaginal birth (Analysis 8.5). There were no low quality trials
contributing to the cerebral palsy (Analysis 8.3) or any pharma-
cological analgesia (Analysis 8.7) analyses. Only two studies, one
high quality (Dublin 1985) and one low quality (Athens 1993),
contributed to the analysis for cord blood acidosis (Analysis 8.6).
Removing data from Athens 1993 caused the direction of effect
to change in favour of continuous CTG; however, the confidence
interval still crossed the line of no effect.
We also investigated the differences between high risk, low risk,
and unclear risk trials by interaction tests. It appeared that in a
high-quality trial, there was less cord blood acidosis comparedwith
low-quality trials (P = 0.04; I² = 76.5%). There was significant
subgroup heterogeneity for instrumental vaginal birth (P = 0.007;
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I² = 79.9%), but no clear difference between high- and low-risk
subgroups.
Continuous CTG versus intermittent CTG
(Comparison 9)
Lund 1994 involved 4044 high-risk pregnant women and found
no clear differences between groups for eight of the outcomes
specified in this review: caesarean section (Analysis 9.1) instru-
mental vaginal birth (Analysis 9.2); cord blood acidosis (Analysis
9.3); Apgar score less than seven at five minutes (Analysis 9.4);
neonatal ICU admissions (Analysis 9.5); caesarean section for ab-
normal fetal heat rate pattern and/or fetal acidosis (Analysis 9.6);
spontaneous vaginal birth (Analysis 9.7); or epidural anaesthesia
(Analysis 9.8).
D I S C U S S I O N
Summary of main results
The main reason for the introduction of continuous intrapartum
cardiotocography (CTG) monitoring in clinical practice was a be-
lief that it would reduce rare but devastating outcomes - perinatal
death and neonatal hypoxic brain injury - in otherwise healthy
babies. However, we found no clear difference in perinatal deaths
between pregnancies monitored during labour with continuous
CTG compared to those monitored using intermittent ausculta-
tion.The overall quality of evidence that underpins this conclusion
has been judged as moderate (Summary of findings for the main
comparison). It does, however, seem unrealistic to expect that any
randomised study of intrapartum interventions in modern mater-
nity care will result in an improvement in perinatal deaths that
reaches the conventional level of statistical significance (superior-
ity). For a trial to test a realistic hypothesis that continuous CTG
can prevent one death in one thousand births (0.1%), more than
50,000womenwould have to be randomised. Therefore, it ismore
logical to concentrate on short- and long-term childhood morbid-
ity. Unfortunately, very few clinically-relevant neonatal outcomes
have been reported consistently in all trials.
For decades, low Apgar scores have been used as a surrogate mea-
sure for birth asphyxia and subsequent adverse neurodevelopmen-
tal outcomes. Recent evidence has confirmed a strong association
between low Apgar score (at five minutes after birth) and cerebral
palsy in both low and normal birthweight infants (Lie 2010). We
found no evidence that use of continuous intrapartum CTGmon-
itoring has an impact on Apgar score. However, there were very
few babies with clinically significant low Apgar scores in studies
that assessed this outcome. Therefore, potentially important dif-
ferences between the groups cannot be ruled out.
Hypoxic ischaemic encephalopathy, a more robust measure of hy-
poxic brain injury, was reported in only one study (Athens 1993).
In the absence of any meaningful long-term follow-up data, the
impact of continuous CTG monitoring on a neonate can only be
evaluated based on data from two clinically important outcomes,
that is, neonatal seizures and cerebral palsy.
For both neonatal seizures and cerebral palsy, most data were pro-
vided by Dublin 1985. At first glance, the data appear contra-
dictory. There was a significant reduction in neonatal seizures in
the continuous CTG group, but no impact on cerebral palsy. If
anything, the rates of cerebral palsy appear to be higher in the
continuous CTG group, although the pooled result did not reach
statistical significance. This apparent increase in cerebral palsy in
children monitored by CTG comes from Seattle 1987. However,
the results from this study, the only study of CTGmonitoring dur-
ing preterm labour, are not significant using 99% confidence in-
tervals. In addition, this study excluded infants with birthweights
of more than 1750 g (34% of randomised cohort), which may be
a source of bias. Given that all other outcomes in this trial, in-
cluding caesarean section rates, neonatal seizures and deaths were
almost identical, this may have been a chance finding and should
be interpreted with caution.
It is now generally accepted that cerebral palsy ismore often caused
by antepartum, rather than intrapartum, events (Palmer 1995).
Therefore, it may be unrealistic to expect that intrapartum inter-
ventions will have the capacity to achieve a significant reduction
in cerebral palsy. There are, clearly, some cases of cerebral palsy
that are a direct consequence of intrapartum hypoxic injury. These
cases are very rare, and systematic reviews of randomised trials are
unlikely to have sufficient power to test intrapartum CTG as a
method to reduce cerebral palsy caused by acute and avoidable
intrapartum events.
The reduction in seizures associated with continuous CTG moni-
toring is important, but must be interpreted cautiously in the ab-
sence of good quality long-term follow-up data. It has been sug-
gested that seizures may be a “sentinel event” of a peripartum ad-
versity that does not necessarily always manifest itself as hypoxic
encephalopathy (Dennis 1978; Derham 1985, Keegan 1985; Lien
1995; Spellacy 1985). When asphyxia, infection, brain malforma-
tions and metabolic causes are excluded, some neonatal seizures
are associated with cerebral infarction or neonatal stroke (Estan
1997; Lien 1995). Although the underlying causes are not well
understood, neonatal seizures may have long-term consequences
other than cerebral palsy. One longitudinal study found that some
babies who had neonatal seizures were classified as normal at five
years and had normal overall intelligence in adolescence as assessed
by IQ tests, but had some abnormal results on detailed neuropsy-
chological testing (Temple 1995). Clearly, there is a need for com-
prehensive long-term follow-up of the randomised cohorts that is
not limited to extreme adverse outcomes such as cerebral palsy,
but also includes more subtle neuropsychological assessment.
The results of this review demonstrate that continuous CTGmon-
itoring leads to an increase in caesarean sections. Such an effect
of continuous CTG is clinically plausible because CTG monitor-
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ing leads to more interventions (e.g. fetal blood sampling, am-
niotomy) and more diagnoses of presumed fetal compromise for
which emergency caesarean section is seen as the only safe man-
agement option. However, the overall quality of evidence for this
outcome was judged as low (Summary of findings for the main
comparison). Therefore, the observed increase must be interpreted
cautiously.
It is noteworthy that size and direction of the effect on caesarean
section was consistent for prespecified subgroups, including high-
quality trials and trials where clinicians had access to intrapartum
fetal blood sampling. Subgroup interaction test was only signifi-
cant (I² = 81.6%) for studies in low-risk, high-risk and mixed risk
status, but heterogeneity came from a mixed group. The impact
of CTGmonitoring on caesarean section in low-risk and high-risk
populations appears to be virtually identical, which is contrary to
recommendations frommany professional bodies providing guid-
ance on intrapartum fetal monitoring.
There was some evidence that labour was more painful in the con-
tinuous CTG group, but the statistically significant increase in the
need for any analgesia included general anaesthesia. Therefore, it is
likely that this difference was caused by an increase in the number
of caesarean sections, rather than necessarily more painful labour.
Women report more pain when lying on their backs during labour.
At the times when the studies in this review were undertaken (be-
tween 1976 and 1994), women in the intermittent auscultation
group may well also have been on their backs and not using mo-
bility and positions to help them with their labours. There were
no data from the trials included in the review to enable analysis of
this potential confounder.
We prespecified several subgroups that could have been expected
to influence the direction and size of the differences comparedwith
results when all trials were considered together.We were conscious
that any differences among subgroups and overall results would
have to be interpreted with extreme caution (Rothwell 2005).
With this proviso, we found no subgroup differences of clinical
importance, but the number of trials and women in subgroups
was relatively small.
Overall completeness and applicability of
evidence
Clearly, the lack of long-term follow-up data and inadequate re-
porting of the data according to the clinically important subgroups
is regrettable and limits the applicability of the evidence.
There are also two other issues that should be considered in the
applicability of the evidence reviewed here:
1. Methods of intermittent ascultation differed among
included trials regarding frequency, duration and timing in
relation to contractions; some recorded fetal heartbeat during and
after contractions, others immediately following contractions,
and others were not specific (Table 3). The trials also differed in
additional assessments of fetal wellbeing. For example, in Dublin
1985, which is a large contributor of meta-analysis weight across
most review outcomes, all women had an artifical rupture of
membranes performed within an hour of admission. In addition
to routine artifical rupture of membranes, in Dublin 1985 fetal
blood sampling was performed for all women who had not
delivered within eight hours (1.2% of women in the CTG group
and 2.1% of women in the intermittent auscultation group).
Such practices may be less generalisable to current approaches to
care of women during labour.
2. With the exception of New Delhi 2006, all included studies
were conducted in the 1970s, 1980s, and early 1990s. Since
then, there have been substantial developments in equipment
used to perform cardiotocography and a strong emphasis on
education for all those involved in CTG interpretation (which in
some jurisdictions is mandatory), and continuous review and
refinement of interpretation criteria. Nevertheless, most
technological developments in intrapartum assessment of fetal
wellbeing, including for example, ST waveform analysis (Neilson
2015), expert systems (Lutomski 2015) and computerised
analysis have not shown substantive clinical benefits. In addition,
there was insufficient evidence available to demonstrate a
substantial benefit for applied artificial intelligence, such as
expert systems, in improving interpretation of fetal heart rate
tracings (Lutomski 2015). This might suggest that the data
related to the impact of CTG monitoring is still relevant to
current practice.
Quality of the evidence
Themethodological quality of the included studies was mixed. All
included studies were assessed at high risk of performance bias, all
were unclear or high risk of detection bias, and all were unclear
risk of reporting bias. Figure 1 depicts a summary of risk of bias
assessment for the included studies.
We used GRADEpro software to assess evidence quality for se-
lected GRADE outcomes; for neonatal seizures the evidence was
rated moderate, evidence for cord blood acidosis was rated very
low, and the remaining GRADE outcomes (perinatal mortality,
cerebral palsy, caesarean section, instrumental vaginal birth and
any pharmacological analgesia) were all assessed as low quality.
Evidence was downgraded for risk of bias, imprecision of effect
estimates and high heterogeneity between studies. These ratings
are summarised in Summary of findings for the main comparison.
Potential biases in the review process
Our selection of outcomes in general andmain outcomes in partic-
ularmight have been influencedby our knowledge of the published
literature and the first Cochrane review on this topic (Thacker
2001).
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Agreements and disagreements with other
studies or reviews
Some large cohort studies suggest much more profound benefit
on neonatal morbidity and mortality (Chen 2011). Some obser-
vational data also suggest benefit from fetal blood sampling during
labour in cases of suboptimal CTG (Stein 2006). We found no
evidence that the increase in caesarean section rate was greater if
fetal blood sampling was unavailable; nor did access to fetal blood
sampling influence the difference in neonatal seizures or any other
prespecified outcome.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Translating the evidence from this review into clinical practice
poses significant challenges. One would hope that the quality of
cardiotocography (CTG) equipment, interpretation and training
have improved over the years making the external validity of much
of the data included in this review questionable.
In most included studies, intermittent auscultation was carried
out according to the strict protocols in hospital settings with quick
recourse to continuous monitoring and intervention if required.
In some trials, most notably Dublin 1985, intact fetal membranes
were ruptured at the earliest opportunity to confirm absence of
meconium, and women had one-to-one care from amidwife. This
monitoring package differs significantly from practices in some
modern birth settings (including, for example, stand-alone mid-
wifery units) where artificial rupture of membranes is avoided as
long as possible, and where mobilisation and normality are pro-
moted. In addition, one-to-one care by a midwife, or a nurse-mid-
wife, seems hard to implement in many healthcare settings and is
likely to be an important contributory factor for effectiveness (or
lack of it) of both types of fetal heart rate monitoring.
With this proviso, women should be informed that continuous
CTG during labour is associated with a reduction in the incidence
of neonatal seizures, has no obvious impact on cerebral palsy or
perinatal mortality, but is associated with an increase in the inci-
dence of caesarean section and instrumental vaginal births. The ad-
verse affects of operative births are well described, albeit that longer
term morbidity data are less available than shorter term morbid-
ity data. The possible long-term effects of preventable neonatal
seizures remain unknown. Women also need to be informed of
the loss of mobility associated with the use of continuous CTG in
labour.
Women, practitioners and policymakers need to carefully consider
the absence of evidence that continuous CTG monitoring has a
different impact on caesarean section and neonatal seizures in low-
and high-risk populations and that there is an absence of evidence
from included trials of a beneficial effect for fetal blood sampling.
The risk-benefit debate will continue to focus on caesarean section
and neonatal seizures. Given the perceived conflict between the
risk for the mother (increased caesarean section and instrumental
vaginal delivery rate) and benefit for the baby (decreased incidence
of neonatal seizures), it is difficult tomake quality judgments about
which effect is more important. The issue of effectiveness is par-
ticularly important. CTG advocates will continue to argue that
lack of clear long-term benefit for the child is not proof that in-
termittent auscultation is safe. However, it would seem reasonable
to base clinical decisions on the evidence we currently have rather
than on unknown risks of unknown quantity. Obviously, the risk-
benefit assessment will vary among individuals, policy makers and
healthcare settings. The real challenge is how best to convey this
uncertainty to women and help them to make informed choices
without compromising the normality of labour.
Implications for research
A question remains about whether future randomised trials should
measure efficacy (the intrinsic value of continuous CTG in try-
ing to prevent adverse neonatal outcomes under optimal clinical
conditions) or effectiveness (the effect of this technique in routine
clinical practice).
Along with the need for further investigations into the long-term
effects of operative births for women and babies, much remains to
be learned about the causation and possible links between ante-
natal or intrapartum events, neonatal seizures and long-term neu-
rodevelopmental outcome, bearing in mind the changes in clin-
ical practice over the intervening years (one-to-one-support dur-
ing labour, caesarean section rates). The large number of babies
randomised in this review will now have reached adulthood, and
could potentially provide us with a unique opportunity to clarify if
a reduction in neonatal seizures is something inconsequential that
should not greatly influence women’s and clinicians’ choices, or if
seizure reduction leads to long-term benefits for babies. Defining
meaningful neurological and behavioural outcomes that could be
measured in large cohorts of young adults poses huge challenges.
Data should also be collected from this cohort of women and ba-
bies, while medical records still exist, to describe, where possible,
the women’s mobility and positions during labour and birth, and
clarify if these might impact on outcomes. Research should also
investigate the possible contribution of the supine position to ad-
verse outcomes for the baby, and address the question of whether
the use of mobility and positions can reduce the already low in-
cidence of neonatal seizures and improve psychological outcomes
for women.
A C K N OW L E D G E M E N T S
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Athens 1993
Methods RCT. Assignment by coin toss on admission. Mothers and obstetricians not blinded;
neonatologists collecting data on neonatal outcomes were blinded
Participants Inclusion: Mixed risk. Women with a singleton fetus at 26 or more weeks’ gestation
admitted in spontaneous labour or for induction of labour
Total of 1428 women participated.
Exclusion: Women with known fetal congenital or chromosomal abnormalities
Interventions Intervention: Continuous CTG without FBS
• CTG: external unless trace poor when internal CTG used
• N = 746
Comparison: IA
• N = 682
Outcomes Labour onset, oxytocin administration, duration of labour, premature rupture of the
membranes, meconium-stained liquor, mode of delivery, analgesia/anaesthesia, ’non re-
assuring’ FHR patterns, length of maternal hospital stay, postpartummaternal morbidity
(infection or blood transfusion), duration of ’good quality tracing’
Presentation at birth, birthweight (< 2500, 2500 to 4000, > 4000), Apgar score < 7 @
1 min and @ 5 min, cord arterial pH < 7.10, neonatal resuscitation, NICU admission,
assisted ventilation, length of neonatal hospital stay, neonatal complications (none, HIE,
intraventricular haemorrhage, seizures, hypotonia, necrotising enterocolitis, respiratory
distress, sepsis, hyperbilirubinaemia, hypoglycaemia, congenital anomalies), intrapartum
fetal death, neonatal death, perinatal death, perinatal death from hypoxia
Outcomes analysed: caesarean deliveries, operative vaginal deliveries, 1 minute Apgar
< 4 and < 7, neonatal seizures, NICU admissions, length of stay, and perinatal death.
Outcomes not analysed: presentation, labour, labour duration, PROM, meconium, ma-
ternal infection or blood transfusion
Overall risk of bias High risk of bias including high risk of bias for random sequence generation and con-
cealment of allocation
Notes Study period: October 1990 to June 1991.
Subgroups: Mixed risk; mixed onset of labour; mixed gestation; singletons; no FBS;
mixed parity; low quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “…assigned on admission by a coin toss.
..” However, unexplained high imbalance
in numbers allocated to groups (746 EFM
and 682 IA) suggests a high risk of bias in
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Athens 1993 (Continued)
sequence generation
Allocation concealment (selection bias) High risk No information given. The use of coin toss
to generate the random sequence without
this information suggests there was high
risk of bias in allocation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Neonatologists assessing neonatal out-
comes were blinded to allocation. Not
stated if other outcomes were assessed
blindly but unlikely
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data on all 1428 women were available
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
Copenhagen 1985
Methods RCT. Weekly allocation to either group by random sampling. Method of randomisation
unclear
Participants Inclusion: Mixed risk
Among 1410 women who fulfilled the criteria for entering the study, 349 refused to
participate (primarily due to preference for 1 form of monitoring)
Total of 969 women participated. Baseline outcomes collected for non-participating
group of women
3 twins in CTG group and 6 twins in IA group.
Exclusion: Women with diabetes
Interventions Intervention: Continuous CTG in conjunction with FBS
• CTG: external or internal
• N = 482
Comparison: IA
• N = 487
Outcomes FHR pattern, corrective procedures for pathological FHR pattern (oxygen, change of
maternal position, CS, vacuum extraction), indications for termination of labour (me-
chanical disproportion, bleeding, cord prolapse, maternal disease, fetal disease, lack of
progression, other), presentation at birth, administration of oxytocin, analgesia/anaes-
thesia
Apgar score 0 to 3, 4 to 6, 7 to 10 @ 1 min and @ 5 min, gestational age (including ap-
propriate for gestational age, small-for-gestational age, large-for-gestational age), weight,
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Copenhagen 1985 (Continued)
NICU admissions, asphyxia, oxygen/CPAP requirement, intubation, ventilation, post-
asphyxia pallor, seizures, irritability, neonatal infection, intrapartum death, antepartum
death
Overall risk of bias Moderate risk of bias including unclear risk of bias for random sequence generation and
concealment of allocation
Notes Study period: January 1981 to January 1982 (date women expected to give birth)
Subgroups: Mixed risk; mixed onset of labour; term; both singletons and twins; FBS;
mixed parity; unclear quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “…by random sampling…”
Allocation concealment (selection bias) Unclear risk Unpublished paper refers to ‘The weekly
allocation was furthermore selected...’ This
suggests that allocation may have been
done on a weekly basis but it is unclear
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data on all 969 women available
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
(ITT information in the unpublishedpaper
from this study)
Dallas 1986
Methods Quasi-RCT. Randomisation by alternate months; selective monitoring (policy of using
monitoring only in high-risk pregnancies) versus universal monitoring (use of a monitor
for every pregnancy in which the fetus was considered viable i.e. irrespective of risk status)
Participants 34,995 women included in the study. Data were extracted for 14,618 women with
pregnancies at low risk; 7288 in universal monitoring group where all womenmonitored
by CTG, and 7330 in selective monitoring where women at low risk monitored by IA
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Dallas 1986 (Continued)
Interventions Intervention: Continuous CTG
• CTG: no information on external or internal
• N = 7288
Comparison: IA
• N = 7330
Outcomes Abnormal FHR pattern, CS, intrapartum fetal deaths, neonatal deaths, assisted ventila-
tion, Apgar score < 5 @ 5 min, NICU admission, seizures
Overall risk of bias High risk of bias including high risk of bias for random sequence generation and con-
cealment of allocation
Notes Study period: information not available.
Subgroups: Low risk; mixed onset of labour; mixed gestation; singletons; no FBS; mixed
parity; low quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomisation by alternate months
Allocation concealment (selection bias) High risk Randomisation by alternate months
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information provided
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk The study appears to be free of other
sources of bias
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Denver 1976
Methods RCT. Randomised sealed envelope with participants with even numbers having CTG
while participants with odd numbers had IA
Participants Women at high risk on point system rating; in addition those with meconium stained
fluid, needing oxytocin or abnormal fetal heart tones during labour were eligible to
participate
Total of 483 women participated.
Interventions Intervention: Continuous CTG without FBS
• CTG: internal
• N = 242
Comparison: IA
• N = 241
Outcomes FHR pattern, CS, instrumental vaginal deliveries, anaesthesia, umbilical cord pH, mean
Apgar scores and Apgar scores ≤ 7 and > 7 @ 1 min and @ 5 min, NICU admissions,
temperate abnormalities, jaundice, lethargy, seizures, jitteriness, spontaneous respiration,
intubation, ventilation
Overall risk of bias Moderate risk of bias including unclear risk of bias for random sequence generation and
concealment of allocation
Notes Study period: information not available.
IA group had a CTG monitor attached, which was turned off at bedside but which was
recorded on a covered monitor in the hallway. This CTG was not available to clinicians
during the woman’s labour
Subgroups: High risk; mixed onset of labour; mixed gestation; singletons; no FBS; mixed
parity; unclear quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ‘… previously randomised sealed enve-
lope…’ Women with even number allo-
cated to CTG and women with odd num-
ber allocated to bedside monitor turned off
Allocation concealment (selection bias) Unclear risk Insufficient information provided. Though
randomised sealed envelopes were used, it
is not clear if they were opaque and sequen-
tially numbered. Also women with even
number allocated toCTGandwomenwith
odd number allocated to bedside monitor
turned off
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
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Denver 1976 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data on all 483 women were reported
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
Denver 1979
Methods RCT. Allocation by random numbers in sealed envelopes.
Participants Women at high risk in labour.
Total of 690 women participating with 5 sets of twins (695 infants)
Interventions Intervention 1: Continuous CTG with FBS
• CTG: external until internal feasible
• N = 229
Intervention 2: Continuous CTG without FBS
• CTG: external until internal feasible
• N = 230
Comparison: IA
• N = 231
Outcomes Pre-eclampsia, amnionitis, FHR patterns, CS, instrumental vaginal deliveries, anaesthe-
sia, maternal postpartum infections, oxytocin administration during labour, meconium
Gestational age (including appropriate for gestational age, small-for-gestational age,
large-for-gestational age), mean Apgar score and Apgar score 0 to 3, 4 to 7, 8 to 10 @ 1
min and @ 5 min, umbilical cord blood gases (pH, pO , pCO ), respiratory distress,
pneumonia, seizures, sepsis, meningitis, NICU admission, required antibiotics, Bayley
scales and Milani-Comparetti tests at 9 months of age
Overall risk of bias Moderate risk of bias including unclear risk of bias for random sequence generation and
concealment of allocation
Notes Study period: July 1975 to July 1977.
Intervention 1 and Intervention 2 - data pooled to provide overall data for CTG
Subgroups: High risk; mixed onset of labour; mixed gestation; singletons and twins; no
FBS; mixed parity; unclear quality
Risk of bias
Bias Authors’ judgement Support for judgement
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Denver 1979 (Continued)
Random sequence generation (selection
bias)
Unclear risk No information reported
Allocation concealment (selection bias) Unclear risk “…allotted a sealed envelope…” but no in-
formation on if opaque or if numbered se-
quentially
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk Some low levels of attrition for some out-
comes but insufficient to impact on out-
comes
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
Dublin 1985
Methods RCT. Random allocation by opening the next envelope in a series of serially numbered,
opaque, sealed envelopes
Participants Women at > 28 weeks’ gestation, in labour, clear liquor previously demonstrated. Mixed
risk
Total of 12,964 women participated
Interventions Intervention: Continuous CTG in conjunction with FBS
• CTG: internal
• N = 6474
Comparison: IA
• N = 6490
Outcomes Use of FBS, scalp pH values, randomisation-delivery interval, oxytocin use, analgesia,
CS, operative vaginal deliveries, Apgar score < 3@1min and@5min, intubation,NICU
admission, umbilical cord venous pH values neonatal trauma (e.g. fractured clavicle,
facial nerve injury, intrapartum death, neonatal death, seizures, abnormalities of tone
and reflexes, primary cause of stillbirths and neonatal deaths, labour length, cerebral
palsy at 4 years of age
Overall risk of bias Low risk of bias (no limitations for random sequence generation and allocation conceal-
ment)
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Dublin 1985 (Continued)
Notes Study period: March 1981 to April 1983.
Zelen design.
FBS was performed when the duration of labour exceeded 8 hours. This occurred in 77/
6474 (1.2%) of women in the CTG arm and 139/6486 (2.1%) of women in the IA arm
Subgroups: Mixed risk (separated data only available for seizures); mixed onset of labour;
mixed gestation; singletons and twins; FBS; mixed parity; high quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The sequence was generated using a ran-
dom numbers table, at a central regis-
ter, to randomly select from the range
of permutations available within the bal-
anced blocks. (personal communication
from Adrian Grant, 24.04.12)
Allocation concealment (selection bias) Low risk “…serially numbered, sealed, opaque en-
velopes…”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided other than other
than below:
‘All 30 children who had survived after
neonatal seizures, and 125 (91%) of the
remaining 138 children whose neurolog-
ical status had been judged to be abnor-
mal, underwent a general physical and de-
tailed neurological examinationby an expe-
rienced paediatrician whowas “blind” both
to the trial allocation and to the nature of
the neonatal neurological abnormality.’
Incomplete outcome data (attrition bias)
All outcomes
Low risk No exclusions after randomisation
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
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Lund 1994
Methods RCT. Shuffled opaque envelopes in randomly permuted blocks.
Participants Women with low to moderate risk factors for complications during labour
Total of 4044 women participated.
Interventions Intervention: Continuous CTG with FBS
• CTG: no information on external or internal
• N = 2029
Comparison: Intermittent CTG with FBS
• CTG: no information on external or internal
• N = 2015
Outcomes FHR pattern, time from admission to delivery, length of labour, duration of CTG,
CS, instrumental vaginal deliveries, normal deliveries, umbilical cord arterial pH values,
Apgar score < 7 @ 1 min and 5 min, NICU admission
Overall risk of bias Low risk of bias (unclear risk of bias for random sequence generation and low risk for
allocation concealment)
Notes Study period: October 1989 to May 1991.
Subgroups: these analyses were not undertaken because this study compared continuous
with intermittent CTG
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided, although possi-
bly random sequence due to reference to
‘…randomly permuted blocks…’
Allocation concealment (selection bias) Low risk “…opening an opaque envelope from a
pack of shuffled envelopes in randomly per-
muted blocks…”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk No exclusions after randomisation
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
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Melbourne 1976
Methods RCT. Randomised cards in sealed, consecutively numbered envelopes
Participants Women at high risk.
Total of 350 women participated.
Interventions Intervention: Continuous CTG with FBS
• CTG: external
• N = 175
Comparison: IA
• N = 175
Outcomes Length of labour, induction-delivery interval, oxytocin use, IV fluid volume use, ke-
tonuria, analgesia, CS, instrumental vaginal deliveries, maternal infection
Apgar score (mean grouped) 0 to 3, 4 to 6, 7 to 10 (? timing), resuscitation, NICU
admission, twitching, apneic episodes, hypotonia, convulsions, tachypnoea, high-pitched
cry, hypertonus, neonatal infection, umbilical cord arterial and venous blood gases
Overall risk of bias Low risk of bias (no limitations for random sequence generation and allocation conceal-
ment)
Notes Study period: March 1974 to April 1975.
Subgroups: High risk; mixed onset of labour; mixed gestation; singletons and twins;
FBS; mixed parity; high quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “…randomised cards…”
Allocation concealment (selection bias) Low risk “…sealed consecutively numbered en-
velopes…”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 1 of the 8 clinicians removed all the women
in his care from the trial, although it is not
reported how many women this was. So it
is unclear if this may have introduced bias
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
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Melbourne 1976 (Continued)
Other bias Low risk Appears to be free of other sources of bias
Melbourne 1981
Methods RCT. Randomised cards; envelopes unsealed; biased randomisation in 1 of the partic-
ipating hospitals; 62 low-parity women excluded post-hoc to correct for imbalance in
randomisation
Participants Women at low risk.
Total of 989 women participated.
Randomisation was open and there was a disproportionate number of low-parity women
in the monitored group. Numbers were adjusted by random elimination of 62 women.
Analysis was undertaken using the corrected figures
Interventions Intervention: Continuous CTG without FBS
• CTG: external until membranes ruptured then internal
• N = 445
Comparison: IA
• N = 482
Outcomes Analgesia, ketonuria, CS, instrumental vaginal deliveries, normal deliveries
Apgar score 0 to 3, 4 to 6, 7 to 10@1min, days in ’isolette’, days in nursery, phototherapy,
neonatal death, neurological signs and symptoms (unspecified)
Overall risk of bias Moderate risk of bias including high risk of bias for concealment of allocation
Notes Study period: no information available.
Subgroups: Low risk; mixed onset of labour; term; singletons; FBS; mixed parity; low
quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “…randomization sequences were used…”
Allocation concealment (selection bias) High risk Envelopes were not sealed at 1 of the hos-
pitals and this created more low-parity
women in the monitored group. This was
corrected by random elimination
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
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Melbourne 1981 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
High risk Women were randomly excluded from 1
group to balance the difference in parity
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
New Delhi 2006
Methods RCT but no details on study design
Participants Women at high risk.
100 women who had 1 previous low-transverse CS.
For this pregnancy, singleton and cephalic.
Interventions Intervention: Continuous CTG
• N = 50
Comparison: IA
• N = 50
Outcomes Vaginal birth; CS; forceps; PPH; infection (fever); mean birthweight; Apgar scores;
admission to NICU; assisted ventilation; neonatal morbidity
Overall risk of bias Moderate risk of bias including unclear risk of bias for random sequence generation and
concealment of allocation
Notes Study period: no information
No good information on study methodology.
Subgroups: High risk; mixed onset of labour; mixed gestation; singletons; no FBS; mul-
tiparity; unclear quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...divided randomly...”
Allocation concealment (selection bias) Unclear risk “...divided randomly...”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the in-
terventions used
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New Delhi 2006 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk All 100 women’s data were available
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
Pakistan 1989
Methods RCT. Randomisation by woman selecting 1 of 200 sealed, opaque, unnumbered en-
velopes
Participants Women at high risk (all participants had meconium stained liquor)
Total of 200 women participated with 100 in the CTG group and 100 in the IA group
Interventions Intervention: Continuous CTG with FBS
• CTG: external
• N = 100
Comparison: IA
• N = 100
Outcomes Apgar score < 7 @ 1 min and @ 5 min, CS, instrumental vaginal deliveries, normal
deliveries, stillbirths, early neonatal deaths
Overall risk of bias High risk of bias (including unclear risk of bias for random sequence generation and
high risk of bias for concealment of allocation
Notes Study period: 1988 to 1989.
Data extracted from unpublished trial lodged with the Cochrane Pregnancy and Child-
birth Editorial Office in Liverpool, UK
Subgroups: High risk; mixed onset of labour; mixed gestation; singletons; FBS; mixed
parity; low quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomisation was effected by the
woman selecting one of two hundred... .
..envelopes...”. It is unclear just what this
means
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Pakistan 1989 (Continued)
Allocation concealment (selection bias) High risk “Randomisation was effected by the
woman selecting one of two hundred
sealed, opaque, unnumbered envelopes
containing a card indicating the type of
monitoring to be employed.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “…blinding of the allocated intervention
was not feasible.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk No women were excluded after randomisa-
tion
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
Seattle 1987
Methods RCT. Randomisation by numbered, sealed envelopes.
Participants Women at high risk.
Preterm labour (28 to 32 weeks’ gestation), estimated fetal weight 700 g to 1750 g
Total of 386 women participated with 188 in the CTG group and 188 in the IA group.
Assessing birthweights under 1750 g left 122 in the CTG group and 124 in the IA group
Interventions Intervention: Continuous CTG with FBS
• CTG: external until rupture of membranes then internal
• N = 188 women randomised but 66 excluded from analysis because of low infant
birthweight
Comparison: IA
• N = 188 women randomised but 64 excluded from analyses because of low infant
birthweight
Outcomes Use of tocolytic agents/antenatal glucocorticoids/oxytocin, regional anaesthesia, prema-
ture rupture of membranes, CS
Birthweight, sex of infant, Apgar score 0 to 3 and 4 to 10@1min and@5min, umbilical
cord blood gases, intracranial haemorrhage, severe respiratory distress syndrome, seizures,
perinatal death
Overall risk of bias Moderate risk of bias including unclear risk of bias for random sequence generation and
concealment of allocation
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Seattle 1987 (Continued)
Notes Study period: Nov 1981 to Feb 1985.
Subgroups: High risk; mixed onset of labour; preterm; singletons; FBS; mixed parity;
unclear quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided other than ‘Ran-
domization cards’
Allocation concealment (selection bias) Unclear risk ‘IDnumbers were consecutive, and to enter
a patient the next consecutive envelope was
chosen.’ (Luthy 1987)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk ‘…investigators assessing neurologic devel-
opment were unaware of the monitoring
technique used.’ No information on blind-
ing for other outcomes
Incomplete outcome data (attrition bias)
All outcomes
High risk 130/376 (34%) women were excluded af-
ter randomisation because birthweight >
1750 g and authors wished to study ba-
bies < 1750 g. Similar proportion of exclu-
sions from each group but we still consid-
ered there to be high risk of bias
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
Sheffield 1978
Methods RCT. Sealed envelopes; randomisation details not described.
Participants Women with low risk (high risk women excluded).
Total of 504 women participated.
Interventions Intervention: Continuous CTG without FBS
• CTG: internal
• N = 253
Comparison: IA
• N = 251
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Sheffield 1978 (Continued)
Outcomes Analgesia/anaesthesia, durationof labour, intra or postpartumpyrexia, length ofmaternal
postpartum stay
Birthweight, congenital anomalies, length of hospital stay, type of labour onset, CS,
instrumental vaginal deliveries, normal deliveries, Apgar score (6 or less @ 1min), NICU
admission (including reasons for admission), hypertonicity, umbilical cord blood gases,
perinatal deaths
Overall risk of bias Moderate risk of bias including unclear risk of bias for random sequence generation and
concealment of allocation
Notes Study period: July 1976 to June 1977.
Subgroups: Low risk; mixed onset of labour; term; singletons; no FBS; mixed parity;
unclear quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided
Allocation concealment (selection bias) Unclear risk “…allocated a sealed envelope…” It is un-
clear if these were opaque and numbered
sequentially
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Although not documented, we judged that
women and clinicians were not blind to the
interventions used
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 81/565 (14%) ofwomenwere excludedbut
it is unclear if this was before or after ran-
domisation
Selective reporting (reporting bias) Unclear risk Trial protocol not available for assessment
Other bias Low risk Appears to be free of other sources of bias
CPAP: continuous positive airways pressure
CS: caesarean section
CTG: cardiotocography
EFM: electronic fetal monitoring
FBS: fetal blood sampling
FHR: fetal heart rate
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HIE: hypoxic ischaemic encephalopathy
IA: intermittent auscultation
ITT: intention-to-treat
IV: intravenous
min: minutes
NICU: neonatal intensive care unit
PPH: postpartum haemorrhage
PROM: preterm rupture of membranes
RCT: randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Greece 2012 Study design compared CTG with CTG plus Doppler
Harare 1994 This randomised study did not include continuous CTG. 4 randomised groups received (i) CTG 10 minutes
in every 30 minutes, (ii) Doppler ultrasound monitoring by research midwife, (iii) Pinard stethoscope by
research midwife or (iv) routine auscultation by Pinard (last 10 minutes of every 30 minutes)
Ioannina 2001 Non-randomised trial; 468 women in labour with cervical dilatation less than 5 cm who were continuously
monitored were compared with 346 women in whom CTG monitoring was commenced when cervix was
more than 4 cm dilated. According to the trial report the cohort was divided into 2 groups ’according to
cervical dilatation’
Manchester 1982 This quasi-RCT of 426 women at low risk was excluded because there were no reported data for the control
group
North America 2000 Study design compared CTG with CTG plus continuous fetal pulse oximetry
CTG: cardiotocography
EFM: electronic fetal monitoring
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Continuous CTG versus intermittent auscultation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality (main
outcome)
11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
2 Neonatal seizures (main
outcome)
9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
3 Cerebral palsy (main outcome) 2 13252 Risk Ratio (M-H, Random, 95% CI) 1.75 [0.84, 3.63]
4 Caesarean section (main
outcome)
11 18861 Risk Ratio (M-H, Random, 95% CI) 1.63 [1.29, 2.07]
5 Instrumental vaginal birth (main
outcome)
10 18615 Risk Ratio (M-H, Random, 95% CI) 1.15 [1.01, 1.33]
6 Cord blood acidosis (main
outcome)
2 2494 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.27, 3.11]
7 Any pharmacological analgesia
(main outcome)
3 1677 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.88, 1.09]
8 Hypoxic ischaemic
encephalopathy
1 1428 Risk Ratio (M-H, Fixed, 95% CI) 0.46 [0.04, 5.03]
9 Neurodevelopmental disability
at at least 12 months of age
1 173 Risk Ratio (M-H, Fixed, 95% CI) 3.88 [0.83, 18.17]
10 Apgar score < 7 at 5 minutes 6 4137 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.71, 1.27]
11 Apgar score < 4 at 5 minutes 3 1919 Risk Ratio (M-H, Fixed, 95% CI) 1.80 [0.71, 4.59]
12 Neonatal ICU admissions 10 33167 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.86, 1.18]
13 Fetal blood sampling 2 13929 Risk Ratio (M-H, Fixed, 95% CI) 1.24 [1.05, 1.47]
14 Damage/infection from scalp
electrode or scalp sampling
1 200 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.12, 72.77]
15 Caesarean section for abnormal
FHR pattern and/or acidosis
11 33379 Risk Ratio (M-H, Fixed, 95% CI) 2.38 [1.89, 3.01]
16 Instrumental vaginal birth for
abnormal CTG or fetal acidosis
1 12964 Risk Ratio (M-H, Fixed, 95% CI) 2.54 [1.95, 3.31]
17 Spontaneous vaginal birth 11 18861 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.86, 0.96]
18 Epidural analgesia 8 17630 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.90, 1.12]
19 Oxytocin during 1st and/or
2nd stage of labour
5 3683 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.86, 1.37]
20 Length of stay on NICU 1 206 Mean Difference (IV, Fixed, 95% CI) 0.20 [-1.17, 1.57]
47Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 2. Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
1.1 High risk 5 1974 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.62, 1.74]
1.2 Low risk 3 16049 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.29, 2.58]
1.3 Risk status - mixed or not
specified
3 15490 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.38, 1.24]
2 Neonatal seizures 9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
2.1 High risk 5 4805 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.36, 1.24]
2.2 Low risk 3 25175 Risk Ratio (M-H, Fixed, 95% CI) 0.36 [0.16, 0.79]
2.3 Risk status - mixed or not
specified
2 2406 Risk Ratio (M-H, Fixed, 95% CI) 0.18 [0.01, 3.80]
3 Cerebral palsy 2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.1 High risk 1 173 Risk Ratio (M-H, Fixed, 95% CI) 2.54 [1.10, 5.86]
3.2 Low risk 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Risk status - mixed or not
specified
1 13079 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [0.52, 2.79]
4 Caesarean section 11 18861 Risk Ratio (M-H, Random, 95% CI) 1.63 [1.29, 2.07]
4.1 High risk 6 2069 Risk Ratio (M-H, Random, 95% CI) 1.91 [1.39, 2.61]
4.2 Low risk 2 1431 Risk Ratio (M-H, Random, 95% CI) 2.06 [1.24, 3.45]
4.3 Risk status - mixed or not
specified
3 15361 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.95, 1.36]
5 Instrumental vaginal birth 10 18615 Risk Ratio (M-H, Random, 95% CI) 1.15 [1.01, 1.33]
5.1 High risk 5 1823 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.82, 1.27]
5.2 Low risk 2 1431 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.77, 1.54]
5.3 Risk status - mixed or not
specified
3 15361 Risk Ratio (M-H, Random, 95% CI) 1.33 [1.20, 1.49]
6 Cord blood acidosis 2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
6.1 High risk 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Low risk 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Risk status - mixed or not
specified
2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
7 Any pharmacological analgesia 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
7.1 High risk 2 1173 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.96, 1.06]
7.2 Low risk 1 504 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.79, 1.07]
7.3 Risk status - mixed or not
specified
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Comparison 3. Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
1.1 Spontaneous labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Induction of labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Onset of labour - not
specified
11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
2 Neonatal seizures 9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
2.1 Spontaneous labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Induction of labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Onset of labour - not
specified
9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
3 Cerebral palsy 2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.1 Spontaneous labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Induction of labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Onset of labour - not
specified
2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
4 Caesarean section 11 18861 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [1.25, 1.64]
4.1 Spontaneous labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Induction of labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Onset of labour - not
specified
11 18861 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [1.25, 1.64]
5 Instrumental vaginal birth 10 18615 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.31]
5.1 Spontaneous labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Induction of labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Onset of labour - not
specified
10 18615 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.31]
6 Cord blood acidosis 2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
6.1 Spontaneous labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Induction of labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Onset of labour - not
specified
2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
7 Any pharmacological analgesia 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
7.1 Spontaneous labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Induction of labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Onset of labour - not
specified
3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
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Comparison 4. Continuous CTG versus IA (preterm/term labour)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
1.1 Preterm labour 1 246 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.52, 1.77]
1.2 Term labour 3 2409 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.22, 3.03]
1.3 Both or gestation not
specified
7 30858 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.50, 1.32]
2 Neonatal seizures 9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
2.1 Preterm labour 1 246 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.37, 2.81]
2.2 Term labour 2 1482 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.08]
2.3 Both or gestation not
specified
6 30658 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.24, 0.72]
3 Cerebral palsy 2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.1 Preterm labour 1 173 Risk Ratio (M-H, Fixed, 95% CI) 2.54 [1.10, 5.86]
3.2 Term labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Both or gestation not
specified
1 13079 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [0.52, 2.79]
4 Caesarean section 11 18861 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [1.25, 1.64]
4.1 Preterm labour 1 246 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.57, 1.82]
4.2 Term labour 3 2400 Risk Ratio (M-H, Fixed, 95% CI) 1.84 [1.25, 2.69]
4.3 Both or gestation not
specified
7 16215 Risk Ratio (M-H, Fixed, 95% CI) 1.41 [1.21, 1.63]
5 Instrumental vaginal birth 10 18615 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.31]
5.1 Preterm labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Term labour 3 2400 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [1.01, 1.37]
5.3 Both or gestation not
specified
7 16215 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [1.11, 1.34]
6 Cord blood acidosis 2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
6.1 Preterm labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Term labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Both or gestation not
specified
2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
7 Any pharmacological analgesia 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
7.1 Preterm labour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Term labour 1 504 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.79, 1.07]
7.3 Both or gestation not
specified
2 1173 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.96, 1.06]
50Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 5. Continuous CTG versus IA (singleton/twin pregnancy)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
1.1 Singleton 7 18406 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.49, 1.21]
1.2 Twins 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Both or singleton/twins
not specified
4 15107 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.55, 1.97]
2 Neonatal seizures 9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
2.1 Singleton 5 17279 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.32, 1.46]
2.2 Twins 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Both or singleton/twins
not specified
4 15107 Risk Ratio (M-H, Fixed, 95% CI) 0.41 [0.22, 0.76]
3 Cerebral palsy 2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.1 Singleton 1 173 Risk Ratio (M-H, Fixed, 95% CI) 2.54 [1.10, 5.86]
3.2 Twins 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Both or singleton/twins
not specified
1 13079 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [0.52, 2.79]
4 Caesarean section 11 18861 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [1.25, 1.64]
4.1 Singleton 7 3888 Risk Ratio (M-H, Fixed, 95% CI) 1.58 [1.30, 1.93]
4.2 Twins 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Both or singleton/twins
not specified
4 14973 Risk Ratio (M-H, Fixed, 95% CI) 1.33 [1.11, 1.59]
5 Instrumental vaginal birth 10 18615 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.31]
5.1 Singleton 6 3642 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [1.00, 1.28]
5.2 Twins 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Both or singleton/twins
not specified
4 14973 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [1.13, 1.38]
6 Cord blood acidosis 2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
6.1 Singleton 1 1419 Risk Ratio (M-H, Fixed, 95% CI) 1.58 [0.89, 2.81]
6.2 Twins 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Both or singleton/twins
not specified
1 1075 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.16, 1.29]
7 Any pharmacological analgesia 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
7.1 Singleton 2 987 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.86, 1.01]
7.2 Twins 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Both or singleton/twins
not specified
1 690 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [1.00, 1.12]
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Comparison 6. Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.59, 1.23]
1.1 Continuous CTG plus
FBS
7 16131 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.64, 1.47]
1.2 Continuous CTG alone -
no FBS
5 17382 Risk Ratio (M-H, Fixed, 95% CI) 0.57 [0.26, 1.24]
2 Neonatal seizures 9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
2.1 Continuous CTG plus
FBS
5 15004 Risk Ratio (M-H, Fixed, 95% CI) 0.49 [0.29, 0.84]
2.2 Continuous CTG alone -
no FBS
5 17382 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.18, 1.44]
3 Cerebral palsy 2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.1 Continuous CTG plus
FBS
2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.2 Continuous CTG alone -
no FBS
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Caesarean section 11 18861 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [1.25, 1.64]
4.1 Continuous CTG plus
FBS
7 16001 Risk Ratio (M-H, Fixed, 95% CI) 1.34 [1.14, 1.58]
4.2 Continuous CTG alone -
no FBS
5 2860 Risk Ratio (M-H, Fixed, 95% CI) 1.63 [1.30, 2.06]
5 Instrumental vaginal birth 10 18615 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.31]
5.1 Continuous CTG plus
FBS
6 15755 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [1.16, 1.39]
5.2 Continuous CTG alone -
no FBS
5 2860 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.90, 1.22]
6 Cord blood acidosis 2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
6.1 Continuous CTG plus
FBS
1 1075 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.16, 1.29]
6.2 Continuous CTG alone -
no FBS
1 1419 Risk Ratio (M-H, Fixed, 95% CI) 1.58 [0.89, 2.81]
7 Any pharmacological analgesia 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
7.1 Continuous CTG plus
FBS
2 849 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.90, 1.07]
7.2 Continuous CTG alone -
no FBS
2 828 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.92, 1.05]
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Comparison 7. Continuous CTG versus IA (primiparous/multiparous women)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
1.1 Primaparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Multiparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Both or parity not
specified
11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
2 Neonatal seizures 9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
2.1 Primaparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Multiparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Both or parity not
specified
9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
3 Cerebral palsy 2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.1 Primaparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Multiparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Both or parity not
specified
2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
4 Caesarean section 11 18961 Risk Ratio (M-H, Fixed, 95% CI) 1.44 [1.26, 1.64]
4.1 Primaparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Multiparous women 1 100 Risk Ratio (M-H, Fixed, 95% CI) 1.55 [0.81, 2.96]
4.3 Both or parity not
specified
11 18861 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [1.25, 1.64]
5 Instrumental vaginal birth 10 18715 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.30]
5.1 Primaparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Multiparous women 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.04, 3.10]
5.3 Both or parity not
specified
10 18615 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.31]
6 Cord blood acidosis 2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
6.1 Primaparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Multiparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Both or parity not
specified
2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
7 Any pharmacological analgesia 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
7.1 Primaparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Multiparous women 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Both or parity not
specified
3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
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Comparison 8. Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Perinatal mortality 11 33513 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.59, 1.24]
1.1 High-quality trials 2 13434 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.49, 2.05]
1.2 Low-quality trials 4 17173 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.28, 1.18]
1.3 Quality of trials unclear 5 2906 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.58, 1.71]
2 Neonatal seizures 9 32386 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.31, 0.80]
2.1 High-quality trials 2 13434 Risk Ratio (M-H, Fixed, 95% CI) 0.40 [0.21, 0.77]
2.2 Low-quality trials 2 16046 Risk Ratio (M-H, Fixed, 95% CI) 0.26 [0.04, 1.60]
2.3 Quality of trials unclear 5 2906 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.38, 1.81]
3 Cerebral palsy 2 13252 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.97, 3.11]
3.1 High-quality trials 1 13079 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [0.52, 2.79]
3.2 Low-quality trials 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Quality of trials unclear 1 173 Risk Ratio (M-H, Fixed, 95% CI) 2.54 [1.10, 5.86]
4 Caesarean section 11 18861 Risk Ratio (M-H, Random, 95% CI) 1.63 [1.29, 2.07]
4.1 High-quality trials 2 13314 Risk Ratio (M-H, Random, 95% CI) 1.27 [0.88, 1.83]
4.2 Low-quality trials 3 2555 Risk Ratio (M-H, Random, 95% CI) 1.77 [0.92, 3.41]
4.3 Quality of trials unclear 6 2992 Risk Ratio (M-H, Random, 95% CI) 1.81 [1.34, 2.44]
5 Instrumental vaginal birth 10 18615 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.12, 1.31]
5.1 High-quality trials 2 13314 Risk Ratio (M-H, Fixed, 95% CI) 1.26 [1.13, 1.42]
5.2 Low-quality trials 3 2555 Risk Ratio (M-H, Fixed, 95% CI) 1.39 [1.17, 1.64]
5.3 Quality of trials unclear 5 2746 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.87, 1.16]
6 Cord blood acidosis 2 2494 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.72, 1.89]
6.1 High-quality trials 1 1075 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.16, 1.29]
6.2 Low-quality trials 1 1419 Risk Ratio (M-H, Fixed, 95% CI) 1.58 [0.89, 2.81]
6.3 Quality of trials unclear 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Any pharmacological analgesia 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
7.1 High-quality trials 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Low-quality trials 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Quality of trials unclear 3 1677 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.93, 1.04]
Comparison 9. Continuous CTG versus intermittent CTG
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Caesarean section (main
outcome)
1 4044 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.84, 1.97]
2 Instrumental vaginal birth (main
outcome)
1 4044 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.92, 1.46]
3 Cord blood acidosis (main
outcome)
1 4044 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [0.95, 2.14]
4 Apgar score < 7 at 5 minutes 1 4044 Risk Ratio (M-H, Fixed, 95% CI) 2.65 [0.70, 9.97]
5 Neonatal ICU admissions 1 4044 Risk Ratio (M-H, Fixed, 95% CI) 1.34 [0.91, 1.98]
6 Caesarean section for abnormal
FHR pattern and/or acidosis
1 4044 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [0.66, 2.15]
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7 Spontaneous vaginal birth 1 4044 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.96, 1.00]
8 Epidural analgesia 1 4044 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.92, 1.21]
Analysis 1.1. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 1 Perinatal
mortality (main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 1 Perinatal mortality (main outcome)
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Athens 1993 2/746 9/682 16.0 % 0.20 [ 0.04, 0.94 ]
Copenhagen 1985 2/485 3/493 5.1 % 0.68 [ 0.11, 4.04 ]
Dallas 1986 4/7288 5/7330 8.5 % 0.80 [ 0.22, 3.00 ]
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Denver 1979 3/463 0/232 1.1 % 3.52 [ 0.18, 67.77 ]
Dublin 1985 14/6530 14/6554 23.7 % 1.00 [ 0.48, 2.10 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Pakistan 1989 4/100 5/100 8.5 % 0.80 [ 0.22, 2.89 ]
Seattle 1987 17/122 18/124 30.3 % 0.96 [ 0.52, 1.77 ]
Sheffield 1978 0/253 1/251 2.6 % 0.33 [ 0.01, 8.08 ]
Total (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (Intermittent auscultation)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 2 Neonatal
seizures (main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 2 Neonatal seizures (main outcome)
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Athens 1993 0/746 2/682 5.2 % 0.18 [ 0.01, 3.80 ]
Copenhagen 1985 0/485 0/493 Not estimable
Dallas 1986 1/7288 3/7330 6.0 % 0.34 [ 0.03, 3.22 ]
Denver 1976 2/242 2/241 4.0 % 1.00 [ 0.14, 7.01 ]
Denver 1979 2/463 2/232 5.3 % 0.50 [ 0.07, 3.53 ]
Dublin 1985 12/6530 27/6554 53.7 % 0.45 [ 0.23, 0.88 ]
Melbourne 1976 0/175 4/175 9.0 % 0.11 [ 0.01, 2.05 ]
Seattle 1987 7/122 7/124 13.8 % 1.02 [ 0.37, 2.81 ]
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (Intermittent auscultation)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 3 Cerebral palsy
(main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 3 Cerebral palsy (main outcome)
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Dublin 1985 12/6527 10/6552 49.9 % 1.20 [ 0.52, 2.79 ]
Seattle 1987 16/82 7/91 50.1 % 2.54 [ 1.10, 5.86 ]
Total (95% CI) 6609 6643 100.0 % 1.75 [ 0.84, 3.63 ]
Total events: 28 (Continuous CTG), 17 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.09; Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 4 Caesarean
section (main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 4 Caesarean section (main outcome)
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Athens 1993 71/746 59/682 12.7 % 1.10 [ 0.79, 1.53 ]
Copenhagen 1985 28/482 18/487 8.4 % 1.57 [ 0.88, 2.80 ]
Denver 1976 40/242 16/241 8.8 % 2.49 [ 1.43, 4.32 ]
Denver 1979 67/459 13/231 8.5 % 2.59 [ 1.46, 4.60 ]
Dublin 1985 158/6474 144/6490 14.6 % 1.10 [ 0.88, 1.37 ]
Melbourne 1976 39/175 24/175 10.2 % 1.63 [ 1.02, 2.58 ]
Melbourne 1981 18/445 10/482 6.1 % 1.95 [ 0.91, 4.18 ]
New Delhi 2006 17/50 11/50 7.4 % 1.55 [ 0.81, 2.96 ]
Pakistan 1989 35/100 12/100 8.2 % 2.92 [ 1.61, 5.28 ]
Seattle 1987 19/122 19/124 8.3 % 1.02 [ 0.57, 1.82 ]
Sheffield 1978 24/253 11/251 6.9 % 2.16 [ 1.08, 4.32 ]
Total (95% CI) 9548 9313 100.0 % 1.63 [ 1.29, 2.07 ]
Total events: 516 (Continuous CTG), 337 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.09; Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.05 (P = 0.000052)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 5 Instrumental
vaginal birth (main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 5 Instrumental vaginal birth (main outcome)
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Athens 1993 104/746 62/682 10.1 % 1.53 [ 1.14, 2.06 ]
Copenhagen 1985 85/482 64/487 10.1 % 1.34 [ 1.00, 1.81 ]
Denver 1976 60/242 78/241 10.5 % 0.77 [ 0.58, 1.02 ]
Denver 1979 118/459 54/231 10.7 % 1.10 [ 0.83, 1.46 ]
Dublin 1985 528/6474 407/6490 16.4 % 1.30 [ 1.15, 1.47 ]
Melbourne 1976 70/175 67/175 11.3 % 1.04 [ 0.80, 1.36 ]
Melbourne 1981 120/445 101/482 12.4 % 1.29 [ 1.02, 1.62 ]
New Delhi 2006 1/50 3/50 0.4 % 0.33 [ 0.04, 3.10 ]
Pakistan 1989 38/100 27/100 7.2 % 1.41 [ 0.94, 2.12 ]
Sheffield 1978 71/253 78/251 11.0 % 0.90 [ 0.69, 1.18 ]
Total (95% CI) 9426 9189 100.0 % 1.15 [ 1.01, 1.33 ]
Total events: 1195 (Continuous CTG), 941 (Intermittent auscultation)
Heterogeneity: Tau2 = 0.03; Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 2.03 (P = 0.042)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 6 Cord blood
acidosis (main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 6 Cord blood acidosis (main outcome)
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Athens 1993 31/739 18/680 56.4 % 1.58 [ 0.89, 2.81 ]
Dublin 1985 5/540 11/535 43.6 % 0.45 [ 0.16, 1.29 ]
Total (95% CI) 1279 1215 100.0 % 0.92 [ 0.27, 3.11 ]
Total events: 36 (CTG), 29 (Auscultation)
Heterogeneity: Tau2 = 0.61; Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 7 Any
pharmacological analgesia (main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 7 Any pharmacological analgesia (main outcome)
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Denver 1976 183/242 194/241 34.3 % 0.94 [ 0.85, 1.03 ]
Denver 1979 418/459 199/231 41.4 % 1.06 [ 1.00, 1.12 ]
Sheffield 1978 141/253 152/251 24.4 % 0.92 [ 0.79, 1.07 ]
Total (95% CI) 954 723 100.0 % 0.98 [ 0.88, 1.09 ]
Total events: 742 (CTG), 545 (Auscultation)
Heterogeneity: Tau2 = 0.01; Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.35 (P = 0.73)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 8 Hypoxic
ischaemic encephalopathy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 8 Hypoxic ischaemic encephalopathy
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Athens 1993 1/746 2/682 100.0 % 0.46 [ 0.04, 5.03 ]
Total (95% CI) 746 682 100.0 % 0.46 [ 0.04, 5.03 ]
Total events: 1 (CTG), 2 (Auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 9
Neurodevelopmental disability at at least 12 months of age.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 9 Neurodevelopmental disability at at least 12 months of age
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Seattle 1987 7/82 2/91 100.0 % 3.88 [ 0.83, 18.17 ]
Total (95% CI) 82 91 100.0 % 3.88 [ 0.83, 18.17 ]
Total events: 7 (CTG), 2 (Auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 1.72 (P = 0.085)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 10 Apgar score <
7 at 5 minutes.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 10 Apgar score < 7 at 5 minutes
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Athens 1993 31/746 26/682 31.8 % 1.09 [ 0.65, 1.82 ]
Copenhagen 1985 0/485 2/493 2.9 % 0.20 [ 0.01, 4.22 ]
Melbourne 1981 39/445 40/482 44.9 % 1.06 [ 0.69, 1.61 ]
New Delhi 2006 1/50 3/50 3.5 % 0.33 [ 0.04, 3.10 ]
Pakistan 1989 9/100 12/100 14.0 % 0.75 [ 0.33, 1.70 ]
Sheffield 1978 0/253 2/251 2.9 % 0.20 [ 0.01, 4.11 ]
Total (95% CI) 2079 2058 100.0 % 0.95 [ 0.71, 1.27 ]
Total events: 80 (CTG), 85 (Auscultation)
Heterogeneity: Chi2 = 3.71, df = 5 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.72)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 11 Apgar score <
4 at 5 minutes.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 11 Apgar score < 4 at 5 minutes
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Copenhagen 1985 0/485 1/493 21.9 % 0.34 [ 0.01, 8.30 ]
Denver 1979 4/463 1/232 19.6 % 2.00 [ 0.23, 17.83 ]
Seattle 1987 9/122 4/124 58.5 % 2.29 [ 0.72, 7.23 ]
Total (95% CI) 1070 849 100.0 % 1.80 [ 0.71, 4.59 ]
Total events: 13 (CTG), 6 (Auscultation)
Heterogeneity: Chi2 = 1.22, df = 2 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 12 Neonatal ICU
admissions.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 12 Neonatal ICU admissions
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Athens 1993 104/746 102/682 16.0 % 0.93 [ 0.72, 1.20 ]
Copenhagen 1985 51/485 49/493 10.7 % 1.06 [ 0.73, 1.53 ]
Dallas 1986 25/7288 17/7330 5.2 % 1.48 [ 0.80, 2.74 ]
Denver 1976 35/242 28/241 8.0 % 1.24 [ 0.78, 1.98 ]
Denver 1979 52/463 29/232 9.0 % 0.90 [ 0.59, 1.38 ]
Dublin 1985 547/6530 543/6554 24.2 % 1.01 [ 0.90, 1.13 ]
Melbourne 1976 11/175 30/175 4.6 % 0.37 [ 0.19, 0.71 ]
Melbourne 1981 59/445 48/482 11.2 % 1.33 [ 0.93, 1.91 ]
New Delhi 2006 1/50 4/50 0.5 % 0.25 [ 0.03, 2.16 ]
Sheffield 1978 45/253 43/251 10.5 % 1.04 [ 0.71, 1.52 ]
Total (95% CI) 16677 16490 100.0 % 1.01 [ 0.86, 1.18 ]
Total events: 930 (CTG), 893 (Auscultation)
Heterogeneity: Tau2 = 0.02; Chi2 = 16.01, df = 9 (P = 0.07); I2 =44%
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 13 Fetal blood
sampling.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 13 Fetal blood sampling
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Copenhagen 1985 3/482 2/487 0.9 % 1.52 [ 0.25, 9.03 ]
Dublin 1985 286/6474 232/6486 99.1 % 1.24 [ 1.04, 1.46 ]
Total (95% CI) 6956 6973 100.0 % 1.24 [ 1.05, 1.47 ]
Total events: 289 (CTG), 234 (Auscultation)
Heterogeneity: Chi2 = 0.05, df = 1 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 2.47 (P = 0.013)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 14
Damage/infection from scalp electrode or scalp sampling.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 14 Damage/infection from scalp electrode or scalp sampling
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Pakistan 1989 1/100 0/100 100.0 % 3.00 [ 0.12, 72.77 ]
Total (95% CI) 100 100 100.0 % 3.00 [ 0.12, 72.77 ]
Total events: 1 (CTG), 0 (Auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 15 Caesarean
section for abnormal FHR pattern and/or acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 15 Caesarean section for abnormal FHR pattern and/or acidosis
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Athens 1993 40/746 16/682 17.2 % 2.29 [ 1.29, 4.04 ]
Copenhagen 1985 8/482 7/487 7.2 % 1.15 [ 0.42, 3.16 ]
Dallas 1986 64/7288 28/7330 28.7 % 2.30 [ 1.48, 3.58 ]
Denver 1976 18/242 3/241 3.1 % 5.98 [ 1.78, 20.02 ]
Denver 1979 24/459 1/231 1.4 % 12.08 [ 1.64, 88.73 ]
Dublin 1985 25/6474 10/6490 10.3 % 2.51 [ 1.20, 5.21 ]
Melbourne 1976 28/175 14/175 14.4 % 2.00 [ 1.09, 3.67 ]
Melbourne 1981 1/445 0/482 0.5 % 3.25 [ 0.13, 79.55 ]
Pakistan 1989 19/100 7/100 7.2 % 2.71 [ 1.19, 6.17 ]
Seattle 1987 10/122 7/124 7.1 % 1.45 [ 0.57, 3.69 ]
Sheffield 1978 4/253 3/251 3.1 % 1.32 [ 0.30, 5.85 ]
Total (95% CI) 16786 16593 100.0 % 2.38 [ 1.89, 3.01 ]
Total events: 241 (CTG), 96 (Auscultation)
Heterogeneity: Chi2 = 8.96, df = 10 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 7.26 (P < 0.00001)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours CTG Favours IA
67Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.16. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 16 Instrumental
vaginal birth for abnormal CTG or fetal acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 16 Instrumental vaginal birth for abnormal CTG or fetal acidosis
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dublin 1985 190/6474 75/6490 100.0 % 2.54 [ 1.95, 3.31 ]
Total (95% CI) 6474 6490 100.0 % 2.54 [ 1.95, 3.31 ]
Total events: 190 (CTG), 75 (Auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 6.89 (P < 0.00001)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours CTG Favours IA
68Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.17. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 17 Spontaneous
vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 17 Spontaneous vaginal birth
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Athens 1993 571/746 561/682 14.4 % 0.93 [ 0.88, 0.98 ]
Copenhagen 1985 369/482 405/487 13.6 % 0.92 [ 0.86, 0.98 ]
Denver 1976 142/242 147/241 7.7 % 0.96 [ 0.83, 1.11 ]
Denver 1979 274/459 164/231 9.9 % 0.84 [ 0.75, 0.94 ]
Dublin 1985 5788/6474 5939/6490 16.5 % 0.98 [ 0.97, 0.99 ]
Melbourne 1976 66/175 84/175 3.9 % 0.79 [ 0.61, 1.00 ]
Melbourne 1981 307/445 371/482 12.4 % 0.90 [ 0.83, 0.97 ]
New Delhi 2006 32/50 36/50 3.3 % 0.89 [ 0.68, 1.16 ]
Pakistan 1989 27/100 61/100 2.1 % 0.44 [ 0.31, 0.63 ]
Seattle 1987 88/122 97/124 7.8 % 0.92 [ 0.80, 1.07 ]
Sheffield 1978 158/253 162/251 8.5 % 0.97 [ 0.85, 1.10 ]
Total (95% CI) 9548 9313 100.0 % 0.91 [ 0.86, 0.96 ]
Total events: 7822 (CTG), 8027 (Auscultation)
Heterogeneity: Tau2 = 0.00; Chi2 = 45.18, df = 10 (P<0.00001); I2 =78%
Test for overall effect: Z = 3.50 (P = 0.00046)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 18 Epidural
analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 18 Epidural analgesia
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Athens 1993 2/746 2/682 0.4 % 0.91 [ 0.13, 6.47 ]
Copenhagen 1985 51/482 34/487 6.1 % 1.52 [ 1.00, 2.30 ]
Denver 1976 51/242 69/241 12.5 % 0.74 [ 0.54, 1.01 ]
Denver 1979 93/459 48/231 11.6 % 0.98 [ 0.71, 1.33 ]
Dublin 1985 194/6474 195/6486 35.3 % 1.00 [ 0.82, 1.21 ]
Melbourne 1976 50/175 43/175 7.8 % 1.16 [ 0.82, 1.65 ]
Seattle 1987 56/122 53/124 9.5 % 1.07 [ 0.81, 1.42 ]
Sheffield 1978 87/253 92/251 16.7 % 0.94 [ 0.74, 1.19 ]
Total (95% CI) 8953 8677 100.0 % 1.00 [ 0.90, 1.12 ]
Total events: 584 (CTG), 536 (Auscultation)
Heterogeneity: Chi2 = 8.77, df = 7 (P = 0.27); I2 =20%
Test for overall effect: Z = 0.07 (P = 0.95)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 19 Oxytocin
during 1st and/or 2nd stage of labour.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 19 Oxytocin during 1st and/or 2nd stage of labour
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Athens 1993 508/746 308/682 22.7 % 1.51 [ 1.37, 1.66 ]
Copenhagen 1985 194/482 195/487 21.4 % 1.01 [ 0.86, 1.17 ]
Denver 1979 139/459 64/231 18.6 % 1.09 [ 0.85, 1.40 ]
Melbourne 1976 109/175 110/175 21.2 % 0.99 [ 0.84, 1.17 ]
Seattle 1987 41/122 50/124 16.1 % 0.83 [ 0.60, 1.16 ]
Total (95% CI) 1984 1699 100.0 % 1.08 [ 0.86, 1.37 ]
Total events: 991 (CTG), 727 (Auscultation)
Heterogeneity: Tau2 = 0.06; Chi2 = 37.02, df = 4 (P<0.00001); I2 =89%
Test for overall effect: Z = 0.67 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 1.20. Comparison 1 Continuous CTG versus intermittent auscultation, Outcome 20 Length of stay
on NICU.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 1 Continuous CTG versus intermittent auscultation
Outcome: 20 Length of stay on NICU
Study or subgroup CTG Auscultation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Athens 1993 104 5.2 (5) 102 5 (5) 100.0 % 0.20 [ -1.17, 1.57 ]
Total (95% CI) 104 102 100.0 % 0.20 [ -1.17, 1.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Continuous CTG versus IA (pregnancy risk status - high/low), Outcome 1
Perinatal mortality.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 2 Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome: 1 Perinatal mortality
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High risk
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Denver 1979 3/463 0/232 1.1 % 3.52 [ 0.18, 67.77 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Pakistan 1989 4/100 5/100 8.5 % 0.80 [ 0.22, 2.89 ]
Seattle 1987 17/122 18/124 30.3 % 0.96 [ 0.52, 1.77 ]
Subtotal (95% CI) 1102 872 43.4 % 1.04 [ 0.62, 1.74 ]
Total events: 27 (Continuous CTG), 25 (IA)
Heterogeneity: Chi2 = 1.16, df = 4 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.14 (P = 0.89)
2 Low risk
Dallas 1986 4/7288 5/7330 8.5 % 0.80 [ 0.22, 3.00 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Sheffield 1978 0/253 1/251 2.6 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 7986 8063 11.8 % 0.87 [ 0.29, 2.58 ]
Total events: 5 (Continuous CTG), 6 (IA)
Heterogeneity: Chi2 = 1.02, df = 2 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.80)
3 Risk status - mixed or not specified
Athens 1993 2/746 9/682 16.0 % 0.20 [ 0.04, 0.94 ]
Copenhagen 1985 2/485 3/493 5.1 % 0.68 [ 0.11, 4.04 ]
Dublin 1985 14/6530 14/6554 23.7 % 1.00 [ 0.48, 2.10 ]
Subtotal (95% CI) 7761 7729 44.8 % 0.68 [ 0.38, 1.24 ]
Total events: 18 (Continuous CTG), 26 (IA)
Heterogeneity: Chi2 = 3.46, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 1.26 (P = 0.21)
Total (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Chi2 = 1.09, df = 2 (P = 0.58), I2 =0.0%
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Analysis 2.2. Comparison 2 Continuous CTG versus IA (pregnancy risk status - high/low), Outcome 2
Neonatal seizures.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 2 Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome: 2 Neonatal seizures
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High risk
Denver 1976 2/242 2/241 4.0 % 1.00 [ 0.14, 7.01 ]
Denver 1979 2/463 2/232 5.3 % 0.50 [ 0.07, 3.53 ]
Dublin 1985 5/1492 8/1539 15.7 % 0.64 [ 0.21, 1.97 ]
Melbourne 1976 0/175 4/175 9.0 % 0.11 [ 0.01, 2.05 ]
Seattle 1987 7/122 7/124 13.8 % 1.02 [ 0.37, 2.81 ]
Subtotal (95% CI) 2494 2311 47.8 % 0.67 [ 0.36, 1.24 ]
Total events: 16 (Continuous CTG), 23 (IA)
Heterogeneity: Chi2 = 2.36, df = 4 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
2 Low risk
Dallas 1986 1/7288 3/7330 6.0 % 0.34 [ 0.03, 3.22 ]
Dublin 1985 7/5038 19/5015 38.0 % 0.37 [ 0.15, 0.87 ]
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 12579 12596 46.9 % 0.36 [ 0.16, 0.79 ]
Total events: 8 (Continuous CTG), 23 (IA)
Heterogeneity: Chi2 = 0.01, df = 2 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 2.55 (P = 0.011)
3 Risk status - mixed or not specified
Athens 1993 0/746 2/682 5.2 % 0.18 [ 0.01, 3.80 ]
Copenhagen 1985 0/485 0/493 Not estimable
Subtotal (95% CI) 1231 1175 5.2 % 0.18 [ 0.01, 3.80 ]
Total events: 0 (Continuous CTG), 2 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.68, df = 8 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 2.88 (P = 0.0040)
Test for subgroup differences: Chi2 = 1.89, df = 2 (P = 0.39), I2 =0.0%
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Analysis 2.3. Comparison 2 Continuous CTG versus IA (pregnancy risk status - high/low), Outcome 3
Cerebral palsy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 2 Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome: 3 Cerebral palsy
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High risk
Seattle 1987 16/82 7/91 39.9 % 2.54 [ 1.10, 5.86 ]
Subtotal (95% CI) 82 91 39.9 % 2.54 [ 1.10, 5.86 ]
Total events: 16 (Continuous CTG), 7 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
2 Low risk
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Risk status - mixed or not specified
Dublin 1985 12/6527 10/6552 60.1 % 1.20 [ 0.52, 2.79 ]
Subtotal (95% CI) 6527 6552 60.1 % 1.20 [ 0.52, 2.79 ]
Total events: 12 (Continuous CTG), 10 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
Total (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Chi2 = 1.52, df = 1 (P = 0.22), I2 =34%
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Analysis 2.4. Comparison 2 Continuous CTG versus IA (pregnancy risk status - high/low), Outcome 4
Caesarean section.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 2 Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome: 4 Caesarean section
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 High risk
Denver 1976 40/242 16/241 8.8 % 2.49 [ 1.43, 4.32 ]
Denver 1979 67/459 13/231 8.5 % 2.59 [ 1.46, 4.60 ]
Melbourne 1976 39/175 24/175 10.2 % 1.63 [ 1.02, 2.58 ]
New Delhi 2006 17/50 11/50 7.4 % 1.55 [ 0.81, 2.96 ]
Pakistan 1989 35/100 12/100 8.2 % 2.92 [ 1.61, 5.28 ]
Seattle 1987 19/122 19/124 8.3 % 1.02 [ 0.57, 1.82 ]
Subtotal (95% CI) 1148 921 51.3 % 1.91 [ 1.39, 2.61 ]
Total events: 217 (Continuous CTG), 95 (IA)
Heterogeneity: Tau2 = 0.07; Chi2 = 9.36, df = 5 (P = 0.10); I2 =47%
Test for overall effect: Z = 4.01 (P = 0.000061)
2 Low risk
Melbourne 1981 18/445 10/482 6.1 % 1.95 [ 0.91, 4.18 ]
Sheffield 1978 24/253 11/251 6.9 % 2.16 [ 1.08, 4.32 ]
Subtotal (95% CI) 698 733 13.0 % 2.06 [ 1.24, 3.45 ]
Total events: 42 (Continuous CTG), 21 (IA)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 2.77 (P = 0.0055)
3 Risk status - mixed or not specified
Athens 1993 71/746 59/682 12.7 % 1.10 [ 0.79, 1.53 ]
Copenhagen 1985 28/482 18/487 8.4 % 1.57 [ 0.88, 2.80 ]
Dublin 1985 158/6474 144/6490 14.6 % 1.10 [ 0.88, 1.37 ]
Subtotal (95% CI) 7702 7659 35.6 % 1.14 [ 0.95, 1.36 ]
Total events: 257 (Continuous CTG), 221 (IA)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.33, df = 2 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 1.43 (P = 0.15)
Total (95% CI) 9548 9313 100.0 % 1.63 [ 1.29, 2.07 ]
Total events: 516 (Continuous CTG), 337 (IA)
Heterogeneity: Tau2 = 0.09; Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.05 (P = 0.000052)
Test for subgroup differences: Chi2 = 10.89, df = 2 (P = 0.00), I2 =82%
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Analysis 2.5. Comparison 2 Continuous CTG versus IA (pregnancy risk status - high/low), Outcome 5
Instrumental vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 2 Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome: 5 Instrumental vaginal birth
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 High risk
Denver 1976 60/242 78/241 10.5 % 0.77 [ 0.58, 1.02 ]
Denver 1979 118/459 54/231 10.7 % 1.10 [ 0.83, 1.46 ]
Melbourne 1976 70/175 67/175 11.3 % 1.04 [ 0.80, 1.36 ]
New Delhi 2006 1/50 3/50 0.4 % 0.33 [ 0.04, 3.10 ]
Pakistan 1989 38/100 27/100 7.2 % 1.41 [ 0.94, 2.12 ]
Subtotal (95% CI) 1026 797 40.0 % 1.02 [ 0.82, 1.27 ]
Total events: 287 (Continuous CTG), 229 (IA)
Heterogeneity: Tau2 = 0.03; Chi2 = 7.52, df = 4 (P = 0.11); I2 =47%
Test for overall effect: Z = 0.17 (P = 0.87)
2 Low risk
Melbourne 1981 120/445 101/482 12.4 % 1.29 [ 1.02, 1.62 ]
Sheffield 1978 71/253 78/251 11.0 % 0.90 [ 0.69, 1.18 ]
Subtotal (95% CI) 698 733 23.4 % 1.09 [ 0.77, 1.54 ]
Total events: 191 (Continuous CTG), 179 (IA)
Heterogeneity: Tau2 = 0.05; Chi2 = 3.82, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 0.46 (P = 0.64)
3 Risk status - mixed or not specified
Athens 1993 104/746 62/682 10.1 % 1.53 [ 1.14, 2.06 ]
Copenhagen 1985 85/482 64/487 10.1 % 1.34 [ 1.00, 1.81 ]
Dublin 1985 528/6474 407/6490 16.4 % 1.30 [ 1.15, 1.47 ]
Subtotal (95% CI) 7702 7659 36.6 % 1.33 [ 1.20, 1.49 ]
Total events: 717 (Continuous CTG), 533 (IA)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.01, df = 2 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 5.27 (P < 0.00001)
Total (95% CI) 9426 9189 100.0 % 1.15 [ 1.01, 1.33 ]
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(. . . Continued)
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total events: 1195 (Continuous CTG), 941 (IA)
Heterogeneity: Tau2 = 0.03; Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 2.03 (P = 0.042)
Test for subgroup differences: Chi2 = 5.33, df = 2 (P = 0.07), I2 =63%
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Analysis 2.6. Comparison 2 Continuous CTG versus IA (pregnancy risk status - high/low), Outcome 6 Cord
blood acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 2 Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome: 6 Cord blood acidosis
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High risk
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Low risk
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Risk status - mixed or not specified
Athens 1993 31/739 18/680 62.9 % 1.58 [ 0.89, 2.81 ]
Dublin 1985 5/540 11/535 37.1 % 0.45 [ 0.16, 1.29 ]
Subtotal (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
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(. . . Continued)
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.61 (P = 0.54)
Total (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Continuous CTG versus IA (pregnancy risk status - high/low), Outcome 7 Any
pharmacological analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 2 Continuous CTG versus IA (pregnancy risk status - high/low)
Outcome: 7 Any pharmacological analgesia
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High risk
Denver 1976 183/242 194/241 31.8 % 0.94 [ 0.85, 1.03 ]
Denver 1979 418/459 199/231 43.3 % 1.06 [ 1.00, 1.12 ]
Subtotal (95% CI) 701 472 75.1 % 1.01 [ 0.96, 1.06 ]
Total events: 601 (Continuous CTG), 393 (IA)
Heterogeneity: Chi2 = 4.65, df = 1 (P = 0.03); I2 =78%
Test for overall effect: Z = 0.27 (P = 0.79)
2 Low risk
Sheffield 1978 141/253 152/251 24.9 % 0.92 [ 0.79, 1.07 ]
Subtotal (95% CI) 253 251 24.9 % 0.92 [ 0.79, 1.07 ]
Total events: 141 (Continuous CTG), 152 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
3 Risk status - mixed or not specified
Subtotal (95% CI) 0 0 Not estimable
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(. . . Continued)
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Chi2 = 1.27, df = 1 (P = 0.26), I2 =21%
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Analysis 3.1. Comparison 3 Continuous CTG versus IA (onset of labour - spontaneous/induced), Outcome 1
Perinatal mortality.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 3 Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome: 1 Perinatal mortality
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Spontaneous labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Induction of labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Onset of labour - not specified
Athens 1993 2/746 9/682 16.0 % 0.20 [ 0.04, 0.94 ]
Copenhagen 1985 2/485 3/493 5.1 % 0.68 [ 0.11, 4.04 ]
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(. . . Continued)
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dallas 1986 4/7288 5/7330 8.5 % 0.80 [ 0.22, 3.00 ]
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Denver 1979 3/463 0/232 1.1 % 3.52 [ 0.18, 67.77 ]
Dublin 1985 14/6530 14/6554 23.7 % 1.00 [ 0.48, 2.10 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Pakistan 1989 4/100 5/100 8.5 % 0.80 [ 0.22, 2.89 ]
Seattle 1987 17/122 18/124 30.3 % 0.96 [ 0.52, 1.77 ]
Sheffield 1978 0/253 1/251 2.6 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Total (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Continuous CTG versus IA (onset of labour - spontaneous/induced), Outcome 2
Neonatal seizures.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 3 Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome: 2 Neonatal seizures
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Spontaneous labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Induction of labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Onset of labour - not specified
Athens 1993 0/746 2/682 5.2 % 0.18 [ 0.01, 3.80 ]
Copenhagen 1985 0/485 0/493 Not estimable
Dallas 1986 1/7288 3/7330 6.0 % 0.34 [ 0.03, 3.22 ]
Denver 1976 2/242 2/241 4.0 % 1.00 [ 0.14, 7.01 ]
Denver 1979 2/463 2/232 5.3 % 0.50 [ 0.07, 3.53 ]
Dublin 1985 12/6530 27/6554 53.7 % 0.45 [ 0.23, 0.88 ]
Melbourne 1976 0/175 4/175 9.0 % 0.11 [ 0.01, 2.05 ]
Seattle 1987 7/122 7/124 13.8 % 1.02 [ 0.37, 2.81 ]
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Continuous CTG versus IA (onset of labour - spontaneous/induced), Outcome 3
Cerebral palsy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 3 Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome: 3 Cerebral palsy
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Spontaneous labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Induction of labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Onset of labour - not specified
Dublin 1985 12/6527 10/6552 60.1 % 1.20 [ 0.52, 2.79 ]
Seattle 1987 16/82 7/91 39.9 % 2.54 [ 1.10, 5.86 ]
Subtotal (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Total (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 Continuous CTG versus IA (onset of labour - spontaneous/induced), Outcome 4
Caesarean section.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 3 Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome: 4 Caesarean section
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Spontaneous labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Induction of labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Onset of labour - not specified
Athens 1993 71/746 59/682 18.0 % 1.10 [ 0.79, 1.53 ]
Copenhagen 1985 28/482 18/487 5.2 % 1.57 [ 0.88, 2.80 ]
Denver 1976 40/242 16/241 4.7 % 2.49 [ 1.43, 4.32 ]
Denver 1979 67/459 13/231 5.0 % 2.59 [ 1.46, 4.60 ]
Dublin 1985 158/6474 144/6490 41.9 % 1.10 [ 0.88, 1.37 ]
Melbourne 1976 39/175 24/175 7.0 % 1.63 [ 1.02, 2.58 ]
Melbourne 1981 18/445 10/482 2.8 % 1.95 [ 0.91, 4.18 ]
New Delhi 2006 17/50 11/50 3.2 % 1.55 [ 0.81, 2.96 ]
Pakistan 1989 35/100 12/100 3.5 % 2.92 [ 1.61, 5.28 ]
Seattle 1987 19/122 19/124 5.5 % 1.02 [ 0.57, 1.82 ]
Sheffield 1978 24/253 11/251 3.2 % 2.16 [ 1.08, 4.32 ]
Subtotal (95% CI) 9548 9313 100.0 % 1.43 [ 1.25, 1.64 ]
Total events: 516 (Continuous CTG), 337 (IA)
Heterogeneity: Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 5.30 (P < 0.00001)
Total (95% CI) 9548 9313 100.0 % 1.43 [ 1.25, 1.64 ]
Total events: 516 (Continuous CTG), 337 (IA)
Heterogeneity: Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 5.30 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 3.5. Comparison 3 Continuous CTG versus IA (onset of labour - spontaneous/induced), Outcome 5
Instrumental vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 3 Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome: 5 Instrumental vaginal birth
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Spontaneous labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Induction of labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Onset of labour - not specified
Athens 1993 104/746 62/682 6.8 % 1.53 [ 1.14, 2.06 ]
Copenhagen 1985 85/482 64/487 6.7 % 1.34 [ 1.00, 1.81 ]
Denver 1976 60/242 78/241 8.2 % 0.77 [ 0.58, 1.02 ]
Denver 1979 118/459 54/231 7.5 % 1.10 [ 0.83, 1.46 ]
Dublin 1985 528/6474 407/6490 42.5 % 1.30 [ 1.15, 1.47 ]
Melbourne 1976 70/175 67/175 7.0 % 1.04 [ 0.80, 1.36 ]
Melbourne 1981 120/445 101/482 10.1 % 1.29 [ 1.02, 1.62 ]
New Delhi 2006 1/50 3/50 0.3 % 0.33 [ 0.04, 3.10 ]
Pakistan 1989 38/100 27/100 2.8 % 1.41 [ 0.94, 2.12 ]
Sheffield 1978 71/253 78/251 8.2 % 0.90 [ 0.69, 1.18 ]
Subtotal (95% CI) 9426 9189 100.0 % 1.21 [ 1.12, 1.31 ]
Total events: 1195 (Continuous CTG), 941 (IA)
Heterogeneity: Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.75 (P < 0.00001)
Total (95% CI) 9426 9189 100.0 % 1.21 [ 1.12, 1.31 ]
Total events: 1195 (Continuous CTG), 941 (IA)
Heterogeneity: Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.75 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 3.6. Comparison 3 Continuous CTG versus IA (onset of labour - spontaneous/induced), Outcome 6
Cord blood acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 3 Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome: 6 Cord blood acidosis
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Spontaneous labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Induction of labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Onset of labour - not specified
Athens 1993 31/739 18/680 62.9 % 1.58 [ 0.89, 2.81 ]
Dublin 1985 5/540 11/535 37.1 % 0.45 [ 0.16, 1.29 ]
Subtotal (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Total (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 3.7. Comparison 3 Continuous CTG versus IA (onset of labour - spontaneous/induced), Outcome 7
Any pharmacological analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 3 Continuous CTG versus IA (onset of labour - spontaneous/induced)
Outcome: 7 Any pharmacological analgesia
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Spontaneous labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Induction of labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Onset of labour - not specified
Denver 1976 183/242 194/241 31.8 % 0.94 [ 0.85, 1.03 ]
Denver 1979 418/459 199/231 43.3 % 1.06 [ 1.00, 1.12 ]
Sheffield 1978 141/253 152/251 24.9 % 0.92 [ 0.79, 1.07 ]
Subtotal (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Total (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Continuous CTG versus IA (preterm/term labour), Outcome 1 Perinatal
mortality.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 4 Continuous CTG versus IA (preterm/term labour)
Outcome: 1 Perinatal mortality
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm labour
Seattle 1987 17/122 18/124 30.3 % 0.96 [ 0.52, 1.77 ]
Subtotal (95% CI) 122 124 30.3 % 0.96 [ 0.52, 1.77 ]
Total events: 17 (Continuous CTG), 18 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.13 (P = 0.90)
2 Term labour
Copenhagen 1985 2/485 3/493 5.1 % 0.68 [ 0.11, 4.04 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Sheffield 1978 0/253 1/251 2.6 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 1183 1226 8.4 % 0.82 [ 0.22, 3.03 ]
Total events: 3 (Continuous CTG), 4 (IA)
Heterogeneity: Chi2 = 1.07, df = 2 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.77)
3 Both or gestation not specified
Athens 1993 2/746 9/682 16.0 % 0.20 [ 0.04, 0.94 ]
Dallas 1986 4/7288 5/7330 8.5 % 0.80 [ 0.22, 3.00 ]
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Denver 1979 3/463 0/232 1.1 % 3.52 [ 0.18, 67.77 ]
Dublin 1985 14/6530 14/6554 23.7 % 1.00 [ 0.48, 2.10 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Pakistan 1989 4/100 5/100 8.5 % 0.80 [ 0.22, 2.89 ]
Subtotal (95% CI) 15544 15314 61.2 % 0.81 [ 0.50, 1.32 ]
Total events: 30 (Continuous CTG), 35 (IA)
Heterogeneity: Chi2 = 4.97, df = 6 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.84 (P = 0.40)
Total (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Chi2 = 0.18, df = 2 (P = 0.91), I2 =0.0%
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Analysis 4.2. Comparison 4 Continuous CTG versus IA (preterm/term labour), Outcome 2 Neonatal
seizures.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 4 Continuous CTG versus IA (preterm/term labour)
Outcome: 2 Neonatal seizures
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm labour
Seattle 1987 7/122 7/124 13.8 % 1.02 [ 0.37, 2.81 ]
Subtotal (95% CI) 122 124 13.8 % 1.02 [ 0.37, 2.81 ]
Total events: 7 (Continuous CTG), 7 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
2 Term labour
Copenhagen 1985 0/485 0/493 Not estimable
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 738 744 3.0 % 0.33 [ 0.01, 8.08 ]
Total events: 0 (Continuous CTG), 1 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
3 Both or gestation not specified
Athens 1993 0/746 2/682 5.2 % 0.18 [ 0.01, 3.80 ]
Dallas 1986 1/7288 3/7330 6.0 % 0.34 [ 0.03, 3.22 ]
Denver 1976 2/242 2/241 4.0 % 1.00 [ 0.14, 7.01 ]
Denver 1979 2/463 2/232 5.3 % 0.50 [ 0.07, 3.53 ]
Dublin 1985 12/6530 27/6554 53.7 % 0.45 [ 0.23, 0.88 ]
Melbourne 1976 0/175 4/175 9.0 % 0.11 [ 0.01, 2.05 ]
Subtotal (95% CI) 15444 15214 83.2 % 0.42 [ 0.24, 0.72 ]
Total events: 17 (Continuous CTG), 40 (IA)
Heterogeneity: Chi2 = 1.95, df = 5 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 3.09 (P = 0.0020)
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Test for subgroup differences: Chi2 = 2.36, df = 2 (P = 0.31), I2 =15%
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Analysis 4.3. Comparison 4 Continuous CTG versus IA (preterm/term labour), Outcome 3 Cerebral palsy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 4 Continuous CTG versus IA (preterm/term labour)
Outcome: 3 Cerebral palsy
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm labour
Seattle 1987 16/82 7/91 39.9 % 2.54 [ 1.10, 5.86 ]
Subtotal (95% CI) 82 91 39.9 % 2.54 [ 1.10, 5.86 ]
Total events: 16 (Continuous CTG), 7 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
2 Term labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or gestation not specified
Dublin 1985 12/6527 10/6552 60.1 % 1.20 [ 0.52, 2.79 ]
Subtotal (95% CI) 6527 6552 60.1 % 1.20 [ 0.52, 2.79 ]
Total events: 12 (Continuous CTG), 10 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
Total (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Chi2 = 1.52, df = 1 (P = 0.22), I2 =34%
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Analysis 4.4. Comparison 4 Continuous CTG versus IA (preterm/term labour), Outcome 4 Caesarean
section.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 4 Continuous CTG versus IA (preterm/term labour)
Outcome: 4 Caesarean section
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm labour
Seattle 1987 19/122 19/124 5.5 % 1.02 [ 0.57, 1.82 ]
Subtotal (95% CI) 122 124 5.5 % 1.02 [ 0.57, 1.82 ]
Total events: 19 (Continuous CTG), 19 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
2 Term labour
Copenhagen 1985 28/482 18/487 5.2 % 1.57 [ 0.88, 2.80 ]
Melbourne 1981 18/445 10/482 2.8 % 1.95 [ 0.91, 4.18 ]
Sheffield 1978 24/253 11/251 3.2 % 2.16 [ 1.08, 4.32 ]
Subtotal (95% CI) 1180 1220 11.2 % 1.84 [ 1.25, 2.69 ]
Total events: 70 (Continuous CTG), 39 (IA)
Heterogeneity: Chi2 = 0.52, df = 2 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 3.11 (P = 0.0019)
3 Both or gestation not specified
Athens 1993 71/746 59/682 18.0 % 1.10 [ 0.79, 1.53 ]
Denver 1976 40/242 16/241 4.7 % 2.49 [ 1.43, 4.32 ]
Denver 1979 67/459 13/231 5.0 % 2.59 [ 1.46, 4.60 ]
Dublin 1985 158/6474 144/6490 41.9 % 1.10 [ 0.88, 1.37 ]
Melbourne 1976 39/175 24/175 7.0 % 1.63 [ 1.02, 2.58 ]
New Delhi 2006 17/50 11/50 3.2 % 1.55 [ 0.81, 2.96 ]
Pakistan 1989 35/100 12/100 3.5 % 2.92 [ 1.61, 5.28 ]
Subtotal (95% CI) 8246 7969 83.3 % 1.41 [ 1.21, 1.63 ]
Total events: 427 (Continuous CTG), 279 (IA)
Heterogeneity: Chi2 = 21.55, df = 6 (P = 0.001); I2 =72%
Test for overall effect: Z = 4.56 (P < 0.00001)
Total (95% CI) 9548 9313 100.0 % 1.43 [ 1.25, 1.64 ]
Total events: 516 (Continuous CTG), 337 (IA)
Heterogeneity: Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 5.30 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.00, df = 2 (P = 0.22), I2 =33%
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Analysis 4.5. Comparison 4 Continuous CTG versus IA (preterm/term labour), Outcome 5 Instrumental
vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 4 Continuous CTG versus IA (preterm/term labour)
Outcome: 5 Instrumental vaginal birth
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Term labour
Copenhagen 1985 85/482 64/487 6.7 % 1.34 [ 1.00, 1.81 ]
Melbourne 1981 120/445 101/482 10.1 % 1.29 [ 1.02, 1.62 ]
Sheffield 1978 71/253 78/251 8.2 % 0.90 [ 0.69, 1.18 ]
Subtotal (95% CI) 1180 1220 25.0 % 1.18 [ 1.01, 1.37 ]
Total events: 276 (Continuous CTG), 243 (IA)
Heterogeneity: Chi2 = 5.01, df = 2 (P = 0.08); I2 =60%
Test for overall effect: Z = 2.10 (P = 0.036)
3 Both or gestation not specified
Athens 1993 104/746 62/682 6.8 % 1.53 [ 1.14, 2.06 ]
Denver 1976 60/242 78/241 8.2 % 0.77 [ 0.58, 1.02 ]
Denver 1979 118/459 54/231 7.5 % 1.10 [ 0.83, 1.46 ]
Dublin 1985 528/6474 407/6490 42.5 % 1.30 [ 1.15, 1.47 ]
Melbourne 1976 70/175 67/175 7.0 % 1.04 [ 0.80, 1.36 ]
New Delhi 2006 1/50 3/50 0.3 % 0.33 [ 0.04, 3.10 ]
Pakistan 1989 38/100 27/100 2.8 % 1.41 [ 0.94, 2.12 ]
Subtotal (95% CI) 8246 7969 75.0 % 1.22 [ 1.11, 1.34 ]
Total events: 919 (Continuous CTG), 698 (IA)
Heterogeneity: Chi2 = 17.15, df = 6 (P = 0.01); I2 =65%
Test for overall effect: Z = 4.26 (P = 0.000020)
Total (95% CI) 9426 9189 100.0 % 1.21 [ 1.12, 1.31 ]
Total events: 1195 (Continuous CTG), 941 (IA)
Heterogeneity: Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.75 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.16, df = 1 (P = 0.69), I2 =0.0%
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Analysis 4.6. Comparison 4 Continuous CTG versus IA (preterm/term labour), Outcome 6 Cord blood
acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 4 Continuous CTG versus IA (preterm/term labour)
Outcome: 6 Cord blood acidosis
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Term labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or gestation not specified
Athens 1993 31/739 18/680 62.9 % 1.58 [ 0.89, 2.81 ]
Dublin 1985 5/540 11/535 37.1 % 0.45 [ 0.16, 1.29 ]
Subtotal (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Total (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 4.7. Comparison 4 Continuous CTG versus IA (preterm/term labour), Outcome 7 Any
pharmacological analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 4 Continuous CTG versus IA (preterm/term labour)
Outcome: 7 Any pharmacological analgesia
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm labour
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Term labour
Sheffield 1978 141/253 152/251 24.9 % 0.92 [ 0.79, 1.07 ]
Subtotal (95% CI) 253 251 24.9 % 0.92 [ 0.79, 1.07 ]
Total events: 141 (Continuous CTG), 152 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
3 Both or gestation not specified
Denver 1976 183/242 194/241 31.8 % 0.94 [ 0.85, 1.03 ]
Denver 1979 418/459 199/231 43.3 % 1.06 [ 1.00, 1.12 ]
Subtotal (95% CI) 701 472 75.1 % 1.01 [ 0.96, 1.06 ]
Total events: 601 (Continuous CTG), 393 (IA)
Heterogeneity: Chi2 = 4.65, df = 1 (P = 0.03); I2 =78%
Test for overall effect: Z = 0.27 (P = 0.79)
Total (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Chi2 = 1.27, df = 1 (P = 0.26), I2 =21%
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Analysis 5.1. Comparison 5 Continuous CTG versus IA (singleton/twin pregnancy), Outcome 1 Perinatal
mortality.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 5 Continuous CTG versus IA (singleton/twin pregnancy)
Outcome: 1 Perinatal mortality
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton
Athens 1993 2/746 9/682 16.0 % 0.20 [ 0.04, 0.94 ]
Dallas 1986 4/7288 5/7330 8.5 % 0.80 [ 0.22, 3.00 ]
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Pakistan 1989 4/100 5/100 8.5 % 0.80 [ 0.22, 2.89 ]
Seattle 1987 17/122 18/124 30.3 % 0.96 [ 0.52, 1.77 ]
Sheffield 1978 0/253 1/251 2.6 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 9196 9210 68.4 % 0.77 [ 0.49, 1.21 ]
Total events: 30 (Continuous CTG), 39 (IA)
Heterogeneity: Chi2 = 5.06, df = 6 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.12 (P = 0.26)
2 Twins
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or singleton/twins not specified
Copenhagen 1985 2/485 3/493 5.1 % 0.68 [ 0.11, 4.04 ]
Denver 1979 3/463 0/232 1.1 % 3.52 [ 0.18, 67.77 ]
Dublin 1985 14/6530 14/6554 23.7 % 1.00 [ 0.48, 2.10 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Subtotal (95% CI) 7653 7454 31.6 % 1.04 [ 0.55, 1.97 ]
Total events: 20 (Continuous CTG), 18 (IA)
Heterogeneity: Chi2 = 0.88, df = 3 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
Total (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Chi2 = 0.56, df = 1 (P = 0.46), I2 =0.0%
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Analysis 5.2. Comparison 5 Continuous CTG versus IA (singleton/twin pregnancy), Outcome 2 Neonatal
seizures.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 5 Continuous CTG versus IA (singleton/twin pregnancy)
Outcome: 2 Neonatal seizures
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton
Athens 1993 0/746 2/682 5.2 % 0.18 [ 0.01, 3.80 ]
Dallas 1986 1/7288 3/7330 6.0 % 0.34 [ 0.03, 3.22 ]
Denver 1976 2/242 2/241 4.0 % 1.00 [ 0.14, 7.01 ]
Seattle 1987 7/122 7/124 13.8 % 1.02 [ 0.37, 2.81 ]
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 8651 8628 32.0 % 0.69 [ 0.32, 1.46 ]
Total events: 10 (Continuous CTG), 15 (IA)
Heterogeneity: Chi2 = 2.03, df = 4 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 0.98 (P = 0.33)
2 Twins
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or singleton/twins not specified
Copenhagen 1985 0/485 0/493 Not estimable
Denver 1979 2/463 2/232 5.3 % 0.50 [ 0.07, 3.53 ]
Dublin 1985 12/6530 27/6554 53.7 % 0.45 [ 0.23, 0.88 ]
Melbourne 1976 0/175 4/175 9.0 % 0.11 [ 0.01, 2.05 ]
Subtotal (95% CI) 7653 7454 68.0 % 0.41 [ 0.22, 0.76 ]
Total events: 14 (Continuous CTG), 33 (IA)
Heterogeneity: Chi2 = 0.88, df = 2 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 2.84 (P = 0.0044)
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Test for subgroup differences: Chi2 = 1.11, df = 1 (P = 0.29), I2 =10%
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Analysis 5.3. Comparison 5 Continuous CTG versus IA (singleton/twin pregnancy), Outcome 3 Cerebral
palsy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 5 Continuous CTG versus IA (singleton/twin pregnancy)
Outcome: 3 Cerebral palsy
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton
Seattle 1987 16/82 7/91 39.9 % 2.54 [ 1.10, 5.86 ]
Subtotal (95% CI) 82 91 39.9 % 2.54 [ 1.10, 5.86 ]
Total events: 16 (Continuous CTG), 7 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
2 Twins
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or singleton/twins not specified
Dublin 1985 12/6527 10/6552 60.1 % 1.20 [ 0.52, 2.79 ]
Subtotal (95% CI) 6527 6552 60.1 % 1.20 [ 0.52, 2.79 ]
Total events: 12 (Continuous CTG), 10 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
Total (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Chi2 = 1.52, df = 1 (P = 0.22), I2 =34%
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Analysis 5.4. Comparison 5 Continuous CTG versus IA (singleton/twin pregnancy), Outcome 4 Caesarean
section.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 5 Continuous CTG versus IA (singleton/twin pregnancy)
Outcome: 4 Caesarean section
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton
Athens 1993 71/746 59/682 18.0 % 1.10 [ 0.79, 1.53 ]
Denver 1976 40/242 16/241 4.7 % 2.49 [ 1.43, 4.32 ]
Melbourne 1981 18/445 10/482 2.8 % 1.95 [ 0.91, 4.18 ]
New Delhi 2006 17/50 11/50 3.2 % 1.55 [ 0.81, 2.96 ]
Pakistan 1989 35/100 12/100 3.5 % 2.92 [ 1.61, 5.28 ]
Seattle 1987 19/122 19/124 5.5 % 1.02 [ 0.57, 1.82 ]
Sheffield 1978 24/253 11/251 3.2 % 2.16 [ 1.08, 4.32 ]
Subtotal (95% CI) 1958 1930 40.8 % 1.58 [ 1.30, 1.93 ]
Total events: 224 (Continuous CTG), 138 (IA)
Heterogeneity: Chi2 = 14.62, df = 6 (P = 0.02); I2 =59%
Test for overall effect: Z = 4.51 (P < 0.00001)
2 Twins
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or singleton/twins not specified
Copenhagen 1985 28/482 18/487 5.2 % 1.57 [ 0.88, 2.80 ]
Denver 1979 67/459 13/231 5.0 % 2.59 [ 1.46, 4.60 ]
Dublin 1985 158/6474 144/6490 41.9 % 1.10 [ 0.88, 1.37 ]
Melbourne 1976 39/175 24/175 7.0 % 1.63 [ 1.02, 2.58 ]
Subtotal (95% CI) 7590 7383 59.2 % 1.33 [ 1.11, 1.59 ]
Total events: 292 (Continuous CTG), 199 (IA)
Heterogeneity: Chi2 = 9.05, df = 3 (P = 0.03); I2 =67%
Test for overall effect: Z = 3.13 (P = 0.0017)
Total (95% CI) 9548 9313 100.0 % 1.43 [ 1.25, 1.64 ]
Total events: 516 (Continuous CTG), 337 (IA)
Heterogeneity: Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 5.30 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.58, df = 1 (P = 0.21), I2 =37%
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Analysis 5.5. Comparison 5 Continuous CTG versus IA (singleton/twin pregnancy), Outcome 5
Instrumental vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 5 Continuous CTG versus IA (singleton/twin pregnancy)
Outcome: 5 Instrumental vaginal birth
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton
Athens 1993 104/746 62/682 6.8 % 1.53 [ 1.14, 2.06 ]
Denver 1976 60/242 78/241 8.2 % 0.77 [ 0.58, 1.02 ]
Melbourne 1981 120/445 101/482 10.1 % 1.29 [ 1.02, 1.62 ]
New Delhi 2006 1/50 3/50 0.3 % 0.33 [ 0.04, 3.10 ]
Pakistan 1989 38/100 27/100 2.8 % 1.41 [ 0.94, 2.12 ]
Sheffield 1978 71/253 78/251 8.2 % 0.90 [ 0.69, 1.18 ]
Subtotal (95% CI) 1836 1806 36.4 % 1.13 [ 1.00, 1.28 ]
Total events: 394 (Continuous CTG), 349 (IA)
Heterogeneity: Chi2 = 17.32, df = 5 (P = 0.004); I2 =71%
Test for overall effect: Z = 1.91 (P = 0.057)
2 Twins
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or singleton/twins not specified
Copenhagen 1985 85/482 64/487 6.7 % 1.34 [ 1.00, 1.81 ]
Denver 1979 118/459 54/231 7.5 % 1.10 [ 0.83, 1.46 ]
Dublin 1985 528/6474 407/6490 42.5 % 1.30 [ 1.15, 1.47 ]
Melbourne 1976 70/175 67/175 7.0 % 1.04 [ 0.80, 1.36 ]
Subtotal (95% CI) 7590 7383 63.6 % 1.25 [ 1.13, 1.38 ]
Total events: 801 (Continuous CTG), 592 (IA)
Heterogeneity: Chi2 = 3.23, df = 3 (P = 0.36); I2 =7%
Test for overall effect: Z = 4.45 (P < 0.00001)
Total (95% CI) 9426 9189 100.0 % 1.21 [ 1.12, 1.31 ]
Total events: 1195 (Continuous CTG), 941 (IA)
Heterogeneity: Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.75 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.57, df = 1 (P = 0.21), I2 =36%
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Analysis 5.6. Comparison 5 Continuous CTG versus IA (singleton/twin pregnancy), Outcome 6 Cord blood
acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 5 Continuous CTG versus IA (singleton/twin pregnancy)
Outcome: 6 Cord blood acidosis
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton
Athens 1993 31/739 18/680 62.9 % 1.58 [ 0.89, 2.81 ]
Subtotal (95% CI) 739 680 62.9 % 1.58 [ 0.89, 2.81 ]
Total events: 31 (Continuous CTG), 18 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.58 (P = 0.11)
2 Twins
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or singleton/twins not specified
Dublin 1985 5/540 11/535 37.1 % 0.45 [ 0.16, 1.29 ]
Subtotal (95% CI) 540 535 37.1 % 0.45 [ 0.16, 1.29 ]
Total events: 5 (Continuous CTG), 11 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
Total (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Chi2 = 4.25, df = 1 (P = 0.04), I2 =76%
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Analysis 5.7. Comparison 5 Continuous CTG versus IA (singleton/twin pregnancy), Outcome 7 Any
pharmacological analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 5 Continuous CTG versus IA (singleton/twin pregnancy)
Outcome: 7 Any pharmacological analgesia
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Singleton
Denver 1976 183/242 194/241 31.8 % 0.94 [ 0.85, 1.03 ]
Sheffield 1978 141/253 152/251 24.9 % 0.92 [ 0.79, 1.07 ]
Subtotal (95% CI) 495 492 56.7 % 0.93 [ 0.86, 1.01 ]
Total events: 324 (Continuous CTG), 346 (IA)
Heterogeneity: Chi2 = 0.06, df = 1 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.095)
2 Twins
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or singleton/twins not specified
Denver 1979 418/459 199/231 43.3 % 1.06 [ 1.00, 1.12 ]
Subtotal (95% CI) 459 231 43.3 % 1.06 [ 1.00, 1.12 ]
Total events: 418 (Continuous CTG), 199 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.84 (P = 0.066)
Total (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Chi2 = 5.88, df = 1 (P = 0.02), I2 =83%
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Analysis 6.1. Comparison 6 Continuous CTG versus IA (access to FBS during labour - yes/no), Outcome 1
Perinatal mortality.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 6 Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome: 1 Perinatal mortality
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Continuous CTG plus FBS
Copenhagen 1985 2/485 3/493 5.0 % 0.68 [ 0.11, 4.04 ]
Denver 1979 1/230 0/116 1.1 % 1.52 [ 0.06, 37.01 ]
Dublin 1985 14/6530 14/6554 23.5 % 1.00 [ 0.48, 2.10 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Pakistan 1989 4/100 5/100 8.4 % 0.80 [ 0.22, 2.89 ]
Seattle 1987 17/122 18/124 30.0 % 0.96 [ 0.52, 1.77 ]
Subtotal (95% CI) 8087 8044 70.5 % 0.97 [ 0.64, 1.47 ]
Total events: 40 (Continuous CTG), 41 (IA)
Heterogeneity: Chi2 = 0.88, df = 6 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 0.14 (P = 0.89)
2 Continuous CTG alone - no FBS
Athens 1993 2/746 9/682 15.8 % 0.20 [ 0.04, 0.94 ]
Dallas 1986 4/7288 5/7330 8.4 % 0.80 [ 0.22, 3.00 ]
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Denver 1979 2/233 0/116 1.1 % 2.50 [ 0.12, 51.65 ]
Sheffield 1978 0/253 1/251 2.5 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 8762 8620 29.5 % 0.57 [ 0.26, 1.24 ]
Total events: 10 (Continuous CTG), 16 (IA)
Heterogeneity: Chi2 = 4.09, df = 4 (P = 0.39); I2 =2%
Test for overall effect: Z = 1.41 (P = 0.16)
Total (95% CI) 16849 16664 100.0 % 0.85 [ 0.59, 1.23 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 5.90, df = 11 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.85 (P = 0.40)
Test for subgroup differences: Chi2 = 1.38, df = 1 (P = 0.24), I2 =27%
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Analysis 6.2. Comparison 6 Continuous CTG versus IA (access to FBS during labour - yes/no), Outcome 2
Neonatal seizures.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 6 Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome: 2 Neonatal seizures
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Continuous CTG plus FBS
Copenhagen 1985 0/485 0/493 Not estimable
Denver 1979 0/230 1/116 3.9 % 0.17 [ 0.01, 4.11 ]
Dublin 1985 12/6530 27/6554 53.0 % 0.45 [ 0.23, 0.88 ]
Melbourne 1976 0/175 4/175 8.9 % 0.11 [ 0.01, 2.05 ]
Seattle 1987 7/122 7/124 13.7 % 1.02 [ 0.37, 2.81 ]
Subtotal (95% CI) 7542 7462 79.4 % 0.49 [ 0.29, 0.84 ]
Total events: 19 (Continuous CTG), 39 (IA)
Heterogeneity: Chi2 = 3.46, df = 3 (P = 0.33); I2 =13%
Test for overall effect: Z = 2.61 (P = 0.0090)
2 Continuous CTG alone - no FBS
Athens 1993 0/746 2/682 5.1 % 0.18 [ 0.01, 3.80 ]
Dallas 1986 1/7288 3/7330 5.9 % 0.34 [ 0.03, 3.22 ]
Denver 1976 2/242 2/241 3.9 % 1.00 [ 0.14, 7.01 ]
Denver 1979 2/233 1/116 2.6 % 1.00 [ 0.09, 10.87 ]
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 8762 8620 20.6 % 0.51 [ 0.18, 1.44 ]
Total events: 5 (Continuous CTG), 9 (IA)
Heterogeneity: Chi2 = 1.40, df = 4 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.86, df = 8 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.91 (P = 0.0036)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.96), I2 =0.0%
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Analysis 6.3. Comparison 6 Continuous CTG versus IA (access to FBS during labour - yes/no), Outcome 3
Cerebral palsy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 6 Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome: 3 Cerebral palsy
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Continuous CTG plus FBS
Dublin 1985 12/6527 10/6552 60.1 % 1.20 [ 0.52, 2.79 ]
Seattle 1987 16/82 7/91 39.9 % 2.54 [ 1.10, 5.86 ]
Subtotal (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
2 Continuous CTG alone - no FBS
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Not applicable
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Analysis 6.4. Comparison 6 Continuous CTG versus IA (access to FBS during labour - yes/no), Outcome 4
Caesarean section.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 6 Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome: 4 Caesarean section
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Continuous CTG plus FBS
Copenhagen 1985 28/482 18/487 5.2 % 1.57 [ 0.88, 2.80 ]
Denver 1979 26/229 7/116 2.7 % 1.88 [ 0.84, 4.20 ]
Dublin 1985 158/6474 144/6490 41.9 % 1.10 [ 0.88, 1.37 ]
Melbourne 1976 39/175 24/175 7.0 % 1.63 [ 1.02, 2.58 ]
Melbourne 1981 18/445 10/482 2.8 % 1.95 [ 0.91, 4.18 ]
Pakistan 1989 35/100 12/100 3.5 % 2.92 [ 1.61, 5.28 ]
Seattle 1987 19/122 19/124 5.5 % 1.02 [ 0.57, 1.82 ]
Subtotal (95% CI) 8027 7974 68.6 % 1.34 [ 1.14, 1.58 ]
Total events: 323 (Continuous CTG), 234 (IA)
Heterogeneity: Chi2 = 13.02, df = 6 (P = 0.04); I2 =54%
Test for overall effect: Z = 3.52 (P = 0.00044)
2 Continuous CTG alone - no FBS
Athens 1993 71/746 59/682 18.0 % 1.10 [ 0.79, 1.53 ]
Denver 1976 40/242 16/241 4.7 % 2.49 [ 1.43, 4.32 ]
Denver 1979 41/230 6/115 2.3 % 3.42 [ 1.49, 7.81 ]
New Delhi 2006 17/50 11/50 3.2 % 1.55 [ 0.81, 2.96 ]
Sheffield 1978 24/253 11/251 3.2 % 2.16 [ 1.08, 4.32 ]
Subtotal (95% CI) 1521 1339 31.4 % 1.63 [ 1.30, 2.06 ]
Total events: 193 (Continuous CTG), 103 (IA)
Heterogeneity: Chi2 = 11.50, df = 4 (P = 0.02); I2 =65%
Test for overall effect: Z = 4.18 (P = 0.000029)
Total (95% CI) 9548 9313 100.0 % 1.43 [ 1.25, 1.64 ]
Total events: 516 (Continuous CTG), 337 (IA)
Heterogeneity: Chi2 = 25.65, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 5.30 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.88, df = 1 (P = 0.17), I2 =47%
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Analysis 6.5. Comparison 6 Continuous CTG versus IA (access to FBS during labour - yes/no), Outcome 5
Instrumental vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 6 Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome: 5 Instrumental vaginal birth
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Continuous CTG plus FBS
Copenhagen 1985 85/482 64/487 6.7 % 1.34 [ 1.00, 1.81 ]
Denver 1979 54/229 27/116 3.7 % 1.01 [ 0.68, 1.52 ]
Dublin 1985 528/6474 407/6490 42.5 % 1.30 [ 1.15, 1.47 ]
Melbourne 1976 70/175 67/175 7.0 % 1.04 [ 0.80, 1.36 ]
Melbourne 1981 120/445 101/482 10.1 % 1.29 [ 1.02, 1.62 ]
Pakistan 1989 38/100 27/100 2.8 % 1.41 [ 0.94, 2.12 ]
Subtotal (95% CI) 7905 7850 72.8 % 1.27 [ 1.16, 1.39 ]
Total events: 895 (Continuous CTG), 693 (IA)
Heterogeneity: Chi2 = 3.85, df = 5 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 5.06 (P < 0.00001)
2 Continuous CTG alone - no FBS
Athens 1993 104/746 62/682 6.8 % 1.53 [ 1.14, 2.06 ]
Denver 1976 60/242 78/241 8.2 % 0.77 [ 0.58, 1.02 ]
Denver 1979 64/230 27/115 3.8 % 1.19 [ 0.80, 1.75 ]
New Delhi 2006 1/50 3/50 0.3 % 0.33 [ 0.04, 3.10 ]
Sheffield 1978 71/253 78/251 8.2 % 0.90 [ 0.69, 1.18 ]
Subtotal (95% CI) 1521 1339 27.2 % 1.05 [ 0.90, 1.22 ]
Total events: 300 (Continuous CTG), 248 (IA)
Heterogeneity: Chi2 = 13.54, df = 4 (P = 0.01); I2 =70%
Test for overall effect: Z = 0.65 (P = 0.51)
Total (95% CI) 9426 9189 100.0 % 1.21 [ 1.12, 1.31 ]
Total events: 1195 (Continuous CTG), 941 (IA)
Heterogeneity: Chi2 = 22.59, df = 10 (P = 0.01); I2 =56%
Test for overall effect: Z = 4.75 (P < 0.00001)
Test for subgroup differences: Chi2 = 4.34, df = 1 (P = 0.04), I2 =77%
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Analysis 6.6. Comparison 6 Continuous CTG versus IA (access to FBS during labour - yes/no), Outcome 6
Cord blood acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 6 Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome: 6 Cord blood acidosis
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Continuous CTG plus FBS
Dublin 1985 5/540 11/535 37.1 % 0.45 [ 0.16, 1.29 ]
Subtotal (95% CI) 540 535 37.1 % 0.45 [ 0.16, 1.29 ]
Total events: 5 (Continuous CTG), 11 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
2 Continuous CTG alone - no FBS
Athens 1993 31/739 18/680 62.9 % 1.58 [ 0.89, 2.81 ]
Subtotal (95% CI) 739 680 62.9 % 1.58 [ 0.89, 2.81 ]
Total events: 31 (Continuous CTG), 18 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.58 (P = 0.11)
Total (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Chi2 = 4.25, df = 1 (P = 0.04), I2 =76%
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Analysis 6.7. Comparison 6 Continuous CTG versus IA (access to FBS during labour - yes/no), Outcome 7
Any pharmacological analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 6 Continuous CTG versus IA (access to FBS during labour - yes/no)
Outcome: 7 Any pharmacological analgesia
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Continuous CTG plus FBS
Denver 1979 209/229 100/116 21.7 % 1.06 [ 0.97, 1.15 ]
Sheffield 1978 141/253 152/251 24.9 % 0.92 [ 0.79, 1.07 ]
Subtotal (95% CI) 482 367 46.6 % 0.98 [ 0.90, 1.07 ]
Total events: 350 (Continuous CTG), 252 (IA)
Heterogeneity: Chi2 = 3.72, df = 1 (P = 0.05); I2 =73%
Test for overall effect: Z = 0.35 (P = 0.73)
2 Continuous CTG alone - no FBS
Denver 1976 183/242 194/241 31.8 % 0.94 [ 0.85, 1.03 ]
Denver 1979 209/230 99/115 21.6 % 1.06 [ 0.97, 1.15 ]
Subtotal (95% CI) 472 356 53.4 % 0.99 [ 0.92, 1.05 ]
Total events: 392 (Continuous CTG), 293 (IA)
Heterogeneity: Chi2 = 3.51, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 0.41 (P = 0.68)
Total (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.21, df = 3 (P = 0.07); I2 =58%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.98), I2 =0.0%
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Analysis 7.1. Comparison 7 Continuous CTG versus IA (primiparous/multiparous women), Outcome 1
Perinatal mortality.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 7 Continuous CTG versus IA (primiparous/multiparous women)
Outcome: 1 Perinatal mortality
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Primaparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or parity not specified
Athens 1993 2/746 9/682 16.0 % 0.20 [ 0.04, 0.94 ]
Copenhagen 1985 2/485 3/493 5.1 % 0.68 [ 0.11, 4.04 ]
Dallas 1986 4/7288 5/7330 8.5 % 0.80 [ 0.22, 3.00 ]
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Denver 1979 3/463 0/232 1.1 % 3.52 [ 0.18, 67.77 ]
Dublin 1985 14/6530 14/6554 23.7 % 1.00 [ 0.48, 2.10 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Pakistan 1989 4/100 5/100 8.5 % 0.80 [ 0.22, 2.89 ]
Seattle 1987 17/122 18/124 30.3 % 0.96 [ 0.52, 1.77 ]
Sheffield 1978 0/253 1/251 2.6 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Total (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (IA)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 7.2. Comparison 7 Continuous CTG versus IA (primiparous/multiparous women), Outcome 2
Neonatal seizures.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 7 Continuous CTG versus IA (primiparous/multiparous women)
Outcome: 2 Neonatal seizures
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Primaparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or parity not specified
Athens 1993 0/746 2/682 5.2 % 0.18 [ 0.01, 3.80 ]
Copenhagen 1985 0/485 0/493 Not estimable
Dallas 1986 1/7288 3/7330 6.0 % 0.34 [ 0.03, 3.22 ]
Denver 1976 2/242 2/241 4.0 % 1.00 [ 0.14, 7.01 ]
Denver 1979 2/463 2/232 5.3 % 0.50 [ 0.07, 3.53 ]
Dublin 1985 12/6530 27/6554 53.7 % 0.45 [ 0.23, 0.88 ]
Melbourne 1976 0/175 4/175 9.0 % 0.11 [ 0.01, 2.05 ]
Seattle 1987 7/122 7/124 13.8 % 1.02 [ 0.37, 2.81 ]
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (Continuous CTG), 48 (IA)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Test for subgroup differences: Not applicable
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Analysis 7.3. Comparison 7 Continuous CTG versus IA (primiparous/multiparous women), Outcome 3
Cerebral palsy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 7 Continuous CTG versus IA (primiparous/multiparous women)
Outcome: 3 Cerebral palsy
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Primaparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or parity not specified
Dublin 1985 12/6527 10/6552 60.1 % 1.20 [ 0.52, 2.79 ]
Seattle 1987 16/82 7/91 39.9 % 2.54 [ 1.10, 5.86 ]
Subtotal (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Total (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (IA)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Not applicable
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Analysis 7.4. Comparison 7 Continuous CTG versus IA (primiparous/multiparous women), Outcome 4
Caesarean section.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 7 Continuous CTG versus IA (primiparous/multiparous women)
Outcome: 4 Caesarean section
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Primaparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiparous women
New Delhi 2006 17/50 11/50 3.1 % 1.55 [ 0.81, 2.96 ]
Subtotal (95% CI) 50 50 3.1 % 1.55 [ 0.81, 2.96 ]
Total events: 17 (Continuous CTG), 11 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
3 Both or parity not specified
Athens 1993 71/746 59/682 17.4 % 1.10 [ 0.79, 1.53 ]
Copenhagen 1985 28/482 18/487 5.1 % 1.57 [ 0.88, 2.80 ]
Denver 1976 40/242 16/241 4.5 % 2.49 [ 1.43, 4.32 ]
Denver 1979 67/459 13/231 4.9 % 2.59 [ 1.46, 4.60 ]
Dublin 1985 158/6474 144/6490 40.6 % 1.10 [ 0.88, 1.37 ]
Melbourne 1976 39/175 24/175 6.8 % 1.63 [ 1.02, 2.58 ]
Melbourne 1981 18/445 10/482 2.7 % 1.95 [ 0.91, 4.18 ]
New Delhi 2006 17/50 11/50 3.1 % 1.55 [ 0.81, 2.96 ]
Pakistan 1989 35/100 12/100 3.4 % 2.92 [ 1.61, 5.28 ]
Seattle 1987 19/122 19/124 5.3 % 1.02 [ 0.57, 1.82 ]
Sheffield 1978 24/253 11/251 3.1 % 2.16 [ 1.08, 4.32 ]
Subtotal (95% CI) 9548 9313 96.9 % 1.43 [ 1.25, 1.64 ]
Total events: 516 (Continuous CTG), 337 (IA)
Heterogeneity: Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 5.30 (P < 0.00001)
Total (95% CI) 9598 9363 100.0 % 1.44 [ 1.26, 1.64 ]
Total events: 533 (Continuous CTG), 348 (IA)
Heterogeneity: Chi2 = 25.16, df = 11 (P = 0.01); I2 =56%
Test for overall effect: Z = 5.44 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
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Analysis 7.5. Comparison 7 Continuous CTG versus IA (primiparous/multiparous women), Outcome 5
Instrumental vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 7 Continuous CTG versus IA (primiparous/multiparous women)
Outcome: 5 Instrumental vaginal birth
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Primaparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiparous women
New Delhi 2006 1/50 3/50 0.3 % 0.33 [ 0.04, 3.10 ]
Subtotal (95% CI) 50 50 0.3 % 0.33 [ 0.04, 3.10 ]
Total events: 1 (Continuous CTG), 3 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
3 Both or parity not specified
Athens 1993 104/746 62/682 6.7 % 1.53 [ 1.14, 2.06 ]
Copenhagen 1985 85/482 64/487 6.6 % 1.34 [ 1.00, 1.81 ]
Denver 1976 60/242 78/241 8.1 % 0.77 [ 0.58, 1.02 ]
Denver 1979 118/459 54/231 7.5 % 1.10 [ 0.83, 1.46 ]
Dublin 1985 528/6474 407/6490 42.3 % 1.30 [ 1.15, 1.47 ]
Melbourne 1976 70/175 67/175 7.0 % 1.04 [ 0.80, 1.36 ]
Melbourne 1981 120/445 101/482 10.1 % 1.29 [ 1.02, 1.62 ]
New Delhi 2006 1/50 3/50 0.3 % 0.33 [ 0.04, 3.10 ]
Pakistan 1989 38/100 27/100 2.8 % 1.41 [ 0.94, 2.12 ]
Sheffield 1978 71/253 78/251 8.2 % 0.90 [ 0.69, 1.18 ]
Subtotal (95% CI) 9426 9189 99.7 % 1.21 [ 1.12, 1.31 ]
Total events: 1195 (Continuous CTG), 941 (IA)
Heterogeneity: Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.75 (P < 0.00001)
Total (95% CI) 9476 9239 100.0 % 1.21 [ 1.12, 1.30 ]
Total events: 1196 (Continuous CTG), 944 (IA)
Heterogeneity: Chi2 = 23.52, df = 10 (P = 0.01); I2 =57%
Test for overall effect: Z = 4.69 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.28, df = 1 (P = 0.26), I2 =22%
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Analysis 7.6. Comparison 7 Continuous CTG versus IA (primiparous/multiparous women), Outcome 6
Cord blood acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 7 Continuous CTG versus IA (primiparous/multiparous women)
Outcome: 6 Cord blood acidosis
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Primaparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or parity not specified
Athens 1993 31/739 18/680 62.9 % 1.58 [ 0.89, 2.81 ]
Dublin 1985 5/540 11/535 37.1 % 0.45 [ 0.16, 1.29 ]
Subtotal (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Total (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 7.7. Comparison 7 Continuous CTG versus IA (primiparous/multiparous women), Outcome 7 Any
pharmacological analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 7 Continuous CTG versus IA (primiparous/multiparous women)
Outcome: 7 Any pharmacological analgesia
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Primaparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Multiparous women
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Both or parity not specified
Denver 1976 183/242 194/241 31.8 % 0.94 [ 0.85, 1.03 ]
Denver 1979 418/459 199/231 43.3 % 1.06 [ 1.00, 1.12 ]
Sheffield 1978 141/253 152/251 24.9 % 0.92 [ 0.79, 1.07 ]
Subtotal (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Total (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 8.1. Comparison 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies),
Outcome 1 Perinatal mortality.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome: 1 Perinatal mortality
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Dublin 1985 14/6530 14/6554 23.7 % 1.00 [ 0.48, 2.10 ]
Melbourne 1976 1/175 1/175 1.7 % 1.00 [ 0.06, 15.86 ]
Subtotal (95% CI) 6705 6729 25.4 % 1.00 [ 0.49, 2.05 ]
Total events: 15 (Continuous CTG), 15 (Intermittent auscultation)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
2 Low-quality trials
Athens 1993 2/746 9/682 16.0 % 0.20 [ 0.04, 0.94 ]
Dallas 1986 4/7288 5/7330 8.5 % 0.80 [ 0.22, 3.00 ]
Melbourne 1981 1/445 0/482 0.8 % 3.25 [ 0.13, 79.55 ]
Pakistan 1989 4/100 5/100 8.5 % 0.80 [ 0.22, 2.89 ]
Subtotal (95% CI) 8579 8594 33.8 % 0.58 [ 0.28, 1.18 ]
Total events: 11 (Continuous CTG), 19 (Intermittent auscultation)
Heterogeneity: Chi2 = 3.41, df = 3 (P = 0.33); I2 =12%
Test for overall effect: Z = 1.50 (P = 0.13)
3 Quality of trials unclear
Copenhagen 1985 2/485 3/493 5.1 % 0.68 [ 0.11, 4.04 ]
Denver 1976 2/242 1/241 1.7 % 1.99 [ 0.18, 21.82 ]
Denver 1979 3/463 0/232 1.1 % 3.52 [ 0.18, 67.77 ]
Seattle 1987 17/122 18/124 30.3 % 0.96 [ 0.52, 1.77 ]
Sheffield 1978 0/253 1/251 2.6 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 1565 1341 40.8 % 1.00 [ 0.58, 1.71 ]
Total events: 24 (Continuous CTG), 23 (Intermittent auscultation)
Heterogeneity: Chi2 = 1.67, df = 4 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.00 (P = 1.0)
Total (95% CI) 16849 16664 100.0 % 0.86 [ 0.59, 1.24 ]
Total events: 50 (Continuous CTG), 57 (Intermittent auscultation)
Heterogeneity: Chi2 = 6.17, df = 10 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Chi2 = 1.66, df = 2 (P = 0.44), I2 =0.0%
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Analysis 8.2. Comparison 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies),
Outcome 2 Neonatal seizures.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome: 2 Neonatal seizures
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Dublin 1985 12/6530 27/6554 53.7 % 0.45 [ 0.23, 0.88 ]
Melbourne 1976 0/175 4/175 9.0 % 0.11 [ 0.01, 2.05 ]
Subtotal (95% CI) 6705 6729 62.7 % 0.40 [ 0.21, 0.77 ]
Total events: 12 (CTG), 31 (Auscultation)
Heterogeneity: Chi2 = 0.84, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 2.76 (P = 0.0058)
2 Low-quality trials
Athens 1993 0/746 2/682 5.2 % 0.18 [ 0.01, 3.80 ]
Dallas 1986 1/7288 3/7330 6.0 % 0.34 [ 0.03, 3.22 ]
Subtotal (95% CI) 8034 8012 11.2 % 0.26 [ 0.04, 1.60 ]
Total events: 1 (CTG), 5 (Auscultation)
Heterogeneity: Chi2 = 0.10, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.45 (P = 0.15)
3 Quality of trials unclear
Copenhagen 1985 0/485 0/493 Not estimable
Denver 1976 2/242 2/241 4.0 % 1.00 [ 0.14, 7.01 ]
Denver 1979 2/463 2/232 5.3 % 0.50 [ 0.07, 3.53 ]
Seattle 1987 7/122 7/124 13.8 % 1.02 [ 0.37, 2.81 ]
Sheffield 1978 0/253 1/251 3.0 % 0.33 [ 0.01, 8.08 ]
Subtotal (95% CI) 1565 1341 26.1 % 0.83 [ 0.38, 1.81 ]
Total events: 11 (CTG), 12 (Auscultation)
Heterogeneity: Chi2 = 0.76, df = 3 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.47 (P = 0.64)
Total (95% CI) 16304 16082 100.0 % 0.50 [ 0.31, 0.80 ]
Total events: 24 (CTG), 48 (Auscultation)
Heterogeneity: Chi2 = 4.10, df = 7 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 2.89 (P = 0.0039)
Test for subgroup differences: Chi2 = 2.55, df = 2 (P = 0.28), I2 =22%
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Analysis 8.3. Comparison 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies),
Outcome 3 Cerebral palsy.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome: 3 Cerebral palsy
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Dublin 1985 12/6527 10/6552 60.1 % 1.20 [ 0.52, 2.79 ]
Subtotal (95% CI) 6527 6552 60.1 % 1.20 [ 0.52, 2.79 ]
Total events: 12 (Continuous CTG), 10 (Intermittent auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
2 Low-quality trials
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (Intermittent auscultation)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Quality of trials unclear
Seattle 1987 16/82 7/91 39.9 % 2.54 [ 1.10, 5.86 ]
Subtotal (95% CI) 82 91 39.9 % 2.54 [ 1.10, 5.86 ]
Total events: 16 (Continuous CTG), 7 (Intermittent auscultation)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
Total (95% CI) 6609 6643 100.0 % 1.74 [ 0.97, 3.11 ]
Total events: 28 (Continuous CTG), 17 (Intermittent auscultation)
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Chi2 = 1.52, df = 1 (P = 0.22), I2 =34%
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Analysis 8.4. Comparison 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies),
Outcome 4 Caesarean section.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome: 4 Caesarean section
Study or subgroup CTG Auscultation Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 High-quality trials
Dublin 1985 158/6474 144/6490 14.6 % 1.10 [ 0.88, 1.37 ]
Melbourne 1976 39/175 24/175 10.2 % 1.63 [ 1.02, 2.58 ]
Subtotal (95% CI) 6649 6665 24.8 % 1.27 [ 0.88, 1.83 ]
Total events: 197 (CTG), 168 (Auscultation)
Heterogeneity: Tau2 = 0.04; Chi2 = 2.22, df = 1 (P = 0.14); I2 =55%
Test for overall effect: Z = 1.26 (P = 0.21)
2 Low-quality trials
Athens 1993 71/746 59/682 12.7 % 1.10 [ 0.79, 1.53 ]
Melbourne 1981 18/445 10/482 6.1 % 1.95 [ 0.91, 4.18 ]
Pakistan 1989 35/100 12/100 8.2 % 2.92 [ 1.61, 5.28 ]
Subtotal (95% CI) 1291 1264 26.9 % 1.77 [ 0.92, 3.41 ]
Total events: 124 (CTG), 81 (Auscultation)
Heterogeneity: Tau2 = 0.25; Chi2 = 8.60, df = 2 (P = 0.01); I2 =77%
Test for overall effect: Z = 1.71 (P = 0.088)
3 Quality of trials unclear
Copenhagen 1985 28/482 18/487 8.4 % 1.57 [ 0.88, 2.80 ]
Denver 1976 40/242 16/241 8.8 % 2.49 [ 1.43, 4.32 ]
Denver 1979 67/459 13/231 8.5 % 2.59 [ 1.46, 4.60 ]
New Delhi 2006 17/50 11/50 7.4 % 1.55 [ 0.81, 2.96 ]
Seattle 1987 19/122 19/124 8.3 % 1.02 [ 0.57, 1.82 ]
Sheffield 1978 24/253 11/251 6.9 % 2.16 [ 1.08, 4.32 ]
Subtotal (95% CI) 1608 1384 48.3 % 1.81 [ 1.34, 2.44 ]
Total events: 195 (CTG), 88 (Auscultation)
Heterogeneity: Tau2 = 0.04; Chi2 = 7.33, df = 5 (P = 0.20); I2 =32%
Test for overall effect: Z = 3.91 (P = 0.000092)
Total (95% CI) 9548 9313 100.0 % 1.63 [ 1.29, 2.07 ]
Total events: 516 (CTG), 337 (Auscultation)
Heterogeneity: Tau2 = 0.09; Chi2 = 25.09, df = 10 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.05 (P = 0.000052)
Test for subgroup differences: Chi2 = 2.31, df = 2 (P = 0.31), I2 =13%
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Analysis 8.5. Comparison 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies),
Outcome 5 Instrumental vaginal birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome: 5 Instrumental vaginal birth
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Dublin 1985 528/6474 407/6490 42.5 % 1.30 [ 1.15, 1.47 ]
Melbourne 1976 70/175 67/175 7.0 % 1.04 [ 0.80, 1.36 ]
Subtotal (95% CI) 6649 6665 49.5 % 1.26 [ 1.13, 1.42 ]
Total events: 598 (Continuous CTG), 474 (Intermittent auscultation)
Heterogeneity: Chi2 = 2.24, df = 1 (P = 0.13); I2 =55%
Test for overall effect: Z = 4.05 (P = 0.000052)
2 Low-quality trials
Athens 1993 104/746 62/682 6.8 % 1.53 [ 1.14, 2.06 ]
Melbourne 1981 120/445 101/482 10.1 % 1.29 [ 1.02, 1.62 ]
Pakistan 1989 38/100 27/100 2.8 % 1.41 [ 0.94, 2.12 ]
Subtotal (95% CI) 1291 1264 19.7 % 1.39 [ 1.17, 1.64 ]
Total events: 262 (Continuous CTG), 190 (Intermittent auscultation)
Heterogeneity: Chi2 = 0.85, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 3.85 (P = 0.00012)
3 Quality of trials unclear
Copenhagen 1985 85/482 64/487 6.7 % 1.34 [ 1.00, 1.81 ]
Denver 1976 60/242 78/241 8.2 % 0.77 [ 0.58, 1.02 ]
Denver 1979 118/459 54/231 7.5 % 1.10 [ 0.83, 1.46 ]
New Delhi 2006 1/50 3/50 0.3 % 0.33 [ 0.04, 3.10 ]
Sheffield 1978 71/253 78/251 8.2 % 0.90 [ 0.69, 1.18 ]
Subtotal (95% CI) 1486 1260 30.8 % 1.00 [ 0.87, 1.16 ]
Total events: 335 (Continuous CTG), 277 (Intermittent auscultation)
Heterogeneity: Chi2 = 9.00, df = 4 (P = 0.06); I2 =56%
Test for overall effect: Z = 0.05 (P = 0.96)
Total (95% CI) 9426 9189 100.0 % 1.21 [ 1.12, 1.31 ]
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(. . . Continued)
Study or subgroup Continuous CTG
Intermittent
auscultation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 1195 (Continuous CTG), 941 (Intermittent auscultation)
Heterogeneity: Chi2 = 22.28, df = 9 (P = 0.01); I2 =60%
Test for overall effect: Z = 4.75 (P < 0.00001)
Test for subgroup differences: Chi2 = 9.93, df = 2 (P = 0.01), I2 =80%
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Analysis 8.6. Comparison 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies),
Outcome 6 Cord blood acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome: 6 Cord blood acidosis
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Dublin 1985 5/540 11/535 37.1 % 0.45 [ 0.16, 1.29 ]
Subtotal (95% CI) 540 535 37.1 % 0.45 [ 0.16, 1.29 ]
Total events: 5 (Continuous CTG), 11 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
2 Low-quality trials
Athens 1993 31/739 18/680 62.9 % 1.58 [ 0.89, 2.81 ]
Subtotal (95% CI) 739 680 62.9 % 1.58 [ 0.89, 2.81 ]
Total events: 31 (Continuous CTG), 18 (IA)
Heterogeneity: not applicable
Test for overall effect: Z = 1.58 (P = 0.11)
3 Quality of trials unclear
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
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(. . . Continued)
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 1279 1215 100.0 % 1.16 [ 0.72, 1.89 ]
Total events: 36 (Continuous CTG), 29 (IA)
Heterogeneity: Chi2 = 4.26, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Chi2 = 4.25, df = 1 (P = 0.04), I2 =76%
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Analysis 8.7. Comparison 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies),
Outcome 7 Any pharmacological analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 8 Continuous CTG versus IA (sensitivity analysis: high and low quality studies)
Outcome: 7 Any pharmacological analgesia
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 High-quality trials
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Low-quality trials
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Continuous CTG), 0 (IA)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Quality of trials unclear
Denver 1976 183/242 194/241 31.8 % 0.94 [ 0.85, 1.03 ]
Denver 1979 418/459 199/231 43.3 % 1.06 [ 1.00, 1.12 ]
Sheffield 1978 141/253 152/251 24.9 % 0.92 [ 0.79, 1.07 ]
Subtotal (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
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(. . . Continued)
Study or subgroup Continuous CTG IA Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Total (95% CI) 954 723 100.0 % 0.99 [ 0.93, 1.04 ]
Total events: 742 (Continuous CTG), 545 (IA)
Heterogeneity: Chi2 = 7.20, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 9.1. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 1 Caesarean section
(main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 1 Caesarean section (main outcome)
Study or subgroup Continuous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 48/2029 37/2015 100.0 % 1.29 [ 0.84, 1.97 ]
Total (95% CI) 2029 2015 100.0 % 1.29 [ 0.84, 1.97 ]
Total events: 48 (Continuous CTG), 37 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Not applicable
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Analysis 9.2. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 2 Instrumental vaginal
birth (main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 2 Instrumental vaginal birth (main outcome)
Study or subgroup Continuous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 148/2029 127/2015 100.0 % 1.16 [ 0.92, 1.46 ]
Total (95% CI) 2029 2015 100.0 % 1.16 [ 0.92, 1.46 ]
Total events: 148 (Continuous CTG), 127 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours continuous CTG Favours intermittent CTG
Analysis 9.3. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 3 Cord blood acidosis
(main outcome).
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 3 Cord blood acidosis (main outcome)
Study or subgroup Continuous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 56/2029 39/2015 100.0 % 1.43 [ 0.95, 2.14 ]
Total (95% CI) 2029 2015 100.0 % 1.43 [ 0.95, 2.14 ]
Total events: 56 (Continuous CTG), 39 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.72 (P = 0.085)
Test for subgroup differences: Not applicable
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Analysis 9.4. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 4 Apgar score < 7 at 5
minutes.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 4 Apgar score < 7 at 5 minutes
Study or subgroup Continuous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 8/2029 3/2015 100.0 % 2.65 [ 0.70, 9.97 ]
Total (95% CI) 2029 2015 100.0 % 2.65 [ 0.70, 9.97 ]
Total events: 8 (Continuous CTG), 3 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.44 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 9.5. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 5 Neonatal ICU
admissions.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 5 Neonatal ICU admissions
Study or subgroup Continuous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 58/2029 43/2015 100.0 % 1.34 [ 0.91, 1.98 ]
Total (95% CI) 2029 2015 100.0 % 1.34 [ 0.91, 1.98 ]
Total events: 58 (Continuous CTG), 43 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
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Analysis 9.6. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 6 Caesarean section for
abnormal FHR pattern and/or acidosis.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 6 Caesarean section for abnormal FHR pattern and/or acidosis
Study or subgroup Continous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 24/2029 20/2015 100.0 % 1.19 [ 0.66, 2.15 ]
Total (95% CI) 2029 2015 100.0 % 1.19 [ 0.66, 2.15 ]
Total events: 24 (Continous CTG), 20 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 9.7. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 7 Spontaneous vaginal
birth.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 7 Spontaneous vaginal birth
Study or subgroup Continuous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 1833/2029 1851/2015 100.0 % 0.98 [ 0.96, 1.00 ]
Total (95% CI) 2029 2015 100.0 % 0.98 [ 0.96, 1.00 ]
Total events: 1833 (Continuous CTG), 1851 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 1.70 (P = 0.089)
Test for subgroup differences: Not applicable
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Analysis 9.8. Comparison 9 Continuous CTG versus intermittent CTG, Outcome 8 Epidural analgesia.
Review: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
Comparison: 9 Continuous CTG versus intermittent CTG
Outcome: 8 Epidural analgesia
Study or subgroup Continuous CTG Intermittent CTG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lund 1994 369/2029 347/2015 100.0 % 1.06 [ 0.92, 1.21 ]
Total (95% CI) 2029 2015 100.0 % 1.06 [ 0.92, 1.21 ]
Total events: 369 (Continuous CTG), 347 (Intermittent CTG)
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours continuous CTG Favours intermittent CTG
A D D I T I O N A L T A B L E S
Table 1. Methods of fetal heart rate monitoring
Method Description
Fetal stethoscope (Pinard) - for intermittent monitoring (IA) This is a trumpet-shaped device, which is placed on the mother’s
abdomen and the caregiver listens for the heart beat at the other
end. This is a simple instrument of relatively low cost
Hand-held Doppler ultrasound monitor - for intermittent mon-
itoring (IA)
The device is placed on the mother’s abdomen with gel smeared
on the underside of the ultrasound transducer. This allows the
ultrasound beam to travel from the fetal heart to the transducer
without interruption
External cardiotocography - for continuous or intermittent mon-
itoring
The fetal heart rate and the activity of the uterine muscle are de-
tected by two transducers placed on the mother’s abdomen (one
above the fetal heart and the other at the fundus). Doppler ul-
trasound provides the information which is recorded on a paper
strip known as a cardiotocograph (CTG)
Internal cardiotocography - for continuous monitoring An electrode is placed directly on the baby’s presenting part to
detect the fetal ECG signal. Again the signals are recorded on a
paper strip (CTG). This method can only be used if membranes
(fore-waters) have ruptured either spontaneously or artificially
ECG: electrocardiogram
127Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
IA: intermittent auscultation
Table 2. Additional descriptive information from included studies
Study 1 carer to
1 woman
Induction ARM Oxytocin Mobility Birth po-
sitions
Women’s
views
Social
context
Experi-
ence of
staff
Athens
1993
Yes Induc-
tion - 11%
overall
No infor-
mation
Augmen-
ta-
tion - 46%
overall
No mobil-
ity -
all women
with
IV line in-
serted
Semi-
Fowler or
lateral
No infor-
mation
No infor-
mation
IA stan-
dard prac-
tice, EFM
intensive
training
provided
Copen-
hagen
1985
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
EFM only
ap-
plied when
women no
longer
wished to
walk
around
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Dallas
1986
2 women:
1 nurse
Excluded
women
whose
labours
were
induced
No infor-
mation
Excluded
women
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Denver
1976
IA:
yes CTG:
no infor-
mation
Included
women
whose
labours
were
induced
No infor-
mation
Included
women
given oxy-
tocin for
augmenta-
tion
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Denver
1979
Yes No specific
informa-
tion
No infor-
mation
29%
of women
given oxy-
tocin for
augmenta-
tion
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Dublin
1985
Yes Included
women
whose
labours
were
induced
ARM
within an
hour of ad-
mission to
check
23%
of women
given oxy-
tocin for
augmenta-
IA, prob-
ably more
mobile
No infor-
mation
Women’s
views
sought and
published
separately
No infor-
mation
No infor-
mation
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Table 2. Additional descriptive information from included studies (Continued)
liquor tion
Lund 1994 No infor-
mation
Included
women
whose
labours
were
induced
No infor-
mation
48%
of women
were given
ocytocin
for induc-
tion or ac-
celeration
Women in
CTG
group of-
fered
telemetry
if wished
mobility
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Mel-
bourne
1976
No infor-
mation
Induc-
tion - 42%
overall
No infor-
mation
63%
of women
given
oxytocin in
labour
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Exp staff.
Mel-
bourne
1981
No infor-
mation
No infor-
mation
ARM
when in es-
tablished
labour or
for obstet-
ric reasons
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Pakistan
1989
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
New Delhi
2006
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
Seattle
1987
Yes No infor-
mation
ARM at 7
cm
unless clin-
ically indi-
cated prior
to 7 cm
Included
women
given oxy-
tocin
No infor-
mation
No infor-
mation
Women’s
views
sought and
published
separately.
No infor-
mation
No infor-
mation
Sheffield
1978
No infor-
mation
Included
women
whose
labours
were
induced
Augmen-
tation with
ARM
alone or in
combina-
tion with
oxytocin if
progress
fell below
nomogram
Oxy-
tocin was
adminis-
tered to all
women as
indicated
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
ARM: artificial rupture of membranes
CTG: cardiotocography
EFM: electronic fetal monitoring
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IA: intermittent auscultation
IV: intravenous
Table 3. Intermittent auscultation methods - additional information from included studies
Study Intermittent auscultation details Additional details
Method Frequency
first and
second
stages
Before
/ during /
following
contrac-
tion;
Duration
ARM Oxytocin FBS Admis-
sion CTG
Risk level 1 carer to
1 woman
Athens
1993
Sonicaid First stage:
At least ev-
ery 15
minutes
Second
stage: Ev-
ery 5 min-
utes
During
and
following.
Duration:
For 1 min
including
at least 30
seconds af-
ter the con-
traction
No infor-
mation
Augmen-
ta-
tion - 46%
overall
No No infor-
mation
High and
low risk
Yes
Copen-
hagen
1985
No infor-
mation
First stage:
At least 15
s twice an
hour up to
5
cm. Above
5 cm every
15minutes
Second
stage: After
every con-
traction
Following.
Duration:
30 seconds
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
High and
low risk
No infor-
mation
Dallas
1986
Hand-held
device
First stage:
Every 30
minutes
Sec-
ond stage:
No infor-
mation
No infor-
mation
No infor-
mation
Excluded
women
given oxy-
tocin for
augmenta-
tion
No infor-
mation
No infor-
mation
Low and
high risk
2 women:
1 nurse
Denver
1976
No infor-
mation
First stage:
Every 15
minutes
Second
stage: ev-
Following.
Duration:
30 seconds
No infor-
mation
Included
women
given oxy-
tocin for
No infor-
mation
No infor-
mation
High risk IA: yes
CTG: no
informa-
tion
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Table 3. Intermittent auscultation methods - additional information from included studies (Continued)
ery 5 min-
utes
augmenta-
tion
Denver
1979
No infor-
mation
First stage:
Every 15
minutes
Second
stage: ev-
ery 5 min-
utes
Following.
Duration:
30 seconds
No infor-
mation
29%
of women
given oxy-
tocin for
augmenta-
tion
No No infor-
mation
High risk Yes
Dublin
1985
Pinard un-
less dif-
ficult then
used
Doppler
ultrasound
First stage:
Every 15
minutes
Sec-
ond stage:
Every
interval be-
tween con-
tractions
Following.
Duration:
1 minute
ARM
within an
hour of ad-
mission to
check
liquor
23%
of women
given oxy-
tocin for
augmenta-
tion
When
labour > 8
hours.
CTG: 77/
6474
(1.2%) IA:
139/6486
(2.1%)
No infor-
mation
No infor-
mation
Yes
Lund 1994 Contin-
uous mon-
itoring
if oxytocin
or epidural
used.
Back to IA
if stable. If
FHR
changes
appeared,
or if there
were
other com-
plications,
contin-
uous mon-
itoring was
instituted
First stage:
15 to 30
minutes
Sec-
ond stage:
Continu-
ous CTG
No infor-
mation
No infor-
mation
48%
of women
were given
ocytocin
for induc-
tion or ac-
celeration
No infor-
mation
No infor-
mation
Low-mod-
erate risk
No infor-
mation
Mel-
bourne
1976
No infor-
mation
First stage:
Intermit-
tent
Sec-
ond stage:
No infor-
mation
None No infor-
mation
63%
of women
given
oxytocin in
labour
No No infor-
mation
High risk
women
only
No infor-
mation
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Table 3. Intermittent auscultation methods - additional information from included studies (Continued)
Mel-
bourne
1981
No infor-
mation
First stage:
Intermit-
tent
Sec-
ond stage:
No infor-
mation
None ARM
when in es-
tablished
labour or
for obstet-
ric reasons
No infor-
mation
No No infor-
mation
Low risk No infor-
mation
Pakistan
1989
Pinard First stage:
Every 15
minutes
Sec-
ond stage:
No infor-
mation
No infor-
mation
No infor-
mation
No infor-
mation
No as
a matter of
policy
No infor-
mation
All
had meco-
nium dur-
ing labour
No infor-
mation
New Delhi
2006
No infor-
mation
First stage:
Every 15
minutes
Second
stage: Ev-
ery 5 min-
utes
Following.
Duration:
1 minute
No infor-
mation
No infor-
mation
No infor-
ma-
tion - ap-
pears not,
as any un-
reassuring
FHR went
straight to
CS or for-
ceps
No infor-
mation
All post-
caesarean
women
No infor-
mation
Seattle
1987
No infor-
mation
First stage:
Every 15
minutes
Second
stage: Ev-
ery 5 min-
utes
No infor-
mation
ARM at 7
cm
unless clin-
ically indi-
cated prior
to 7 cm
Included
women
given oxy-
tocin
No No infor-
mation
Low birth-
weight fe-
tus 26 to
32 weeks
gestation
Yes
Sheffield
1978
Pinard
(if any dif-
ficulty
a Sonicaid
was
used inter-
mittently)
First stage:
Every 15
minutes or
more if in-
dicated
Sec-
ond stage:
No infor-
mation
During or
imme-
diately fol-
lowing
contrac-
tion.
Duration:
1 minute
Augmen-
tation-
with ARM
alone or in
combina-
tion with
oxytocin if
progress
fell below
nomogram
Oxy-
tocin was
adminis-
tered to all
women as
indicated
No infor-
mation
No infor-
mation
Low risk
women
only
No infor-
mation
ARM: artificial rupture of membranes
CTG: cardiotocography
EFM: electronic fetal monitoring
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FBS: fetal blood sampling
FHR: fetal heart rate
IA: intermittent auscultation
F E E D B A C K
Ingemarsson, 30 March 2008
Summary
In this review you comment on the significant reduction in neonatal seizures associated with continuous cardiotocography rather than
intermittent auscultation, but then put this in opposition to the increase in caesarean section. Yet, more caesarean sections are performed
without clinical indication, on maternal ‘request’ than are performed for threatening fetal hypoxia. Moreover, you stress that continuous
cardiotocography is not associated with any beneficial effect on the risk of cerebral palsy, because 80%-85% of cases have an antenatal
origin and therefore intrapartum CTG can not be expected to have a great impact on the overall figure.
A recent Swedish study (Lindström 2006) reported outcome at 15-19 years of age after moderate hypoxic-ischaemic encephalopathy
(Sarnat II with neonatal seizures in most cases). Of 43 children with moderate hypoxic-ischaemic encephalopathy, 15 had cerebral
palsy. Of the 28 children without encephalopathy, 20 had cognitive problems. Only 8 of the 43 children had no problem later in life.
So, a halving in neonatal seizures with continuous cardiotocography seems to me, as an old obstetrician, to be a very good outcome.
(Summary of feedback from Ingemar Ingemarsson, March 2008)
Reply
Thank you for your comments. In our review, we feel we have clearly articulated the perceived conflict between our findings of increased
caesarean section and instrumental vaginal birth and decreased incidence of neonatal seizures associated with continuous CTG when
compared with intermittent auscultation.
We are unaware of any high quality evidence that demonstrates a higher rate of caesarean sections due to maternal ‘request’ than due
to hypoxia. Caesarean sections for maternal ‘request’ is a complex issue and there are those who have argued that it is not a significant
influencing factor on caesarean rates (Gamble 2007) Even if such evidence existed, we believe that this is addressing a different question
from that in our review.
The focus of the quoted study by Lindström et al (Lindström 2006) is on neonatal encephalopathy. In our review, we highlighted that
much remains to be learned about the causation and possible links between antenatal or intrapartum events, neonatal seizures and
long-term neurodevelopmental outcome. For this reason we believe it reasonable to base clinical decisions on the evidence we currently
have.
Contributors
Zarko Alfirevic
Declan Devane
Gillian Gyte
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Panteghini, 30 September 2013
Summary
I have two comments about this review:
1) In the continuously monitored group the relative risk of perinatal mortality is lower rather than in the intermittently monitored
group (RR 0.86). This result may be important for women when they choose which method of fetal monitoring to adopt during labour.
Is it not more useful to present the absolute and relative risk, so the woman, her midwife and doctor can decide if these are significant
to them or not? To consider a result significant only if it is statistically significant (and only if statistically significant at a given level of
significance, such as 5%) is an arbitrary decision that needs to be shared with the woman and her clinical team.
2) An interesting question raised by this review is which method of intermittent auscultation is best. The review lumps together different
types of intermittent auscultation; for example, auscultation during and after a contraction, and auscultation only after a contraction.
The review assesses the relationship between pH at birth and the method of foetal heart monitoring rate (intermittent or continuous)
in two studies (Athens 1993; Dublin 1985), and does not find any difference between the two methods as regards neonatal pH at birth.
It is interesting to note that in the Dublin trial, which used intermittent auscultation only after a contraction, the pH at birth was
worse for woman allocated intermittent auscultation rather than continuous monitoring (RR 0.45, 95% CI 0.16 - 1.29). In contrast,
in the Athens trial, which used intermittent auscultation during and after the contraction, pH at birth was better for woman allocated
intermittent auscultation (RR 1.58, 95% CI 0.89 - 2.81).
The importance of decelerations during the contraction and their impact on foetal wellbeing is now well known. Therefore theNational
Institute for Clinical Excellence (NICE) (1) considers monitoring to be reassuring only if there are no decelerations. Some guidelines
advise monitoring the foetal heart after a contraction (2), others during and after (3), and others again do not specify the timing of
auscultation in relation to contraction (4). The review is appropriate in not drawing any conclusions about what is the best method of
intermittent monitoring. We think that guidelines should state both that the mode of intermittent monitoring and the choice of one
method rather than another is a grade C recommendation (personal opinion) (5) as, in the light of this review, we do not know which
method of intermittent monitoring is best (although we could suppose that intermittent auscultation during and after a contraction
may be better than auscultation only after a contraction for preventing low pH at birth).
References
(1) NICE. Intrapartum care, 2008; p219-220 Tables 13.1, 13.2.
(2) Royal College of Midwives. Evidence based guidelines for midwifery-led care in labour,2012.
(3) American College of Nurse and Midwives. Intermittent Auscultation for Intrapartum Fetal Heart Rate Surveillance. Journal of
Midwifery and Women’s Health, 2010; 55: 397-403.
(4) Association of Women’s Health Obstetric and Neonatal Nurses. Fetal Heart Monitoring, 2008
(5) Danti L, Di Tommaso MR, Maffetti G, Carfagna M. Cardiotocografia. Milano 2010, Piccin editore.
Comment submitted by Marco Panteghini, September 2013
Reply
1) We agree that the concept of statistical significance arbitrary and therefore needs to be shared with the woman and her clinical team
as such. However, focusing on point estimates of relative or absolute risk reduction is not a solution. Whilst it is correct that the relative
risk for perinatal mortality is 0.86, the 95% confidence intervals suggests that use of cardiotocography is compatible with much higher
risk reduction (41%), but also with an increase in perinatal mortality (up to 23%). For this reason, we concluded that the observed
difference in perinatal death is not significant, both clinical and statistical terms.
2) We agree that the issue of generaliziblity (external validity) of the data from this review is important not just for cardiotocography,
but also for intermittent auscultation (IA). The protocols for IA, training and monitoring of adherence varied considerably in the
studies and in clinical practice world wide, We have added Table 3 to highlight this issue and discussed further in the section Overall
completeness and applicability of evidence.
Contributors
Zarko Alfirevic
Declan Devane
Gillian Gyte
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WH A T ’ S N E W
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H I S T O R Y
Protocol first published: Issue 3, 2006
Review first published: Issue 3, 2006
Date Event Description
20 March 2017 Amended Minor edits to the text and table to clarify that Sheffield
1978 study participants were at low risk of complica-
tions. We have made edits to the Included studies sec-
tion and the Characteristics of included studies table
for Sheffield 1978.
30 November 2016 Feedback has been incorporated The review authors have added a response to Feedback
2.
30 November 2016 New search has been performed Search updated - no new studies identified.
30 November 2016 New citation required but conclusions have not
changed
We have now incorporated updated methods includ-
ing the use of GRADE to assess the quality of the ev-
idence and inclusion of a summary of findings table
We have restructured the plain language summary to
incorporate standardised headings
We have change ’primary outcomes’ to ’main out-
comes’ and ’secondary outcomes’ to ’other important
outcomes’
The discussion has been updated in response to
Feedback 2.
30 September 2013 Feedback has been incorporated Feedback 2 received from Marco Panteghini.
31 December 2012 New search has been performed Search updated. Two trial reports identified. One new
study has been included (New Delhi 2006) and one is
awaiting classification (Greece 2012).
This review is now comprised of 13 included stud-
ies (involving over 37,000 women) and four excluded
studies
31 December 2012 New citation required but conclusions have not
changed
The inclusion of one new study has not changed the
results and conclusions of this review
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We incorporated updated methods including the use of GRADE to assess the quality of the evidence and inclusion of Summary of
findings for the main comparison as recommended by Cochrane’s MECIR standards.
We restructured the plain language summary to incorporate standardised headings in line with Cochrane Pregnancy and Childbirth
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We changed ’primary outcomes’ to ’main outcomes’ and ’secondary outcomes’ to ’other important outcomes’. We felt these terms were
appropriate for both ’plain language’ and to avoid any confusion with primary outcomes used in trials.
We used interaction tests to further explore the effect of quality of trials on the analyses.
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